VAERS Reports 027E22-A

VAERS 2723203

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: AR
Alter: 73,0
Geschlecht: F
Eingang: 12.12.2023
Impfdatum: 04.10.2022
Beginn: 11.12.2023
Tage bis Beginn: 433,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction COVID-19

Symptomtext

hospitalized with COVID

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: CAD s/p CABG, HTN, Diverticulitis, Hypothyroidism, HFpEF, and DMII presenting from an OSH with NSTEMI and COVID infection
Andere Medikamente: unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2658858

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: -
Alter: 57,0
Geschlecht: M
Eingang: 20.07.2023
Impfdatum: 03.10.2022
Beginn: 16.11.2022
Tage bis Beginn: 44,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure

Symptomtext

ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2655435

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

kritisch

Staat: -
Alter: 76,0
Geschlecht: F
Eingang: 12.07.2023
Impfdatum: 05.10.2022
Beginn: 12.04.2023
Tage bis Beginn: 189,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Asthma Hypertension

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/12/2023 HTN (HYPERTENSION) ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/12/2023 ASTHMA, UNSPECIFIED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2653208

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: -
Alter: 73,0
Geschlecht: F
Eingang: 06.07.2023
Impfdatum: 16.11.2022
Beginn: 06.03.2023
Tage bis Beginn: 110,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Hypotension

Symptomtext

HYPOTENSION ACUTE HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649937

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 27.06.2023
Impfdatum: 26.10.2022
Beginn: 01.12.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Symptom recurrence

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/15/2022 & 1/19/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649874

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

kritisch

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 27.06.2023
Impfdatum: 19.10.2022
Beginn: 21.03.2023
Tage bis Beginn: 153,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac failure congestive Pulmonary embolism

Symptomtext

I26.99 ACUTE PULMONARY EMBOLISM 3/19/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I26.99 ACUTE PULMONARY EMBOLISM 3/19/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2648816

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: -
Alter: 95,0
Geschlecht: M
Eingang: 23.06.2023
Impfdatum: 26.10.2022
Beginn: 28.12.2022
Tage bis Beginn: 63,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Chronic respiratory failure Respiratory failure

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642811

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: -
Alter: 82,0
Geschlecht: F
Eingang: 08.06.2023
Impfdatum: 18.10.2022
Beginn: 22.11.2022
Tage bis Beginn: 35,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure

Symptomtext

ACUTE RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642290

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: -
Alter: 86,0
Geschlecht: F
Eingang: 07.06.2023
Impfdatum: 03.10.2022
Beginn: 15.10.2022
Tage bis Beginn: 12,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Pulmonary embolism Symptom recurrence

Symptomtext

ACUTE PULMONARY EMBOLISM 11/7/2022 - RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2639078

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 31.05.2023
Impfdatum: 26.10.2022
Beginn: 17.12.2022
Tage bis Beginn: 52,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acidosis Acute myocardial infarction Acute respiratory failure Cardiac failure congestive Cardiogenic shock Pneumonia aspiration

Symptomtext

I21.4 ACUTE NON ST ELEVATION MI 2/14/2023 ASPIRATION PNEUMONIA J96.00 ACUTE RESPIRATORY FAILURE 2/8/2023 ASPIRATION PNEUMONIA R57.0 CARDIOGENIC SHOCK 2/14/2023 ASPIRATION PNEUMONIA I21.4 ACUTE NON ST ELEVATION MI 2/14/2023 CHF, STAGE D J96.00 ACUTE RESPIRATORY FAILURE 2/8/2023 CHF, STAGE D R57.0 CARDIOGENIC SHOCK 2/14/2023 CHF, STAGE D I21.4 ACUTE NON ST ELEVATION MI 2/14/2023 ACIDOSIS, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 2/8/2023 ACIDOSIS, UNSPECIFIED R57.0 CARDIOGENIC SHOCK 2/14/2023 ACIDOSIS, UNSPECIFIED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636852

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

kritisch

Staat: -
Alter: 75,0
Geschlecht: F
Eingang: 25.05.2023
Impfdatum: 08.10.2022
Beginn: 26.12.2022
Tage bis Beginn: 79,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Chronic respiratory failure Hypoxia Respiratory failure

Symptomtext

CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2609929

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: MN
Alter: 64,0
Geschlecht: F
Eingang: 05.04.2023
Impfdatum: 03.11.2022
Beginn: 18.12.2022
Tage bis Beginn: 45,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthma COVID-19 Chest pain Chronic obstructive pulmonary disease Condition aggravated Cough Dyspnoea Hypoxia SARS-CoV-2 test positive

Symptomtext

Patient with history of asthma and diabetes type II was seen in the ED on 12/18/22 for evaluation of difficulty breathing, shortness of breath, cough, and chest pain. She was found to be hypoxic at 86% and required oxygen supplementation. COVID-19 PCR test performed in the ED returned positive. She was admitted 12/18/22 - 12/22/22 for acute respiratory failure with hypoxia, COVID-19, and acute exacerbation of COPD and asthma, among other diagnoses. The provider suspects the COVID-19 infection triggered a COPD exacerbation which caused her acute respiratory failure. Patient was able to be weaned to room air prior to discharge. She is fully vaccinated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2580484

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: MO
Alter: 92,0
Geschlecht: M
Eingang: 13.02.2023
Impfdatum: 22.10.2022
Beginn: 29.12.2022
Tage bis Beginn: 68,0
Dosis: 4
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Covid-related death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: Diabetes
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2577316

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: MN
Alter: 87,0
Geschlecht: F
Eingang: 07.02.2023
Impfdatum: 30.09.2022
Beginn: 28.11.2022
Tage bis Beginn: 59,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Cough Dyspnoea Nasal congestion SARS-CoV-2 test positive

Symptomtext

Patient brought to the ED by EMS on 11/28/22 for shortness of breath, weakness, cough, and nasal congestion. Per EMS report, patient had blood oxygen of 85% so was placed on 4L en route. COVID PCR test done in the ED on 11/28 resulted positive. Patient admitted 11/28/22 - 11/30/22 for acute respiratory failure with hypoxia, pneumonia due to COVID-19, among other problems. Patient was weaned off O2 quickly and was able to be on room air.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565674

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

kritisch

Staat: WI
Alter: 71,0
Geschlecht: M
Eingang: 31.01.2023
Impfdatum: 11.10.2022
Beginn: 11.11.2022
Tage bis Beginn: 31,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Hemiparesis

Symptomtext

STROKE/ right side paralyses; This spontaneous case was reported by a patient and describes the occurrence of CEREBROVASCULAR ACCIDENT (STROKE/ right side paralyses) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Oct-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Nov-2022, the patient experienced CEREBROVASCULAR ACCIDENT (STROKE/ right side paralyses) (seriousness criterion medically significant). At the time of the report, CEREBROVASCULAR ACCIDENT (STROKE/ right side paralyses) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Company comment: This is a spontaneous case concerning 71 years old male patient, with no medical history, who experienced the unexpected serious (medically significant) AESI event of cerebrovascular accident, which occurred one month after the fourth dose of mRNA-1273. At the time of reporting event is not recovered. No further information on clinical course, lab data, treatment received. Patient elderly age could be risk factor for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565674

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: WI
Alter: 71,0
Geschlecht: M
Eingang: 31.01.2023
Impfdatum: 11.10.2022
Beginn: 11.11.2022
Tage bis Beginn: 31,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Hemiparesis

Symptomtext

STROKE/ right side paralyses; This spontaneous case was reported by a patient and describes the occurrence of CEREBROVASCULAR ACCIDENT (STROKE/ right side paralyses) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Oct-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Nov-2022, the patient experienced CEREBROVASCULAR ACCIDENT (STROKE/ right side paralyses) (seriousness criterion medically significant). At the time of the report, CEREBROVASCULAR ACCIDENT (STROKE/ right side paralyses) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Company comment: This is a spontaneous case concerning 71 years old male patient, with no medical history, who experienced the unexpected serious (medically significant) AESI event of cerebrovascular accident, which occurred one month after the fourth dose of mRNA-1273. At the time of reporting event is not recovered. No further information on clinical course, lab data, treatment received. Patient elderly age could be risk factor for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2557562

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: NH
Alter: 91,0
Geschlecht: F
Eingang: 11.01.2023
Impfdatum: 10.10.2022
Beginn: 07.01.2023
Tage bis Beginn: 89,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Bacterial infection Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Cardiac failure acute Cardiac failure congestive Cardiomegaly Chest X-ray abnormal Condition aggravated Culture urine positive Cystitis Diuretic therapy Dyspnoea Electrocardiogram normal Klebsiella test positive Left ventricular failure Myocardial ischaemia

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 1/7/2023 Discharge Date: Jan 10, 2023 COVID positive date: 01/07/2023 PRESENTING PROBLEM: Acute on chronic diastolic congestive heart failure (HCC) [I50.33] Acute cystitis without hematuria [N30.00] Acute respiratory failure with hypoxia (HCC) [J96.01] Acute on chronic respiratory failure (HCC) [J96.20] Community acquired pneumonia, unspecified laterality [J18.9] Sepsis with acute hypoxic respiratory failure without septic shock, due to unspecified organism (HCC) [A41.9, R65.20, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: 91yo female w/ h/o aortic stenosis and A-fib who presents from skilled nursing facility for shortness of breath. Of note, she had recently tested positive for COVID-19 on 1/6. The patient wears O2 at night. In the ED, initial labs were remarkable for BNP of 1930, WBC of 13.9, and procal of 0.27. CXR showed some cardiomegaly with pulmonary vascular congestion. High sensitivity troponin was elevated but flat and there were no EKG changes; troponin was discussed with cardiology and it was thought to be related to demand ischemia and not ACS. Patient was started on ceftriaxone and azithromycin, remdesivir, as well as steroids and lasix and admitted to the hospital. Patient was quickly able to go down to room air during the day. No bacterial pathogen was isolated and it was thought to be less likely that she was suffering from a secondary bacterial illness. She had a urine culture that had come back positive for klebsiella pneumonia and ABX were continued in the form of ceftriaxone. Patient had a good diuretic response to lasix but with her history of AS and avanced age, decision was made to to keep her on diuretics indefinitely as she appeared overall euvolemic. As the patient clinically improved, decision was made to transition her back to her skilled nursing facility. As she was on room air during the day, she was not continued on steroids. As she had completed 4 days of ABX for a UTI and there was less suspicion for a bacterial pneumonia, ABX were not continued. Lasix was continued for 3 more days. Patient was discharged in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Acute on chronic respiratory failure with hypoxia (HCC) Pneumonia due to COVID-19 virus Acute on chronic respiratory failure (HCC) Nonrheumatic aortic valve stenosis Essential (primary) hypertension Chronic heart failure with preserved ejection fraction (HCC) Paroxysmal A-fib (HCC) Dysphagia Protein-calorie malnutrition, unspecified severity (HCC) Acute cystitis without hematuria Urine retention Dehydration Hypoxemia Closed left hip fracture, sequela Pressure injury of coccygeal region, stage 4 (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet aluminum, magnesium & simethicone (MYLANTA) 200-200-20 MG/5ML SUSP suspension amiodarone (PACERONE) 200 MG tablet amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG enteric coated tablet furosemide (LASIX)
Allergien: NKA
Vorherige Impfungen: -

VAERS 2512485

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 027e22a

kritisch

Staat: IN
Alter: 73,0
Geschlecht: F
Eingang: 20.11.2022
Impfdatum: 13.10.2022
Beginn: 11.11.2022
Tage bis Beginn: 29,0
Dosis: 5
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Acute respiratory failure Angiogram pulmonary abnormal Anion gap Aortic dilatation Arteriosclerosis coronary artery Aspiration Basophil count normal Basophil percentage Blood chloride normal Blood creatinine normal Blood glucose normal Blood lactic acid normal Blood potassium normal Blood sodium normal Blood thyroid stimulating hormone decreased Blood urea increased Brain natriuretic peptide increased

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Encounter Info: Hospital, Inpatient, 11/11/22 - * Final Report * History of Present Illness/Subjective Chief complaint shortness of breath HPI: Patient is a 73-year-old female patient with history of heart failure with preserved ejection fraction, bronchiectasis, COPD, carcinoma of tongue, CVA, chronic hypotension, pulmonary hypertension and rheumatoid arthritis who presented to emergency department via EMS complaining of low blood pressure. Patient reported her blood pressure runs in systolic of 90s but notes it was running in the low 80s this morning. Patient reported lightheadedness and positional changes and dyspnea. Patient also reported several days of low oxygen and increased shortness of breath. She states that her oxygen has been dropping into the 70s. She is from a nursing home and staff reported the oxygen saturation in the 60s this morning patient is usually on 3 L nasal cannula. Patient also has been having yellow sputum and subjective fever and chills. Patient is followed by pulmonology for bronchiectasis. History of Pseudomonas complicated by meropenem causing seizures and tobramycin causing bronchospasm. Patient was last hospitalized in early October and was noted to use nebulizers and without any problems with those. Patient is currently at nursing home and also notes recent RSV breakout at the residence. Patient is DNR/DNI and comprehensive care. She presented with oxygen saturation of 67% on 3 L nasal cannula and hypotensive at 81/53. Patient was recently discharged from Hospital on October 7 where chief diagnoses included sepsis secondary to pneumonia COPD with exacerbation and chronic hypotension. She was treated with broad-spectrum antibiotics at that time. Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) None reported this timeframe Patient Weight Patient Height None Reported General: Alert and oriented, No Acute distress Eye: Pupils are equal, round and reactive to light HEENT: Normocephalic, atraumatic Neck: Supple, normal range of motion Oropharynx: No erythema or drainage. Respiratory: decreased air entry bilaterally, crackles bilaterally Cardiovascular: Normal rate, Regular rhythm. s1 s2 positive Gastrointestinal: Soft, Non-tender. BS present all 4 quadrants Musculoskeletal: Normal range of motion, No focal tenderness Integumentary: Warm, Dry, No rash Neurologic: No focal weakness. Sensation intact. Normal mood and affect. cranial nerves grossly intact Assessment/Plan 1. Acute on chronic respiratory failure J96.20 Patient usually wears 3 L nasal cannula at baseline currently requiring 65 L at 100% oxygen in the emergency room saturating in low 90s. -Acute respiratory failure is likely due to hospital-acquired pneumonia. -Cultures have been obtained and antibiotics have been started. -Continue with high flow nasal cannula patient is DO NOT INTUBATE DO NOT RESUSCITATE. -Our best hope is to continue with high flow nasal cannula and/or BiPAP. -Admit patient to ICU. 2. Severe sepsis with septic shock R65.21 Patient is having severe sepsis meets criteria due to having respiratory rate about 20 tachycardia and hypotension presenting blood pressure 81/53 which has gotten somewhat better to 106/66. -Sepsis bundle in place. -We were unable to give her much fluid because of her BNP being elevated at 945. -Start patient on normal saline 100 mL an hour. -Emergency room doctor has placed a central line. 3. Hospital-acquired pneumonia J18.9 Noted. Patient was recently discharged within last 30 days from our hospital to the nursing home where there is an RSV breakout. -We will start patient on broad-spectrum antibiotics as dictated by sepsis bundle -Follow-up on cultures, procalcitonin levels, Legionella and strep pneumo. -Follow-up on respiratory pathogen panel. 4. Bronchiectasis J47.9 Noted. Patient is seeing physician. -Provider recently have ordered for speech therapy evaluation for aspiration as well as sputum cultures and sputum AFB cultures. I do not see results of these unfortunately. -We will obtain these labs. 5. NSTEMI (non-ST elevated myocardial infarction) I21.4 Patient is likely having type II and STEMI. Patient's cardiac enzymes are elevated at 337 initially then to 520 likely due to severe sepsis. -Emergency room doctor was supposed to run this by cardiology. -We will obtain cardiology consult if needed at this time due to patient's acute respiratory failure with patient is not a candidate for any intervention other than medications. -Start patient on aspirin and Lipitor. 6. Acute on chronic heart failure with preserved ejection fraction (HFpEF) I50.33 Noted. Patient's BNP is quite elevated at 945 as compared to 200 something a month ago when patient was released from us. We will cautiously give her fluids to prevent overload but she requires fluids due to hypotension and severe sepsis with septic shock. -No need for another echo at this time. 7. Chronic hypotension I95.89 Noted 8. Hyperlipidemia E78.5 Resume home medications 9. Hypothyroid E03.9 Recent TSH was 0.948 about 1 month ago. -Resume home medications. Due to a high probability of clinically significant, life threatening deterioration, the patient required my highest level of preparedness to intervene emergently and I personally spent 72 minutes of critical care time directly and personally managing the patient. This critical care time included obtaining a history, examining the patient, pulse oximetry, ordering and reviewing the studies, arranging urgent treatment with development of a management plan, evaluation of the patient?s response to treatment, frequent reassessment, and discussions with other clinicians. The critical care time was performed to assess and manage the high probability of imminent, life-threatening deterioration that could result in multi-organ failure. It was exclusive of separately billable procedures and treating other patients and teaching time. Please see the MDM section and the rest of this note for further information on patient assessment and treatment. Code Status None Recorded Chronic Problem List (HFpEF) heart failure with preserved ejection fraction Allergic reaction due to correct medicinal substance properly administered Anxiety Atrophic vaginitis Bronchiectasis Carcinoma in situ of tongue Chronic diarrhea Chronic eczematoid otitis externa of both ears Chronic hypotension Chronic nausea Compression fracture of L1 vertebra COPD with exacerbation CVA (cerebrovascular accident) Depression Depression DNI (do not intubate) DNR (do not resuscitate) Dry eye syndrome Dysfunction of both eustachian tubes Dysphagia Emphysema/COPD Encounter for long-term (current) use of medications Excessive weight loss Fall Fibromyalgia GERD (gastroesophageal reflux disease) Hip fracture, right Hyperlipidemia Hypotension Hypothyroid Hypoxemia Insomnia Lung nodules Moderate mitral valve regurgitation Nontraumatic flexor tendon rupture Oral cancer Osteoporosis Pulmonary hypertension due to lung disease Rectocele Rheumatoid arthritis Right heart failure due to pulmonary hypertension Seizures Severe obesity Severe tricuspid valve regurgitation Status post myringotomy with tube placement of both ears Weight loss Procedure/Surgical History ?BMT (01/16/2020) ?cardiac catheterization (2020) ?colonoscopy (07/12/2017) ?Bone density scan (03/22/2017) ?Rt Thumb IPJ Fusion TAS 3/29/16 (03/29/2016) ?Lt Thumb IPJ Fusion, Partial Exc of Scaphoid TAS 12/1/2015 (12/01/2015) ?Re exc SCC Left ant tongue (02/01/2013) ?Colonoscopy (12/21/2011) ?Bx tongue by Dr. (06/09/2008) ?EGD with biopsy (03/03/2005) ?Bunion of left great toe ?Bunionectomy ?Bunionectomy ?Carpal tunnel release ?Cholecystectomy ?Foot ?Joint replacement ?knuckles replaced ?leg surgery / several surgeries ?mammogram and pap - pt REFUSES ?nodules removed ?R femur ?Rectocele ?Synovectomy ?Tubal ?Tubes Surgical History Internal 06/07/2021 Rectocele Repair 12/14/2020 Bronchoscopy Diagnostic 07/12/2017 Colonscpy Diagnostic/Screen 05/18/2017 Toe Amputation (Right) 10/14/2016 Bronchoscopy W Bronchial Alveoli Lavage Medications Home Medications (16) Active acetaminophen 500 mg oral tablet 1,000 mg = 2 Tablet, PRN, Orally, Q6H Ambien 10 mg oral tablet 10 mg = 1 Tablet, Orally, At Bedtime balsam Peru-castor oil topical ointment See Instructions, to buttocks topicaqlly every shift for wound care DME Lumbar Back Brace Not Applicable, Other, Unscheduled, LSO for L 1 compression fracture famotidine 20 mg oral tablet 20 mg = 1 Tablet, Orally, BID Imitrex 100 mg oral tablet 100 mg = 1 Tablet, PRN, Orally, ONCE Imodium A-D 2 mg oral tablet 4 mg = 2 Tablet, Orally, Q6H, after each loose stool isosorbide dinitrate 10 mg oral tablet 10 mg = 1 Tablet, Orally, TID Lexapro 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily midodrine 5 mg oral tablet 5 mg = 1 Tablet, Orally, TID, q 8 hrs for bp <90 mirtazapine 7.5 mg oral tablet 7.5 mg = 1 Tablet, Orally, At Bedtime, for appetite stimulant Misc Supplement See Instructions, prosource liquid nutritional supplement 30ml daily nitroGLYCerin 0.4 mg sublingual tablet 0.4 mg = 1 Tablet, PRN Ocuvite 1 Tablet, Orally, QAM Oyster Shell 1,250 mg, Orally, At Bedtime Synthroid 50 mCg (0.05 mg) oral tablet 50 mCg = 1 Tablet, Orally, Daily Active Scheduled Inpatient Medications NORepinephrine PREMIX + Sodium Chloride 0.9% PREMIX IV Titrate - See Comments 2.5013 mCg/min 11/11/22 One-Time Medications Given 11/10/22 00:00:00 TO 11/11/22 14:56:53 None Reported PRN Medications (0600 - 0559) from 11/10 - 11/11 None Reported Allergies Ativan (Swelling Facial, Swelling Pharyngeal) Amitiza ("Bone-chilling cold") Boniva (Kidney dysfunction) Decongestant (Rapid heart rate) Demerol. (Headache, Vomiting) Didronel (Heartburn) Dilaudid (Hives) Flagyl (Hand Swelling, Bone Pain) Fosamax (Bone pain, Heartburn) Protonix (Hives) Remicade ("Numerous") Stadol (Vomiting, Rash) Tolectin 600 (Hives) Viibryd (Fainting, Heart palpitations) Voltaren (Headache) acetaminophen (Sweating, Nausea, Flushing) clobetasol topical (Heart burn, Headache) dicloxacillin (Joint pain, Swollen hands, "Severe" Headache) hydroCHLOROthiazide (bone, joint pain) hydrocodone (Vomiting, Flushing) methotrexate (Nausea, "Severe" weight loss, Confusion) morphine (Headache) Actonel (not noted) Cats (not noted) Unlisted Material/Environmental Allergy (see comment) Social History Alcohol Current, Beer, 1-2 times per week Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment divorced x 3 children, quit smoking in 2007 G4P4, Lives with Children. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Arthritis: Mother. COPD: Father. Cancer: Father. Cancer of ovary: Sister. Depression: Father. Hypothyroid: Mother. Mood disorder: Father. Osteoporosis: Mother. Pulmonary fibrosis: Father. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 7.5 k/cumm (11/11/22 10:04:00) RBC: 4.44 million/cumm (11/11/22 10:04:00) Hgb: 13.9 GM/dL (11/11/22 10:04:00) Hct: 42.2 % (11/11/22 10:04:00) MCV: 95 fL (11/11/22 10:04:00) MCH: 31.4 pg (11/11/22 10:04:00) MCHC: 33 GM/dL (11/11/22 10:04:00) RDW: 14.6 % High (11/11/22 10:04:00) Platelet: 214 k/cumm (11/11/22 10:04:00) MPV: 8.1 fL (11/11/22 10:04:00) Neutrophils %: 68 % (11/11/22 10:04:00) Lymphocytes %: 22 % (11/11/22 10:04:00) Monocytes %: 9 % (11/11/22 10:04:00) Eosinophils %: 0 % (11/11/22 10:04:00) Basophils %: 1 % (11/11/22 10:04:00) Absolute Neutrophil: 5.1 k/cumm (11/11/22 10:04:00) Absolute Lymphocyte: 1.6 k/cumm (11/11/22 10:04:00) Absolute Monocyte: 0.7 k/cumm (11/11/22 10:04:00) Absolute Eosinophil: 0 k/cumm (11/11/22 10:04:00) Absolute Basophil: 0.1 k/cumm (11/11/22 10:04:00) Chemistry: Troponin-I High Sensitivity: 520 ng/L High (11/11/22 12:45:00) BNP Pl QN: 945 pg/mL High (11/11/22 10:04:00) Lactate Venous Pl QN: 1.8 mmol/L (11/11/22 10:04:00) Anion Gap, POC: 15 mmol/L (11/11/22 10:04:00) CO2, POC: 25 mmol/L (11/11/22 10:04:00) BUN, POC: 22 mg/dL High (11/11/22 10:04:00) Chloride, POC: 102 mmol/L (11/11/22 10:04:00) Creatinine, POC: 1 mg/dL (11/11/22 10:04:00) Estimated GFR (CKD-EPI, no race), POC: 59 mL/min/1.73m2 Low (11/11/22 10:04:00) Estimated CRCL (CG), POC: 48 mL/min Low (11/11/22 10:04:00) Glucose, POC: 100 mg/dL High (11/11/22 10:04:00) Potassium, POC: 4.7 mmol/L (11/11/22 10:04:00) Sodium, POC: 136 mmol/L (11/11/22 10:04:00) Coagulation: PT: 12.9 seconds (11/11/22 10:04:00) INR: 1.13 (11/11/22 10:04:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (11/11/22 10:14:00) Coronavirus SARS-CoV2 Rapid: Not Detected (11/11/22 10:14:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/11/2022 10:16 - XR Chest PA or AP Portable IMPRESSION:1. Faint airspace disease of the left costophrenic angle. This mayrepresent basilar atelectasis superimposed upon chronic lung diseaseor infiltrate.2. Similar diffuse coarse lung markings likely related to fibroticlung disease or emphysema.Thank you for consulting our team of subspecialty radiologists. Healthcare providers wishing to discussthis case further can contact the Cardio. For after-hours or emergency department cases, pleasecall. 11/11/2022 12:43 - CTA Chest Pulm Embolism W/IV Contrast IMPRESSION:1. Negative for pulmonary embolism.2. Main pulmonary artery is dilated which can be seen in pulmonaryarterial hypertension.3. Emphysema with diffuse bronchial wall thickening. There are areasof endobronchial debris/secretions within the lower lobes. Increasingsmall tree-in-bud nodularity and areas of consolidation within theinferior aspect of the right middle lobe and lingula as well asthroughout the lung bases. Appearance is favored to represent acomponent of aspiration pneumonitis.4. Similar ectasia of the ascending thoracic aorta.5. Three-vessel coronary artery atherosclerosis.Thank you for consulting our team of subspecialty radiologists. Healthcare providers wishing to discussthis case further can contact.For after-hours or emergency department cases, please call. Signature Line Electronically Signed on 11/11/22 16:21 ________________________________________________________

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2500473

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 07.11.2022
Impfdatum: 07.10.2022
Beginn: 04.11.2022
Tage bis Beginn: 28,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Anticoagulant therapy Asthenia Blood creatinine Blood urea Brain natriuretic peptide COVID-19 Chills Computerised tomogram thorax abnormal Condition aggravated Cough Dehydration Depression Dyspnoea Dyspnoea exertional Fatigue Fibrin D dimer increased Hypophagia

Symptomtext

Chief Complaint: Cough and shortness of breath Additional Medical History: Patient is a 78-year-old male with a history of coronary artery disease, asthma, COPD, arthritis and depression. He presented to the emergency room by EMS complaining of worsening cough and shortness of breath over the last 3 days. Patient states 3 days ago he developed a cough which has progressively become worse. He states the cough is productive at times of yellowish colored sputum. He feels short of breath especially with seen when he is coughing or moving around. He denies fever or chills or sick contacts with similar symptoms. The shortness of breath became significant just prior to arrival at which point he called EMS. EMS arrived on the scene to find the patient hypoxic at 85% on room air. He was transported to the hospital. On 2 L nasal cannula he is oxygenating at 93 to 95%. He is otherwise alert and appropriate. He is in mild distress on presentation. He denies any chest discomfort or swelling of his lower extremities. He quit smoking 25 years ago. Associated Symptoms: cough, depression, fatigue, palpitations, shortness of breath, sputum, weakness, wheezing

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: 2:40 PM patient did respond nicely to oxygen through the nasal cannula at 2 L/min. He will have a full work-up for pneumonia including cardiac enzymes, BNP and D-dimer. He will have blood cultures, lactic acid and COVID testing. Patient will have a nebulizer treatment and steroid given here in the emergency room while we await further testing. 3:11 PM patient is positive for COVID. He also has an elevated D-dimer over 900. Patient will have routine CTA of the chest for further evaluation to rule out a pulmonary embolism. He will require admission for further care and treatment. He continues to rest comfortably at this time and oxygenating well on nasal cannula. 4:59 PM CT of the chest shows multifocal pneumonia with a right lower lobe consolidation. No evidence of pulmonary embolism. The case was discussed with Dr. who accepted the admission for further care and treatment. Problem 1: Acute respiratory failure due to COVID-19 Plan 1: The patient presented with a 3-4 days history of upper respiratory symptoms including productive cough shortness of breath shaking chills. Patient was found to have COVID 19. The patient is vaccinated and booster which make his risk of deterioration less severe. He responded nicely to oxygen continue with the steroids oxygen breathing treatment. Problem 2: Bilateral pneumonia Plan 2: Superimposed on COVID-19. The CT scan clearly showed bilateral scattered focal consolidation consistent with bacterial pneumonia. Patient does have leukocytosis and tachycardia consistent with sepsis. The patient received the fluids antibiotics steroids awaiting culture and sensitivity to adjust oral antibiotics. Problem 3: Dehydration, moderate Plan 3: Patient had decreased p.o. intake and he has a bump in his BUN and creatinine. He received bolus in the emergency room I will continue with the fluid resuscitation. His tachycardia already improved. Problem 4: DVT prophylaxis
Aktuelle Erkrankungen: unknown
Vorgeschichte: CAD Asthma arthritis COPD arrhythmia
Andere Medikamente: Not Currently Taking Home Medications.
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2474244

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

kritisch

Staat: VA
Alter: 64,0
Geschlecht: M
Eingang: 10.10.2022
Impfdatum: 03.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebral haemorrhage Computerised tomogram head abnormal Limb discomfort Magnetic resonance imaging head abnormal Malaise Mobility decreased Musculoskeletal discomfort Seizure

Symptomtext

Started feeling unwell on Wednesday, two days after injection. On Thursday he said his left arm/shoulder felt weird. The following day he was taken to the hospital by ambulance, with loss of mobility in his left side limbs. He experienced 2 seizures in the following 24 hours, and MRI revealed bleeding on the brain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 4,0
Labordaten: CT, MRI
Aktuelle Erkrankungen: Metastatic bladder cancer
Vorgeschichte: -
Andere Medikamente: Zofran, trazodone, miralax
Allergien: -
Vorherige Impfungen: -

VAERS 2658261

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 19.07.2023
Impfdatum: 06.10.2022
Beginn: 16.02.2023
Tage bis Beginn: 133,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Bell's palsy

Symptomtext

RIGHT BELLS PALSY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2612384

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: WA
Alter: 39,0
Geschlecht: F
Eingang: 10.04.2023
Impfdatum: 07.10.2022
Beginn: 27.01.2023
Tage bis Beginn: 112,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Biopsy heart normal Cardiac operation Cardiac ventricular disorder Catheterisation cardiac abnormal Complications of transplanted heart Coronary artery dissection Haemorrhage Heart transplant Intensive care Neuropathy peripheral Oxygen saturation abnormal Peroneal nerve palsy Resuscitation

Symptomtext

On January 27,2023 I experienced a spontaneous coronary artery dissection in the midst of that I erected and was picked up by the paramedics. I underwent a catheter lab and both left ventricles had dissected from my arteries. The doctors decided to connect me to a machine to reoxygenated my blood. I was transferred to the ICU, and when I was operating room, I bled out and had to be revived. I was centrally canulated unorder to re. I came out of surgery with left foot drop and neuropathy. I was then put on the heart transplant list. I had a heart transplant on February 20, 2023, and they had to leave my chest open for three days because the heart was too big. I will continue to have cardiac biopsy every two weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 64,0
Labordaten: 20FEB2023-Now - Cardiac Biopsy - Normal Hemodynamic Status
Aktuelle Erkrankungen: N/A
Vorgeschichte: Immunosuppressed; Heart Failure
Andere Medikamente: Advil; Ubrely; Zyxal
Allergien: Neosporin; Lisinopril; Dairy; Pineapples; Shellfish; Eggs; Indoor Allergies; Outdoor Allergies
Vorherige Impfungen: -

VAERS 2611511

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: WA
Alter: 68,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 12.10.2022
Beginn: 13.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cyclic vomiting syndrome Malaise SARS-CoV-2 test positive Tachycardia Viral pericarditis

Symptomtext

The day after the vaccine I felt general malaise. About a month later I came down with cyclical vomiting syndrome that the doctor attributed to COVID-19. I was vomiting everyday twice a day for two months. After that I developed to tachycardia. I just recently came out of the hospital with viral pericarditis which they say develops in patients that have had COVID-19 or the vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Viral pericarditis
Hospital-Tage: 4,0
Labordaten: 14OCT2022 COVID-19 at home test positive; 04NOV2022 COVID-19 rapid test positive; 03APR2023 COVID-19 rapid test negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypothyroidism
Andere Medikamente: Levothyroxine; atorvastatin; omeprazole; vitamin C; multivitamin; calcium; probiotic
Allergien: Seasonal allergies; sulfa; penicillin
Vorherige Impfungen: -

VAERS 2610433

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: WA
Alter: 62,0
Geschlecht: M
Eingang: 05.04.2023
Impfdatum: 04.10.2022
Beginn: 01.12.2022
Tage bis Beginn: 58,0
Dosis: 5
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Deep vein thrombosis Gait disturbance Swelling Ultrasound scan abnormal

Symptomtext

I was diagnosed with a Deep Vein Thrombosis. I recognized it and went to the ER. They called in an ultrasound and confirmed it. They prescribed Eliquis. I started it that day. In a follow-up with my PCP, I pointed out that the swelling had not gone down, so he set me up for another ultrasound. I could barely walk for the first week. Three months later, I'm walking fine, but the second ultrasound showed little to no improvement. Currently, the swelling has gone down considerably, and I'm on blood thinners.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: 12/2022 Ultrasound - Confirmed Partially Occlusive Thrombus; 03/01/2023 Ultrasound - Confirmed Partially Occlusive Thrombus
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; High Cholesterol; Splenectomy and Pancreas removal due to previous Cancer diagnosis; Hemochromatosis; Vertigo
Andere Medikamente: Simvastatin; Omeprazole; Losartan; Aspirin; Sucralfate; Multivitamin; Glucosamine Chondroitin; Biotin
Allergien: Gluten; Bee Venom; Soap; Latex
Vorherige Impfungen: -

VAERS 2517320

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: MN
Alter: 58,0
Geschlecht: M
Eingang: 26.11.2022
Impfdatum: 14.10.2022
Beginn: 07.11.2022
Tage bis Beginn: 24,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy

Symptomtext

Bell's Palsy, onset 11/07/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Clinical exam
Aktuelle Erkrankungen: None
Vorgeschichte: HTN, Hyperlipidemia, GERD
Andere Medikamente: HCTZ, Lipitor, Protonix, Flomax, Zyrtec
Allergien: PCN
Vorherige Impfungen: -

VAERS 2509496

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: KS
Alter: 75,0
Geschlecht: M
Eingang: 16.11.2022
Impfdatum: 28.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Chest X-ray normal Dyspnoea Intensive care Interstitial lung disease Palpitations Pulmonary fibrosis

Symptomtext

Patient's brother and sister in law came to the pharmacy this morning inquiring about the Moderna Bivalent Booster and Fluad he received on 9/28/22. Patient's brother said that the day after his brother had his IMZ series he started having difficulty in breathing and palpitations. He went into a walk in clinic on 10/10/22 and the prescriber gave him a script of prednisone, azithromycin, and benzonatate. He saw his primary care on 10/20/22, had chest x-rays which were negative for pneumonia, and was given a rx for Medrol DP. He was given a week's supply of furosemide the next day. Patient has been in the hospital for the last 18 days and in the ICU recently with interstitial lung disease and pulmonary fibrosis. Patient is in critical care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 18,0
Labordaten: uncertain
Aktuelle Erkrankungen: uncertain
Vorgeschichte: uncertain
Andere Medikamente: ATORVASTATIN 40MG TAB, AMLODIPINE 5MG TAB, PROZAC 20MG CAP, PROZAC 20MG CAP, CLONAZEPAM 0.5MG TAB, GABAPENTIN 100MG CAP. Above listed are medications he has been on most recently. I cannot confirm compliance or su
Allergien: none known
Vorherige Impfungen: -

VAERS 2494533

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

schwer

Staat: AZ
Alter: 11,0
Geschlecht: M
Eingang: 31.10.2022
Impfdatum: 29.10.2022
Beginn: 29.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

patient fainted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2486204

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: AZ
Alter: 69,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 14.10.2022
Beginn: 18.10.2022
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Blood test Computerised tomogram head normal

Symptomtext

Bell's Palsy - Emergency Room Visit - still in treatment (physical therapy, PO steroids, anti-viral)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: CT of the head clear, blood work 10/18/2022
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes, Hypertension, COPD
Andere Medikamente: Metformin, Lantus, Glipizide, Lisinopril, Aspirin 81, Ropirinole, Metoprolol, Gabapentin
Allergien: Levaquin IV solution
Vorherige Impfungen: -

VAERS 2477075

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: WA
Alter: 30,0
Geschlecht: F
Eingang: 12.10.2022
Impfdatum: 08.10.2022
Beginn: 08.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Electrocardiogram normal Laboratory test normal Myalgia Nausea Syncope

Symptomtext

PATiENT DEVELOPED MYALGIAS, NAUSEA + DiZZiNESS WHILE SITTING ABOUT 6 HOURS AFTER RECEIPT OF COVID BIVALENT VACCINE + SYNCOPE, SEEN IN ER + AT CLINIC HEALTH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: NORMAL LABS + EKG
Aktuelle Erkrankungen: noNE
Vorgeschichte: ASTHMA
Andere Medikamente: ALBUTEROL, SPIronoLAcToNE, BREO ELLIPTA, MIRENA IUD
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2476156

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

schwer

Staat: OH
Alter: 72,0
Geschlecht: F
Eingang: 12.10.2022
Impfdatum: 06.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Angiogram cerebral Blood test Cervical vertebral fracture Computerised tomogram neck Contusion Dizziness Dysstasia Electrocardiogram Eye contusion Face injury Fall Fatigue Malaise Nausea Somnolence Syncope

Symptomtext

Next morning I felt dizzy, nausea and generally unwell at 6 am. Got up to use bathroom and fainted after sitting on toilet. Fell forward and hit head left forehead. Could not stand and crawled about 40 feet back to bed. At 9:30 am tried to get up again and felt like I would faint again. Called my PCP and was referred to ER. where CT's found I fractured my neck at C4. I have contusions and bilateral black eyes and continue to feel sleepy and fatigued. I have to wear an Aspen collar until I see a spine surgeon next week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Bloodwork, EKG, 2 CT's, one an angiogram of brain.
Aktuelle Erkrankungen: none
Vorgeschichte: had Covid in July with complications a month later.
Andere Medikamente: Levothyroxine ; Prilosec 40 mg every other day; Centrum silver daily; Biotin daily; Zoloft 25mg daily; Vitamin D daily, Spironolactone daily
Allergien: Doxycycline and Flovent, codeine
Vorherige Impfungen: Pneumonia Vaccine , pain, I fainted

VAERS 2693399

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge 027E22A

moderat

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 10.10.2023
Impfdatum: 10.10.2022
Beginn: 12.09.2023
Tage bis Beginn: 337,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Adult failure to thrive Asthenia Bacterial test positive Bladder cancer Blood creatinine increased Blood folate normal Blood magnesium normal Blood phosphorus normal Blood pressure increased Blood thyroid stimulating hormone normal COVID-19 Chest X-ray normal Cough Culture urine negative Cystoscopy abnormal Dehydration Dysphagia

Symptomtext

Patient is a 84 y.o. male patient, MD insert to Medical Center with difficulty swallowing foods and recent diagnosis of bladder cancer. Dysphagia Esophageal Strictures Ongoing difficulty swallowing both food, meds and liquids with Sensation of food and liquids getting stuck in his throat. Recent admission for same, reports no improvement since treatment EGD from 08/28/23 showing stenosis of distal esophagus status post dilation x2. Transferred to MC for GI evaluation - consulted GI ordered ST consult for MBS (just seen by ST last admission and thought esophageal etiology) followed by Barium esophagram ST chopped/thin; 2-3 Barium Esophagram 9/14 Tertiary contractions with a questionable stricture involving the distal esophagus, which could be secondary to tertiary contractions with underlying mass not excluded No longer taking linzess since august Started chopped/thin diet. Changed meds to po Pt still reports globus sensation and not eating S/p EGD 9/18 - severe esophageal stenosis at 29 cm, dilated with 12 to 15 mm balloon GI consulted - PPI, repeat EGD with further dilatation in 8 weeks. If symptoms return, then follow up with thoracic surgery for possible stent Tolerating diet AKI 9/11 Cr 2.08, secondary to poor po intake/prerenal Baseline ~ 1.1 Creatinine trending down 1.62, stable Encourage oral intake, IVF stopped 9/19 Nephrology consulted Discussed with urology and Nephrology, outpatient follow with repeat renal function panel next week. If no improvement or worsens, consider right ureteral stent. UTI 100.2 9/17 +urinary frequency CXR negative UA +small leuk, WBC 17, rare bacteria urine culture no growth received ceftriaxone in the hospital. Discharged on Omnicef to complete 5 days Monitor Covid-19 Virus Infection Date of onset of symptoms: 9/17 Symptoms present on admission: fever, cough Date of covid positive test: 9/20 Vaccination status: vaccinated Imaging: CXR - negative Oxygen requirements on admission: RA Current oxygen requirements: 2 Medical therapy: steroids. Discharged on decadron to complete 10 days Anticipated special isolation end date: 9/22 Generalized weakness Malnutrition FTT No focal neurologic deficits. Likely multifactorial ( malnutrition, dehydration AKI, deconditioning). Dietician consulted Unremarkable TSH, LFT, B12/folate, phos, mag A1c 5.6 PT/OT consulted - 2-3 Encourage oral intake Urothelial carcinoma with peritoneal meds Intermittent hematuria Also compatible with lung primary - onc evaluating Diagnosed with cystoscopy on 08/31/23. Associated with peritoneal carcinomatosis. Status post TURBT on 09/05/23 Pathology poorly differentiated carcinoma. Patient supposed to see oncology team in 2 days Oncology consulted - PET outpatient, Tempus ordered Final treatment plan outpatient once this data obtained, onc spoke to patient and family Patient/wife requested urology consult as postop appt scheduled 9/18 Abnormal urinalysis Urinalysis positive for nitrite, leukocyte esterase, WBCs. In setting of recent TURBT ( 09/05/23). Afebrile, no leukocytosis. Denied dysuria or suprapubic pain IV ciprofloxacin started at outside facility, discontinued 9/13 as not clinically consistent with UTI Urine culture negative. Elevated troponin Troponin elevated at outside facility, but flat (84 and 71). In setting of AKI, dehydration, metabolic derangements Per records, chronic, elevated. No chest pain or shortness of breath on presentation. Hemodynamically stable. EKG unchanged from previous. Echocardiogram from 08/2023 with a normal systolic function (EF of 65%) and no significant valvular abnormalities. No further evaluation COPD No exacerbation On RA, dulera, nebs prn, pulm toilet, nebs prn (on albuterol and Brezti at home) Essential HTN Blood pressure still elevated Increased norvasc to 10mg po daily Chronic Anemia - normocytic anemia Iron Deficient and ANemia of chronic disease Hgb 10.5 on admission Baseline about 11 Onc consulted, ordered iron given intermittent hematuria Venofer ordered x2 9/14, last dose 9/15 - start oral iron when able to better take po

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649863

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

moderat

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 27.06.2023
Impfdatum: 27.10.2022
Beginn: 14.04.2023
Tage bis Beginn: 169,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral arteriosclerosis Hypotension

Symptomtext

I95.9 HYPOTENSION 4/20/2023 CEREBRAL ATHEROSCLEROSIS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2647997

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

moderat

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 21.06.2023
Impfdatum: 29.09.2022
Beginn: 04.11.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension

Symptomtext

HYPOTENSION

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2639634

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

moderat

Staat: PA
Alter: 70,0
Geschlecht: M
Eingang: 01.06.2023
Impfdatum: 19.10.2022
Beginn: 01.03.2023
Tage bis Beginn: 133,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Lethargy Neuralgia Paraesthesia Rash SARS-CoV-2 test positive

Symptomtext

I had no reaction to the Moderna vaccine for Dose 5. On 01/20/2023, I was exposed to COVID-19 at a crowded business. I tested positive for COVID-19 on 01/23/2023. My primary symptom was feeling lethargic. I contacted my doctor, but he did not give me a prescription. I don't remember taking anything to help me with my COVID-19 symptoms. On 03/24/2023, I had nerve tingling on my right thigh but no rash. On 03/26/2023, the tingling was more intense, and the rash appeared. I called my doctor on 03/27/2023 and gave me a prescription that I can't remember the name. On 03/30/2023, the rash got better but the tingling/nerve pain was worse. In 04/2023, I got a prescription for Gabapentin, and I felt much better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: 23JAN2023 COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Multivitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2638356

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027e22a

moderat

Staat: -
Alter: 80,0
Geschlecht: F
Eingang: 30.05.2023
Impfdatum: 13.10.2022
Beginn: 25.05.2023
Tage bis Beginn: 224,0
Dosis: 4
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Alanine aminotransferase increased Angiogram pulmonary abnormal Anion gap Arteriosclerosis Aspartate aminotransferase increased Atrial fibrillation Basophil count normal Basophil percentage Blood albumin normal Blood alkaline phosphatase increased Blood bicarbonate increased Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood potassium normal Blood sodium normal

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on May 24, 2023 23:40 EDT Verified By: MD on May 24, 2023 23:40 EDT Encounter Info: Hospital, Observation, 05/25/23 - 05/29/23 * Final Report * Document Has Been Revised Chief Complaint Cough History of Present Illness/Subjective 81-year-old female with dementia coming from skilled nursing facility with cough. Cough, nonproductive, x1 week, mild to moderate, with associated decreased activity and lethargy. Right basilar infiltrate noted on CT. White blood cell count is normal but there are increased polymorphonuclear cells. Serum bicarbonate 31, mildly elevated AST and ALT as well as alkaline phosphatase. Troponin is 18 and flat. Serum bicarbonate 28, renal function normal. CT 1. Abdominal aorta: Again seen is a penetrating atherosclerotic ulcer at the descending thoracic aorta which has enlarged since 7/6/2022. Recommend consideration for endovascular repair. 2. Severe atherosclerotic calcifications through the major arteries in the abdomen and pelvis without definite critical stenosis or occlusion within limitations of the exam. The ascending aorta measures 3.4 x 3.5 cm in diameter. Aneurysmal dilatation of the proximal descending thoracic aorta to 3.5 cm is noted. There is a penetrating ulcer of the lower descending thoracic aorta measuring 1.2 x 1.6 x 2.6 cm. Previously, this measured 1.2 x 1.6 x 2.3 cm. There has been interval enlargement from 2022 but statistically speaking, minimal enlargement. The ED provider reached out to regional hospital, vascular surgery, declined patient transfer as not indicated, nothing to do related to the above findings regarding the aorta, at least not in an acute or emergent fashion. Quit smoking about 3 years ago. Not on home oxygen. No recent antibiotics. She does come from skilled nursing facility. No history of coughing or choking while eating or drinking. No history of dysphagia. Review of Systems Denies fever, chills, chest pain, hemoptysis. No abdomen pain nausea vomiting. Remaining 10 point review of systems negative except as noted above. Physical Exam/Objective Vitals & Measurements most recent past 24 hours Hemodynamics Neurologic Patient Weight Patient Height None Reported Constitutional: No acute distress, well-nourished Eyes: PERRLA normal conjunctiva ENMT: Mucous membranes are dry Neck: Supple, no JVD Respiratory: Good airflow, rales on the right side Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan 1. Healthcare-associated pneumonia J18.9 Nontoxic, no acute distress, infiltrate throughout the right lung. Does not describe history of dysphagia, however, will treat as healthcare associated pneumonia which will also cover for possible aspiration. Will cover with Zosyn, vancomycin, doxycycline for atypicals. Urine antigens. Cultures. Although the patient's daughter denies any history of aspiration or signs suggestive of aspiration/dysphagia, we will go ahead and cover accordingly given age, dementia, radiographic findings. 2. Abnormal CT scan R93.89 Only slight interval increase in known aneurysm, outside vascular surgery indicates no acute needs. Noted. Follow-up as outpatient. 3. Hypertension I10 Blood pressure soft, will gently hydrate and hold antihypertensives 4. Dementia F03.90 Actually does fairly well, she is at the nursing home, uses a walker for ambulation, gets around okay. She actually has decent recollection and is alert and oriented at this time. Of note, the family is somewhat dissatisfied with Facility and would like to look at alternate options, will request case management consultation. 5. Hypoxia R09.02 Supplement and titrate, goal 90% or greater 6. Benign essential hypertension I10 Hold antihypertensives, gently hydrate 7. Paroxysmal atrial fibrillation: Continue amiodarone, apixaban Full code Apixaban 2.5 mg twice daily Code Status Full code Chronic Problem List Abnormal CT scan Alkaline phosphatase raised Bleeding nose Compression fracture of lumbar spine, non-traumatic Compression fracture of spine Cough Elevated alkaline phosphatase level Elevated liver function tests Elevated tumor markers Falling episodes Health care maintenance History of seizures Hypertension Hypotension Hypoxia Low blood pressure reading Memory loss Osteopenia Ovarian ca Ovarian cyst Weight loss Medications Home Medications (27) Active acetaminophen 325 mg oral tablet 650 mg = 2 Tablet, PRN, Orally, Q4H Advair HFA 115mCg-21mCg/inh inhalation aerosol 2 Puff, Inhalation, BID albuterol HFA MDI 90mCg/puff inhalation aerosol 2 Puff, PRN, Inhalation, 4 Times Daily amiodarone 200 mg oral tablet 200 mg = 1 Tablet, Orally, Daily apixaban 2.5 mg oral tablet 2.5 mg = 1 Tablet, Orally, BID Aricept 5 mg oral tablet 5 mg = 1 Tablet, Orally, At Bedtime aspirin 81 mg oral tablet 81 mg = 1 Tablet, Orally, Daily atorvastatin 40 mg oral tablet 40 mg = 1 Tablet, Orally, QHS benzonatate 200 mg oral capsule 200 mg = 1 Capsule, PRN, Orally, TID bisacodyl 10 mg rectal suppository 10 mg = 1 Suppository, Rectally, Daily Breo Ellipta 100 mCg-25 mCg inhalation powder Breo Ellipta 100 mCg-25 mCg inhalation powder Breo Ellipta 100 mCg-25 mCg inhalation powder 1 Puff, Inhalation, Daily cetirizine 10 mg oral capsule dextromethorphan-guaiFENesin-PE 10 mg-100 mg-5 mg/5 mL oral syrup 5 mL, Orally, Q4H ergocalciferol (vitamin D2) 1.25 mg (50,000 intl units) oral capsule 50,000 Units = 1 Capsule, Orally, Every Month furosemide 20 mg oral tablet 20 mg = 1 Tablet, Orally, Daily guaiFENesin-dextromethorphan 200 mg-10 mg/5 mL oral liquid 5 mL, PRN, Orally, Q4H leveTIRACetam 100 mg/mL intravenous solution 500 mg, Orally, BID metHIMazole 5 mg oral tablet 5 mg = 1 Tablet, Orally, Daily metoPROLOL tartrate , Give 12.5 miligram by mouth three timesa day MiraLax oral powder for reconstitution 17 GM, Orally, Daily, dissolve in water before taking Potassium Chloride (Eqv-K-Tab) 8 mEq, Orally, BID senna 8.8 mg/5 mL syrup , Orally, Daily Spiriva Respimat 2.5 mCg/inh inhalation aerosol (60 actuations) 5 mCg = 2 Puff, Inhalation, Daily, 2 puffs daily Synthroid 50 mCg (0.05 mg) oral tablet 50 mCg = 1 Tablet, Orally, Daily Zoloft 25 mg oral tablet 25 mg = 1 Tablet, Orally, Daily Active Scheduled Inpatient Medications None Reported One-Time Medications Given 05/23/23 00:00:00 TO 05/24/23 23:40:43 None Reported PRN Medications (0600 - 0559) from 05/23 - 05/24 None Reported Allergies Flexeril (confusion/hallucinations) Thimerosal (unknown) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment Facility Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Breast cancer: Grandmother (M). Cerebrovascular accident: Mother. Colorectal cancer: Father. High blood pressure: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 10.2 k/cumm (05/24/23 13:30:00) RBC: 4.23 million/cumm (05/24/23 13:30:00) Hgb: 12.3 GM/dL (05/24/23 13:30:00) Hct: 38.1 % (05/24/23 13:30:00) MCV: 90 fL (05/24/23 13:30:00) MCH: 29.1 pg (05/24/23 13:30:00) MCHC: 32.2 GM/dL (05/24/23 13:30:00) RDW: 15.9 % High (05/24/23 13:30:00) Platelet: 377 k/cumm (05/24/23 13:30:00) MPV: 8.2 fL (05/24/23 13:30:00) Neutrophils %: 79 % (05/24/23 13:30:00) Lymphocytes %: 7 % (05/24/23 13:30:00) Monocytes %: 12 % (05/24/23 13:30:00) Eosinophils %: 1 % (05/24/23 13:30:00) Basophils %: 1 % (05/24/23 13:30:00) Absolute Neutrophil: 8.1 k/cumm High (05/24/23 13:30:00) Absolute Lymphocyte: 0.7 k/cumm Low (05/24/23 13:30:00) Absolute Monocyte: 1.2 k/cumm (05/24/23 13:30:00) Absolute Eosinophil: 0.1 k/cumm (05/24/23 13:30:00) Absolute Basophil: 0.1 k/cumm (05/24/23 13:30:00) Chemistry: Sodium SerPl QN: 140 mmol/L (05/24/23 13:30:00) Potassium SerPl QN: 3.7 mmol/L (05/24/23 13:30:00) Chloride SerPl QN: 101 mmol/L (05/24/23 13:30:00) Carbon Dioxide SerPl QN: 28 mmol/L (05/24/23 13:30:00) Anion Gap: 11 mmol/L (05/24/23 13:30:00) BUN SerPl QN: 31 mg/dL High (05/24/23 13:30:00) Creatinine SerPl QN: 1.13 mg/dL (05/24/23 13:30:00) Estimated GFR (CKD-EPI, no race): 49 mL/min/1.73m2 Low (05/24/23 13:30:00) Estimated CRCL (CG): 26 mL/min Low (05/24/23 13:30:00) Glucose SerPl QN: 116 mg/dL High (05/24/23 13:30:00) Calcium Total SerPl QN: 9.8 mg/dL (05/24/23 13:30:00) Alkaline Phos SerPl QN: 140 Units/L High (05/24/23 13:30:00) ALT SerPl QN: 98 Units/L High (05/24/23 13:30:00) AST SerPl QN: 92 Units/L High (05/24/23 13:30:00) Bilirubin Total SerPl QN: 1 mg/dL (05/24/23 13:30:00) Total Protein SerPl QN: 7.4 GM/dL (05/24/23 13:30:00) Albumin SerPl QN: 3.9 GM/dL (05/24/23 13:30:00) Troponin-I High Sensitivity: 15 ng/L High (05/24/23 14:14:00) Coagulation: D-Dimer Pl QN: 323 ng/mL DDU High (05/24/23 13:30:00) Diagnostics Radiology Results - Last 24 hours Across Visits 05/24/2023 13:50 - XR Chest PA or AP Portable IMPRESSION:Mild, stable cardiomegaly.Mild interstitial changes in the lungs appear chronic.No consolidating infiltrates or other acute findings. 05/24/2023 15:34 - CTA Chest Pulm Embolism W/IV Contrast IMPRESSION:1. Negative for pulmonary embolism.2. Bilateral lower peri-bronchial thickening consistent with largeairway disease, likely infectious/inflammatory.3. Right lower lobe airspace disease suggestive of pneumonia4. Cardiomegaly5. Interval enlargement of penetrating ulcer of the descendingthoracic aorta. Consideration should be given to endovascular repair.Thank you for consulting our team of subspecialty radiologists Radiology. 05/24/2023 19:01 - CTA Aorta Runoff W/IV Contrast IMPRESSION:1. Abdominal aorta: Again seen is a penetrating atheroscleroticulcer at the descending thoracic aorta which has enlarged since7/6/2022. Recommend consideration for endovascular repair.2. Severe atherosclerotic calcifications through the major arteriesin the abdomen and pelvis without definite critical stenosis orocclusion within limitations of the exam.3. Lower extremities: Limited study due to venous contamination,motion degradation, and extensive atherosclerotic calcifications. Nofrank occlusion within the major vessels of the thigh or poplitealarteries. Limited assessment of the popliteal artery branches in thecalf. Conventional angiography may be more appropriate for assessingsignificant stenosis.Thank you for consulting our team of subspecialty radiologists Radiology. Signature Line Electronically Signed on 05/24/23 23:40 EDT ________________________________________________________ MD Electronically Signed on 05/25/23 01:26 EDT ________________________________________________________ MD Electronically Signed on 05/25/23 01:36 EDT ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Essential hypertension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2632945

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: CT
Alter: 77,0
Geschlecht: F
Eingang: 17.05.2023
Impfdatum: 14.12.2022
Beginn: 28.04.2023
Tage bis Beginn: 135,0
Dosis: 6
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dyspnoea Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

She did not have an adverse reaction to the vaccine. She tested positive for COVID-19 on 04/28/2023. She was having trouble breathing and low oxygen level. She went to the hospital for eight days. She was discharged from the hospital to a residential facility for physical therapy due to Alzheimer's Disease.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 8,0
Labordaten: 28APR2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Alzheimer's Disease
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2624401

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

moderat

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 27.10.2022
Beginn: 15.02.2023
Tage bis Beginn: 111,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Atelectasis Chest X-ray abnormal Pneumonia Secretion discharge

Symptomtext

I caught something from someone not sure what it was , that let to pneumonia and then it went to infection in the lungs. I had mucus at the bottom of my lung, they changed my medication and gave me an inhaler.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: 14MAR2023- X-ray- Pneumonia; 13APR2023 X-ray- Atelectatic
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2621074

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: WA
Alter: 70,0
Geschlecht: F
Eingang: 25.04.2023
Impfdatum: 11.10.2022
Beginn: 11.04.2023
Tage bis Beginn: 182,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal Dizziness Hypertension

Symptomtext

I was lightheaded and my blood pressure was really high, 200/120. It happened on April 10th and 11th, 2023. I went to the emergency department. I was in the emergency department for about 3 hours and was not treated with anything other than rest. My blood pressure came down on its own and I was discharged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: Blood panels, normal, 04/11/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Lisinopril; Inhaler Ventolin; Claritin; Calcium; Magnesium
Allergien: Ibuprofen; Naproxen; Pistachios; Hazelnut; Macadamia; Cashews; Mangos; Gluten
Vorherige Impfungen: -

VAERS 2620044

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: GA
Alter: 67,0
Geschlecht: F
Eingang: 24.04.2023
Impfdatum: 14.10.2022
Beginn: 13.03.2023
Tage bis Beginn: 150,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Anaemia Arteriogram coronary abnormal Blood test Bundle branch block left Computerised tomogram heart abnormal Dyspnoea Echocardiogram abnormal Electrocardiogram abnormal Exposure to communicable disease Fatigue Haemoglobin decreased Intracardiac thrombus Oropharyngeal pain Pneumonia Respiratory syncytial virus infection Respiratory syncytial virus test positive Respiratory tract congestion Sepsis

Symptomtext

I got symptoms of congestion, sore throat, and fatigue. I went to the nearest urgent care where I tested positive for RSV. My grandson had recently had it, and I'm sure I contracted it from him. While I was there, my physician listened to my heart and told me I needed to go to the emergency room. Once I arrived there, they said I looked anemic and felt out of breath. The doctor ran IVs and fluids and ran a swab to confirm RSV infection. They determined my EKG looked abnormal/irregular, I had pneumonia left lung and sepsis infection in my blood. Once I was admitted, they put me on antibiotics and administering potassium and magnesium. My hemoglobin was extremely low and fell further while I was there. They did a blood transfusion as well later as well as echocardiogram with CT scan of my heart. A CTA scan followed the next day where they concluded I had a left branch bundled clot in my heart. My heart looked healthy besides the bundle that appeared in the scans. After the transfusion and the infection cleared up, I was discharged on the 03/17/2023. During my follow-up today (04/24/2023), my hemoglobin levels are back to normal and all is well again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 5,0
Labordaten: 13MAR2023-16MAR2023 -- Echocardiogram, CT Scan, CTA Scan, Viral Swab, Bloodwork, EKG
Aktuelle Erkrankungen: N/A
Vorgeschichte: Lupus; Sjogren's Syndrome
Andere Medikamente: Hydroxychloroquine; Women's Multivitamin; Bone Strength Calcium Complex; AZO Bladder Control; Prilosec
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2616177

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22-A

moderat

Staat: OR
Alter: 65,0
Geschlecht: F
Eingang: 17.04.2023
Impfdatum: 14.10.2022
Beginn: 02.04.2023
Tage bis Beginn: 170,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia Arthralgia Asthenia COVID-19 Dyspnoea Headache Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had my vaccination on 10/14/2022. On 04/02/2023 I started to have a sore throat. On the evening of 04/03/2023 I had the worst sore throat of my life. I had congestion headache and my hips hurt. I tested COVID-19 Positive on 04/03/2023 at 11PM. I contacted my physical on 04/04/2023 and had prescribed me Paxlovid. I presently feel better but I still have congestion runny nose and sore throat. I am still weak with slight shortness of breath. I still have no taste nor smell.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 04/03/2023 test - COVID-19 Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2616074

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: OH
Alter: 68,0
Geschlecht: F
Eingang: 17.04.2023
Impfdatum: 07.10.2022
Beginn: 30.01.2023
Tage bis Beginn: 115,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest pain Cough Nasopharyngitis Nausea SARS-CoV-2 test positive Sleep disorder

Symptomtext

The symptoms started with a cough on that Monday late in the day. A little bit on Tuesday. I did also start feeling a little bit nauseous. The cough proceeded that Tuesday night and I was awake a lot of the night. It hurt my chest but I never felt like I had any congestion or trouble breathing. On 02/01/2023, I took a home COVID-19 test and it was positive after 15 minutes. At that point, I called my doctor's office and left a message saying I tested positive. Later in the day, I got a text notification from my pharmacy for a prescription ready. The doctor's office never called me back, they just sent me the prescription in. I started the PAXLOVID at night on Wednesday 02/01/2023. I did complete the whole regimen even though it made my mouth taste like metal. I got better pretty quickly and I took another test the week of 02/05/2023 around the 9th and I was negative. Then I was all excited because I was negative. Within a couple of days, I started feeling like I was getting a head or sinus cold. I took another test on 02/13/2023 and I had another positive COVID-19 test. I thought maybe it was a false positive and I did another test on 02/14/2023. I never felt bad other than feeling like I had a head cold. I stayed home but I did not feel super sick. I tested again the following midweek and I was negative again. The rebound was very minimal. I wasn't having the horrible cough during the second round. I do also believe that my husband had COVID-19 in December, but when we took at home COVID-19 tests, they came back negative. They were also expired, but it definitely may have been COVID-19 because they were very similar symptoms to what I experienced.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 01FEB2023 at home COVID-19 test positive; 09FEB2023 at home COVID-19 test negative; 13FEB2023 at home COVID-19 test positive; 14FEB2023 at home COVID-19 test positive; 22FEB2023 at home COVID-19 test negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Alendronate; oxybutynin; estradiol compound; calcium; vitamin B12; vitamin C; vitamin D3; probiotic; METAMUCIL; ibuprofen as needed; zolpidem as needed; pot gummies
Allergien: DIFLUCAN; mild seasonal allergies
Vorherige Impfungen: -

VAERS 2614617

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: MN
Alter: 25,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 07.10.2022
Beginn: 21.02.2023
Tage bis Beginn: 137,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal COVID-19 Chest X-ray normal Chest pain Cough Dyspnoea Electrocardiogram abnormal Headache Oropharyngeal pain Pain Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Wheezing

Symptomtext

It started with a sore throat, cough, runny nose, congestion, headache, body aches and fever at its 101 degrees. I started to have some chest pain and shortness of breath on February 24, 2023, so I went to the emergency room. They ran some test and a chest x-ray which was clear. I was given TYLENOL and I slept. I was discharged. I was not prescribed any medication at that point, but my symptoms were pretty bad. I had symptoms for another week before I went to my doctor for the wheezing and shortness of breath. I was prescribed an albuterol inhaler. My other symptoms were improved by this time. It took about a month to recover from all symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: COVID-19 test positive 02/21/2023. EKG 02/21/2023 a little abnormal. Blood work 02/21/2023 normal. Chest X-ray 02/21/2023 clear
Aktuelle Erkrankungen: N/A
Vorgeschichte: IBS
Andere Medikamente: Multivitamin; aspirin
Allergien: Amoxicillin; shellfish
Vorherige Impfungen: -

VAERS 2612431

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: VA
Alter: 37,0
Geschlecht: F
Eingang: 10.04.2023
Impfdatum: 05.10.2022
Beginn: 09.03.2023
Tage bis Beginn: 155,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chills Cough Dyspnoea Fatigue Feeling abnormal Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

3/09 woke up feeling terrible with fever, chills, congestion, fatigue, coughing, and body aches. Reached out to OB/GYN and was told OTC meds I could take. Symptoms persisted for two weeks. All symptoms have resolved except for cough. Went to walkin clinic and was prescribed augmentin. Still having shortness of breath and coughing

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID-19 - positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2607375

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: NY
Alter: 57,0
Geschlecht: M
Eingang: 31.03.2023
Impfdatum: 10.10.2022
Beginn: 01.12.2022
Tage bis Beginn: 52,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram normal Dizziness Feeling abnormal Paraesthesia Tinnitus

Symptomtext

I experienced some lightheadedness and some tingling in my brain. I went to the emergency room in January of this year because I thought I had a stroke and I heard this popping noise in my head. The doctor found nothing in the CAT scan. I feel better now for the most part, but I have a follow-up with my doctor in April 2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: 01/2023 CAT Scan
Aktuelle Erkrankungen: None
Vorgeschichte: Pre-hypertension; Pre-diabetes
Andere Medikamente: N/A
Allergien: None
Vorherige Impfungen: -

VAERS 2595670

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: WI
Alter: 61,0
Geschlecht: M
Eingang: 13.03.2023
Impfdatum: 15.10.2022
Beginn: 26.12.2022
Tage bis Beginn: 72,0
Dosis: 5
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal COVID-19 Chest X-ray abnormal Cough Dyspnoea Dyspnoea exertional Hilar lymphadenopathy Hypoxia Interstitial lung disease Lung consolidation Lung opacity Lymphadenopathy mediastinal SARS-CoV-2 test positive

Symptomtext

Patient initially had a positive COVID test on 12/8/2022; He was prescribed Paxlovid 12/10/2022 and completed a 5-day course. On 12/26/2022, patient presented to the emergency department due to worsening of shortness of breath, dyspnea on exertion, and cough over the past week; He was tested for COVID on 12/26/2022 and was positive; Chest x-ray on 12/26/2022 showed severe diffuse patchy consolidation. On 12/26/2022 was negative for PE, with extensive bilateral ground glass opacities and interstitial thickening, along with bilateral hilar and mediastinal lymphadenopathy. Patient was diagnosed with COVID-19 with hypoxia, possible secondary bacterial pneumonia. He was admitted to the hospital for treatment. Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 12/8/2022 - positive COVID NAA test; 12/26/2022 - positive COVID NAA test; Chest x-ray on 12/26/2022 showed severe diffuse patchy consolidation; CTA on 12/26/2022 was negative for PE, with extensive bilateral ground glass opacities and interstitial thickening, along with bilateral hilar and mediastinal lymphadenopathy.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Type 2 Diabetes Mellitus, Coronary Artery Disease s/p CABG, Hypertension, Hypersensitivity Lung Disease, Obstructive Sleep Apnea, Hypothyroidism, former smoker, obesity .
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2585981

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: CA
Alter: 37,0
Geschlecht: M
Eingang: 22.02.2023
Impfdatum: 17.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Neuropathy peripheral Postural orthostatic tachycardia syndrome Tilt table test

Symptomtext

Postural orthostatic tachycardia syndrome Neuropathy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Postural orthostatic tachycardia syndrome
Hospital-Tage: -
Labordaten: Tilt Table Test
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2577249

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: IL
Alter: 76,0
Geschlecht: M
Eingang: 07.02.2023
Impfdatum: 21.11.2022
Beginn: 21.11.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Paraesthesia

Symptomtext

client reported, "tingling in arm that goes all the way to his fingers and has been occuring since he received the shot." it was recommended to contact his primary care phusician in regards to his symptoms and was reassured that a report would be filed to the CDC and FDA in a confidential mannor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: not applicable.
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2575048

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 03.02.2023
Impfdatum: 02.11.2022
Beginn: 30.01.2023
Tage bis Beginn: 89,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Asthenia COVID-19 COVID-19 pneumonia Confusional state Cough Exposure to SARS-CoV-2 Laboratory test normal Pyrexia

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 1/30/2023 Discharge Date: Feb 1, 2023 PRESENTING PROBLEM: Acute kidney injury [N17.9] COVID [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: Patient is a 77 y.o. male with past medical history significant for nonischemic cardiomyopathy, afib, HTN, right AKA presented to the ED with generalized weakness and some confusion. His wife was diagnosed with COVID and he has been having a cough and subjective fever. Given his symptoms and inability to get adequate care by his wife due to her COVID and assistants were not traveling to the house with their COVID, he presented to the ER for further evaluation. He remained stable and did not require supplemental oxygen for his COVID. Workup was negative for alternative diagnoses. He worked with PT/OT who had some limited assessment as his prosthesis was at home, but ultimately recommended SNF. After discussion with family he previously did not do well with SNF as they could not meet his needs and therefore they wanted him to return home when stable. His wife felt able to meet his needs at this time as she feels recovered from COVID. CM able to arrange transport, and he was discharged home in stable condition on 2/1/23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Anticoagulated DM (diabetes mellitus), type 2 Low testosterone Glaucoma Sleep apnea HTN (hypertension) Hypercholesterolemia 3-4mm lung nodules and calcified adenopathy, needs follow-up CT thorax in July 2017 History of tobacco use Exogenous obesity Class 2 obesity Nonischemic cardiomyopathy Sinus bradycardia Benign prostatic hyperplasia without lower urinary tract symptoms REM behavioral disorder LVH (left ventricular hypertrophy) Stage 3 chronic kidney disease Chronic combined systolic and diastolic heart failure Ascending aorta dilation Pressure ulcer of sacral region, stage 2 Type 2 diabetes mellitus with stage 3a chronic kidney disease, without long-term current use of insulin Status post left knee replacement Right above-knee amputee Paroxysmal atrial fibrillation Physical deconditioning Adjustment disorder with depressed mood PAD (peripheral artery disease) Left popliteal artery occlusion Malignant neoplasm of skin Normocytic anemia Other artificial openings of gastrointestinal tract status Depression, recurrent Thrombocytopenia, unspecified COVID
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet amLODIPine (NORVASC) 10 MG tablet apixaban (ELIQUIS) 5 MG tablet ascorbic acid (VITAMIN C) 500 MG tablet atorvastatin (LIPITOR) 20 MG tablet carvedilol (COREG) 6.25 MG tablet cholecalciferol (VITAMIN D3
Allergien: MeropenemRash Succinylcholine ErythromycinItching LatexUnknown LisinoprilCough
Vorherige Impfungen: -

VAERS 2567754

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: MN
Alter: 73,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 10.10.2022
Beginn: 15.11.2022
Tage bis Beginn: 36,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia COVID-19 Pneumonia bacterial SARS-CoV-2 test positive Thrombocytopenia

Symptomtext

Patient resides in a group home, and was seen in the ED on 11/15/22 with increasing generalized weakness over the past 2 days as reported by his caretakers. COVID-19 PCR test was done in the ED which was positive. Ultimately, patient was admitted on 11/15 with weakness secondary to COVID, bacterial pneumonia, and thrombocytopenia. He did not require oxygen. Patient was discharged 11/21/22 to his group home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia bacterial
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566768

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: MI
Alter: 83,0
Geschlecht: F
Eingang: 24.01.2023
Impfdatum: 23.10.2022
Beginn: 21.01.2023
Tage bis Beginn: 90,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 Dyspnoea Fatigue Hypoxia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

COVID+ 1/21/23. Vaccination Status - Moderna x4 + moderna BIVALENT x1 Discharge Summary DO (Physician) ? ? General Medicine BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider: MD Admission Date: 1/21/2023 Discharge Date: Jan 23, 2023 Active Hospital Problems Diagnosis Date Noted POA ? COVID-19 01/21/2023 Yes ? Hypoxia ? DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID [U07.1] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 83 y.o. female with a past medical history of chronic obstructive pulmonary disease, paroxysmal atrial fibrillation on Eliquis, rheumatoid arthritis, essential hypertension, among other comorbid conditions presented to the Hospital Emergency Department on 01/21/2023 with complaints of worsening shortness of breath and rhinorrhea onset approximately 2 days prior to presentation. In addition the patient reported significant fatigue. On evaluation in the emergency department the patient was found to be hypoxic and COVID-19 positive. She was admitted to the hospital service under observational status for ongoing management and coordination. She was started on supplemental oxygen, improving her oxygen saturation from 85% on room air to approximately 94% on 2 L of supplemental oxygen via nasal cannula. In addition she was started on Decadron 6 mg daily as well as remdesivir. Over the course of approximately 48 hours of admission the patient is a hypoxia resolved and was able to maintain oxygen saturation above 92% on room air. The remainder of her hospital course was uncomplicated. On 01/23/2023 with labs and vitals stable condition, able to oxygenate well without supplemental oxygen, the patient was discharged home with instructions follow-up with her primary care physician within 7 days of discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: 10/21/22 - home visit by Modern Day House Calls FNP- Vaginal irritation - nystatin-triamcinolone (MYCOLOG) ointment; Apply topically 2 times daily. Apply to affected area. Dispense: 30 g; Refill: 1 - fluconazole (DIFLUCAN) 150 MG tablet; Take 1 tablet by mouth 1 (one) time for 1 dose. Repeat if needed after 3 days Dispense: 2 tablet; Refill: 0
Vorgeschichte: Left carotid artery occlusion Osteoarthritis of spine with radiculopathy, lumbar region Peripheral neuropathy COPD, severe (HCC) Stenosis of right carotid artery Rheumatoid arthritis (HCC) Nodule of left lung Lumbar radiculopathy History of histoplasmosis Hypertension Peripheral vascular disease (HCC) Deafness in left ear Hyperlipidemia Osteoarthritis of left hip Chronic pain syndrome High risk medication use PAF (paroxysmal atrial fibrillation) (HCC) Frequent UTI Back pain Community acquired pneumonia Polymyalgia rheumatica (HCC) Claustrophobia Atherosclerotic heart disease of native coronary artery without angina pectoris Age-related osteoporosis without current pathological fracture History of CVA (cerebrovascular accident) Routine health maintenance Lichen sclerosus et atrophicus of the vulva
Andere Medikamente: Acetaminophen 1,000 mg Oral Every 8 hours PRN Albuterol Sulfate 108 (90 Base) MCG/ACT 2 puffs Inhalation Every 4 hours PRN Alendronate Sodium 70 mg Oral Weekly, Take with water 30 min before breakfast Amoxicillin 250 MG TAKE 1 CAPSULE BY MO
Allergien: codeine -itching
Vorherige Impfungen: -

VAERS 2565699

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22-A

moderat

Staat: WA
Alter: 61,0
Geschlecht: F
Eingang: 23.01.2023
Impfdatum: 28.10.2022
Beginn: 02.12.2022
Tage bis Beginn: 35,0
Dosis: 5
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Tachycardia

Symptomtext

I had my vaccination on 10/28/2022. I had intense tachycardia event on 12/02/2022. I tried to call my physician in which they prescribed me an additional medication. I do not have any other follow ups with specialty care. I do follow up with my physician on 02/03/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Tachycardia
Andere Medikamente: Losartan; Metoprolol
Allergien: Too many to list
Vorherige Impfungen: COVID-19 07/22/2022 Tachycardia

VAERS 2554867

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: TX
Alter: 85,0
Geschlecht: M
Eingang: 09.01.2023
Impfdatum: 28.09.2022
Beginn: 15.12.2022
Tage bis Beginn: 78,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Body temperature increased COVID-19 Dehydration Fall Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I didn't think I had COVID-19, I thought I had a cold. I went to the hospital because a had a fall and got stuck between a bed and a nightstand and couldn't lift myself up. My wife called an ambulance, and I was taken to the hospital. The doctor administered the COVID-19 test and told me the results. I remained in the emergency room until I was admitted, the administered remdesivir thru and IV and gave me more fluids because I was dehydrated. I remained in the hospital 2 additional days. I had diarrhea which was caused by the antibiotics. I had a 104-degree temperature upon arrival and was shocked about how high it was. I was discharged on the 3rd day and told to isolate for 10 days. After about 4 days, it got better. The sore throat was the worse symptom.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: 3,0
Labordaten: COVID-19 PCR test December 16, 2022 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes
Andere Medikamente: Levothyroxine; atorvastatin; glipizide; irbesartan; desmopressin; multivitamin; turmeric
Allergien: BACTRIM
Vorherige Impfungen: -

VAERS 2551581

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: OR
Alter: 58,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 29.09.2022
Beginn: 06.12.2022
Tage bis Beginn: 68,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Diarrhoea Dizziness Fatigue Feeling abnormal Malaise Oropharyngeal pain Pyrexia SARS-CoV-2 test positive Throat tightness Tremor

Symptomtext

I woke up Tuesday morning, December 6, 2022, with a significant sore throat and generally not feeling well. I took a COVID-19 test and it was positive. I took MUCINEX and ADVIL and went back to bed. My fever was 102. I did not have a cough or congestion. I did have severe diarrhea. I had a tele visit with the doctor and I began PAXLOVID on December 6, 2022. On Sunday, December 11th, I was feeling better. I remained to be worn down and fatigued. The following week around December 21st, I started to cough and feel horrible again. I had a fever again. On December 27th I visited the doctor because my throat felt constricted. I was given an inhaler and two antibiotics. I have terrible brain fog, dizzy and continue to feel shaky.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: Home COVID-19, positive, 12/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Anxiety; Neuropathy
Andere Medikamente: Bupropion; gabapentin; prazosin; alprazolam; TYLENOL; vitamin D; PRILOSEC
Allergien: Shellfish sensitivity
Vorherige Impfungen: -

VAERS 2550215

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: UT
Alter: 29,0
Geschlecht: F
Eingang: 04.01.2023
Impfdatum: 03.10.2022
Beginn: 17.10.2022
Tage bis Beginn: 14,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Mobility decreased Muscle tightness Pain in extremity

Symptomtext

I did not have an adverse reaction to the vaccine. Two weeks later on the morning of 10/17, the muscles in my left arm tightened up to the point I couldn't move. I saw my doctor and I was given a prescription for high dose oral steroids for 2 weeks. After the steroids, I can move it a little, but it is very sensitive. I continue to have problems, but I am able to move it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2550208

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: MD
Alter: 67,0
Geschlecht: F
Eingang: 04.01.2023
Impfdatum: 04.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Fatigue Headache Injection site pain Malaise Mobility decreased Oropharyngeal pain Pain Paranasal sinus discomfort Respiratory tract congestion SARS-CoV-2 test positive Vomiting

Symptomtext

On 10/04/2022 I just felt not one hundred percent I had body aches, headache and pain at the injection site. This lasted a day or two after the injection. On 12/14/2022 I was in bed for two days I vomited I had body aches, chills, sore throat, congestion, sinus pressure, fatigue. On 12/17/2022 I tested positive for the COVID-19 virus.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: COVID-19 test result positive.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: SYNTHROID; levothyroxine; calcium
Allergien: Bee sting; sulfa
Vorherige Impfungen: I was sick in bed for one day with body aches and a headache. Age 65. 03/04/2021 COVID-19 MODERNA #012A21A

VAERS 2546988

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: AZ
Alter: 58,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 29.09.2022
Beginn: 18.12.2022
Tage bis Beginn: 80,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal discomfort Blood sodium decreased Chest X-ray normal Cough Decreased appetite Diarrhoea Dyspnoea Fatigue Full blood count abnormal Headache Malaise Nasal congestion Pain Restlessness Rhinorrhoea Sneezing

Symptomtext

On December 18th, 2022 I woke up with a stuffy runny nose, sneezing, coughing, no appetite, and headache. I was really tired and felt blah. Not anything too bad right away. Within two days I felt so horrible it was scary because I am asthmatic. I was having trouble breathing. I have a pulse oximeter to monitor my oxygen. I was coughing, body pain, restlessness, and tired. I didn't have fever. I had diarrhea, stomach upset. I felt so horrible and went to the emergency room. On day four I was able to get PAXLOVID from my doctor and began to feel better. I finished the medication on December 26th, 2022 and began to feel much better. Today I feel icky and I have nasally, congestion, and coughing. When I went to the hospital the emergency room doctor told me not to take it because it was going to make me feel worse so I went to my PCP the next day who did prescribe me the PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 20DEC2022 Chest X-Ray clear; 20DEC2022 CBC normal except my sodium was low
Aktuelle Erkrankungen: N/A
Vorgeschichte: Depression; Anxiety; Fibromyalgia; Arthritis; GERD; Pain; Gastritis; IBS; Asthma; Diabetes
Andere Medikamente: Sucralfate; gabapentin; clonazepam; montelukast; pantoprazole; cetirizine; losartan; metformin; VENTOLIN inhaler; tramadol; clotrimazole betamethasone dipropionate topical cream; VOLTAREN topical cream
Allergien: Peanuts
Vorherige Impfungen: -

VAERS 2545625

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: OK
Alter: 77,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 25.10.2022
Beginn: 28.12.2022
Tage bis Beginn: 64,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Pneumonia

Symptomtext

Admitted to hospital with Bilateral Pneumonia secondary to COVID

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2542845

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: IA
Alter: 79,0
Geschlecht: M
Eingang: 24.12.2022
Impfdatum: 16.12.2022
Beginn: 17.12.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Atrial flutter Cardioversion Implantable defibrillator insertion Ventricular tachycardia

Symptomtext

patient experienced V tach and was shocked by ICD. Presented in Atrial flutter to ED and required emergent cardioversion

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ventricular tachycardia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: cad osa oa gout heart failure
Andere Medikamente: acetaminophen 500 mg tablet allopurinol (ZYLOPRIM) 300 mg tablet amiodarone (CORDARONE) 200 mg tablet apixaban (ELIQUIS) 5 mg tablet carvedilol (COREG) 25 mg tablet furosemide 40 mg tablet losartan 50 mg tablet simvastatin 20 mg tablet zolp
Allergien: Morphine
Vorherige Impfungen: -

VAERS 2521069

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: VA
Alter: 25,0
Geschlecht: M
Eingang: 01.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Dizziness Dyspnoea Electrocardiogram normal Heart rate increased Hypertension Hypoaesthesia Palpitations Paraesthesia

Symptomtext

Pt. complained of dizziness, SOB, heaviness to left chest, palpitations. Also complained of numbness and tingling in all upper and lower extrimities . Vitals: Bp, 159/85 pulse 118. pt stated " They are higher than normal." Alerted emergency personnel, assessment completed and pt advised to go with them to hospital but pt. refused. Paramedic recommended for him to not drive and for someone to take him home. Pt left without notifying us of his transportation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: EKG within normal limits. Other vitals not reported from paramedic.
Aktuelle Erkrankungen: History of ashma
Vorgeschichte: Arrythmia,Ashma, abnormal EKG
Andere Medikamente: N/a
Allergien: N/a
Vorherige Impfungen: -

VAERS 2506048

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 06.10.2022
Beginn: 09.10.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Tachycardia

Symptomtext

Intermittent severe tachycardia documented with light exercise. 192-195 without irregularity. Concern for possible vtach/unable to rule out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: Home monitored
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2499805

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: MI
Alter: 91,0
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Muscle spasms Nausea Tremor

Symptomtext

Patient states that last night she started having chills, shaking, nausea and a cramp under her ribs. This morning she said that that was all better but she had a fever of 99. Instructed patient to continue to monitor and to go in hospital if symptoms worsen or any chest pain or shortness of breath occur.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Afib
Andere Medikamente: unknown
Allergien: Clindamycin, penicillin, sulfa, shellfish
Vorherige Impfungen: Pneumovax

VAERS 2491304

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: MN
Alter: 101,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: 25.10.2022
Beginn: 26.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body temperature increased Dyspnoea Pain in extremity

Symptomtext

sore arm, temp 101.7 F (oral), shortness of breath necessitating supplemental oxygen for approximately 2 hours (2L)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Sore and swollen arm, elevated temp

VAERS 2487379

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: PA
Alter: 65,0
Geschlecht: F
Eingang: 24.10.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dysuria Fatigue Hallucination Hyperhidrosis Migraine Pyrexia

Symptomtext

Patient states that about 1.5 hours after she got home after vaccination that she experienced a fever spike to 104 degress farenheit and was drenched in sweat. She also experienced hallucinations where she "needed to be running" and frantically ran through her house. She developed a migraine and began to urinate in "inappropriate rooms of the house". Patient did not seek medical attention and called us today to report. As of today patient report feeling tired and weak, fever and hallucinations have resolved as well as urination problem. Advised that patient get evaluated by a medical professional.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Sumatriptan, montelukast, albuterol hfa, fentany, norco, dicyclomine, cyclobenzaprine, breztri, fluoxetine, prednisone, lisinopril, pantoprazole, ropinirole, riboflavin, magnesium, isosorbide
Allergien: tetanus toxoid
Vorherige Impfungen: Tetanus vacicne years ago, allergic reaction

VAERS 2478388

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: WI
Alter: 63,0
Geschlecht: F
Eingang: 14.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure increased Crying Dizziness Feeling abnormal Headache Irritability Muscle spasms Pain Palpitations Tinnitus Vertigo Vision blurred

Symptomtext

Ear Ringing/Tinnitus, increased blood pressure, dizziness and vertigo, pounding heartbeat, blurry vision, irritability and crying, feelings of being overwhelmed, muscle cramping, headaches, body aches

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypoadrenalism, Hypothyroidism, Pituitary Adenoma, Chronic Kidney Disease, Asthma, Bladder Cancer, Basal Cell Carcinoma, Kidney Stones, Lumbar Stenosis and Degenerative Spondylolisthesis, Iron Deficiency Anemia, Sicca/Sjogren's Syndrome, Osteoarthritis, Lichen Sclerosus, Rhinitis/Sinusitis
Andere Medikamente: Asmanex, Atenolol, Fluticason Nasal Spray, Gabapentin, Hydrocortisone, Levothyroxine, Loratadine, Restasis, Acetaminophen, Aspercreme, Docusate Sodium, Genteal Eye Drops, Psyllium Fiber, Dextrim Fiber, Senna Laxative Tablet, Glucosamine, Mu
Allergien: Citolopram, Statins, Ropinirole, Metronidazole, Reaction to Pneumonia Vaccine (2002), Reaction to previous Moderna Covid Vaccinations, some metals, aerosol sprays, perfumes, molds and mildews, cigarette and wood smoke, tree and grass pollens, adhesives from bandages, some varieties of dark chocolate or fudge, raw macadamia nuts, some beers
Vorherige Impfungen: Pneumonia Vaccine - 2002 - Rash across upper chest; Covid Vaccines - 2021 to 2022, similar symptoms as reported now

VAERS 2476185

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: OH
Alter: 78,0
Geschlecht: F
Eingang: 12.10.2022
Impfdatum: 12.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea Tachycardia Tremor

Symptomtext

Difficulty breathing, tachycardia, shaking all over. I gave her Epinephrine 0.3mg once time per orders of, and she was also given 2 liters of oxygen. We called 911 and the EMT's took her to the hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: No medical tests or labs in our office. Patient was transported to the hospital.
Aktuelle Erkrankungen: No
Vorgeschichte: Depression, Osteoporsis, Anxiety, Hyperlipidema, Hypertension, GERD, Essential Tremors, Chronic Kidney Disease, stage 3, Raynauda Disease without Gangrene, Diabetes type 2
Andere Medikamente: No medications were given at the time of the Covid Moderna Bilvalent vaccine.
Allergien: Penicillin, Darvon
Vorherige Impfungen: -

VAERS 2476167

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

moderat

Staat: OH
Alter: 62,0
Geschlecht: F
Eingang: 12.10.2022
Impfdatum: 03.10.2022
Beginn: 03.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Migraine Pain

Symptomtext

I developed a migraine withing a few hours of getting the vaccine. This has been waxing and waning since that day, but not gone away. Saw Doctor on 10/10/22. Doctor noticed that vaccine was Moderna and previous versions had been Pfizer. Doctor just took blood pressure and temperature. Prescribed etodolac 400 mg and Acetaminop hencod 3 for pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: All vitals normal.
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Ibuprofen
Allergien: No
Vorherige Impfungen: 2016 flu like symptoms for 3 weeks after flu shot.

VAERS 2474524

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

moderat

Staat: MA
Alter: -
Geschlecht: M
Eingang: 10.10.2022
Impfdatum: -
Beginn: 04.10.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Mobility decreased Pyrexia

Symptomtext

I received a Moderna covid vaccinel-about 12 h later i developed a fever or 102 profound Weakness and ws unable to get out of bed without assistance. This gradually improved over 24-48 8h year prior-About a year prior to this I got a Pfizer Covid Booster and had similar symptoms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: dm htn heart block
Andere Medikamente: fishoil valsartan tamlosin rosvastatin asa
Allergien: niacin
Vorherige Impfungen: -

VAERS 2719060

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

mild

Staat: CA
Alter: 51,0
Geschlecht: M
Eingang: 29.11.2023
Impfdatum: 18.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Biopsy Biopsy lymph gland normal C-reactive protein increased Computerised tomogram abnormal Fatigue Laboratory test normal Lymphadenectomy Lymphadenopathy Red blood cell sedimentation rate increased

Symptomtext

I do not know the exact date the adverse effects started. Nor am I certain that the vaccine is the cause of my health issue. But it is the only remaining diagnosis after visiting 5+ doctors and months of tests. In June 2023, I took routine blood tests, including immune system markers for the first time. While routine, I was feeling fatique for an indefinite amount of time previous to the blood tests. Perhaps as long as a year before the tests - but I wasn't sure of the cause. My immune markers were highly reactive - CRP of 130, high blood sedementation and others. After months of blood tests and various doctors -- infectious diseases specialists, rheumatologist, cardiologist, gastroenterologist, GP - and 3 possible diagnoses - bacterial infection; immune system disorder or tumor - none of the tests could identify a cause. So I did a full body CT scan and found two enlarged mesenteric lymph nodes - one was 5.4 cm and another was only slightly enlargened. I did an endoscopic biopsy which found the tissue to be non-cancerous. 3 weeks of antibiotics followed - and there was no change in my immunomarkers. I then had surgery to remove the two lymph nodes. My doctors expected lymphoma to be the cause. Expert pathology found no disease in the tissue - so sampling error was not repsonsible for a false negative diagnosis of cancer. I also did tests for various immune system disorders. None could be identified. I repeating the blood tests for immune system markers a few weeks ago -- 3 weeks after surgery -- and they were way down, almost back to normal. So I assume the cause of the reaction is now gone. My doctor said that the only other possible cause he could think of was an adverse reaction to the mRNA vaccine - last taken in Oct 2022. He had no conclusive evidence of course - but no other explation could be found by 5 doctors and months of tests. I could have some rare immune system disorder for which there is no test - but the problem appears to be gone, now that the enlargened lymph nodes are gone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: 5,0
Labordaten: 20+ tests. Scanned copies of notes from clinical visits and blood tests can be provided if they might be of help. They only show my immune system reacting to something - and inconclusive tests to find a cause, either of a baceterial infection or immune system disorder. The cause has still not been identified.
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -

VAERS 2716938

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MN
Alter: 67,0
Geschlecht: F
Eingang: 22.11.2023
Impfdatum: 13.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Pain in extremity

Symptomtext

Patient had minimal side effects including sore arm; Patient had minimal side effects including tired; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Patient had minimal side effects including sore arm) and FATIGUE (Patient had minimal side effects including tired) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Patient had minimal side effects including sore arm) and FATIGUE (Patient had minimal side effects including tired). At the time of the report, PAIN IN EXTREMITY (Patient had minimal side effects including sore arm) and FATIGUE (Patient had minimal side effects including tired) outcome was unknown. No concomitant medication was reported. No treatment information was reported. This case was linked to MOD-2023-750219, MOD-2023-750226 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2711540

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 08.11.2023
Impfdatum: 24.10.2022
Beginn: 22.07.2023
Tage bis Beginn: 271,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Ammonia normal Blood lactic acid normal Bradycardia COVID-19 Chest X-ray normal Computerised tomogram head normal Confusional state Cough Diarrhoea Electrocardiogram abnormal Encephalopathy Fatigue Headache Magnetic resonance imaging head normal Mental status changes Myalgia Pyrexia Rhinorrhoea

Symptomtext

BRIEF OVERVIEW: Admission Date: 7/22/2023 Discharge Date: Jul 24, 2023 Discharge Disposition: home or self care DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Encephalopathy [G93.40] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 73-year-old female with PMH significant hypertension, anxiety disorder, depression, ADHD, alcohol use disorder presents to the hospital on 7/22 with concerns for altered mental status. Patient had developed symptoms including fever, cough, rhinorrhea, headache, sneezing, fatigue, diarrhea and myalgias about 6 days prior to presentation. After testing positive for COVID-19, patient was started on Paxlovid on 07/22, of which she may have taken 1-2 doses. Shortly thereafter, patient was noted to have progressive confusion and hence brought to the hospital. Patient was admitted, suspicion for Paxlovid related altered mental status. CT head was negative for acute process, chest x-ray, urinalysis, ammonia, lactic acid were all reassuring. Patient's mental status changes quickly improved, however persisted to have difficulty following commands, understanding information etc.. Out of abundance of caution, MRI brain was done to evaluate for stroke, however was negative. Her mental status changes were likely related to interaction between BuSpar and Paxlovid, with latter being a enzyme inhibitor, likely increased her available BuSpar in her system. She was discharged home on 07/24. Incidentally she was also noted to have asymptomatic bradycardia, EKG showing sinus bradycardia, with good chronotropic effect during daytime. Bradycardia was mostly noted during nighttime. Patient denied any lightheadedness or dizziness or syncope. She also has history of alcohol use disorder, quit drinking about 2 weeks prior to presentation, plans to stay quit. She was given a 10 day course of thiamine. As far as COVID-19 infection, patient was significantly feeling better from her symptomatology, she is nearly 7 days after her symptoms had started, needs no further isolation. Per her request, BuSpar dose was changed to 15 mg twice daily (patient was supposed to be on 30 mg twice daily, however is only taking 30 mg once daily. I suggested to take 15 mg twice daily instead). Adderall was discontinued-she no longer takes it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Dry eye syndrome Essential hypertension Osteoporosis GAD (generalized anxiety disorder) Diverticulitis High cholesterol Osteoarthritis Scoliosis deformity of spine Postmenopausal bleeding Vaginal atrophy Sensation of pressure in bladder area
Andere Medikamente: ascorbic acid (VITAMIN C) 1000 MG tablet atorvastatin (LIPITOR) 20 mg tablet busPIRone (BUSPAR) 30 mg tablet ciclopirox (PENLAC) 8 % solution clindamycin (CLEOCIN T) 1 % external solution cycloSPORINE (RESTASIS) 0.05 % ophthalmic emulsion E
Allergien: Shellfish Allergy Hydrogen PeroxideSwelling Paxlovid [Nirmatrelvir-ritonavir] Zoledronic AcidSwelling, Rash, Dermatitis, Itching
Vorherige Impfungen: -

VAERS 2637290

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: VA
Alter: 66,0
Geschlecht: F
Eingang: 26.05.2023
Impfdatum: 07.12.2022
Beginn: 10.05.2023
Tage bis Beginn: 154,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Malaise Oropharyngeal pain Pain Pain in extremity Pyrexia SARS-CoV-2 test positive

Symptomtext

I had a sore arm for about a day after receiving the vaccine. I tested positive for COVID-19 on 05/10/2023. I had a fever, mild sore throat, cough and body aches. I was really sick for 72 hours. I contacted my provider via telehealth and got a prescription for PAXLOVID. I tolerated the medication without any complications. I did have loose stools taking PAXLOVID. As of today, I still feel fatigued.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 10MAY2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol; GERD; vitamin D Deficiency; Osteoarthritis
Andere Medikamente: N/A
Allergien: DEMEROL; crabs; scallops
Vorherige Impfungen: -

VAERS 2634847

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NJ
Alter: 79,0
Geschlecht: F
Eingang: 22.05.2023
Impfdatum: 08.10.2022
Beginn: 14.02.2023
Tage bis Beginn: 129,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Herpes zoster Injection site pain Pain Pain in extremity Rash

Symptomtext

I had tenderness at the injection spot and achy arm for about a day after receiving the vaccine. I developed shingles on my back on 02/14/2023 that lasted about a week. It started out with pain, but the rash did not show up immediately. I contacted my doctor but never heard back from her. I had made appointments with two other doctors for other reasons and had them look at my back. As of today, I feel better, and the rash is gone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: GERD; Arthritis
Andere Medikamente: Ramipril
Allergien: N/A
Vorherige Impfungen: -

VAERS 2634270

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

mild

Staat: WA
Alter: 51,0
Geschlecht: F
Eingang: 19.05.2023
Impfdatum: 17.11.2022
Beginn: 07.05.2023
Tage bis Beginn: 171,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

COVID-19 Chills Ear congestion Ear pain Exposure to SARS-CoV-2 Fatigue Headache Malaise Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test SARS-CoV-2 test positive Sinus congestion Tinnitus

Symptomtext

On Sunday morning May 7, 2023 I began to have head congestion, severe headache, extreme tiredness. My husband began having these same symptoms on Friday afternoon May 5, 2023. He tested positive at The Walk-in clinic for Covid on Sat May 6, 2023. He had just been asked to go back into the office 1 day per week starting Wed April 26, 2023 . He learned he was exposed to a work colleague who followed the CDC guidelines literally and came into work after 5 days, even though she was still feeling sick. After my husband?s Covid-19 test came back positive, I asked to also be tested, but the clinic provided guidance to not get tested. After I started to feel intense symptoms I decided to get tested on Wed May 9th at the The walk-in clinic. My test came back Covid-19 positive. My symptoms worsened to included fever (102), chills, severe left ear congestion, tinnitis, ear pain, and very bad headache, head congestion. Today is Friday May 19th and I am still testing positive, although the positive signal is now much more faint. I still have a runny nose, sinus and head congestion, left ear tinnitis, and tiredness. My husband tested negative for the first time this morning (Day 15).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Covid-19 positive test Wed May 9, 2023 at The Walk-in office. Home antigen testing every three days.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism
Andere Medikamente: 1). Tirosint, 112 ug, po daily 2). Estradiol, 0.1 mg, transdermal patch, twice per week
Allergien: None
Vorherige Impfungen: -

VAERS 2629719

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: TX
Alter: 69,0
Geschlecht: F
Eingang: 10.05.2023
Impfdatum: 13.10.2022
Beginn: 05.03.2023
Tage bis Beginn: 143,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anosmia Asthenia COVID-19 Exposure to SARS-CoV-2 Paranasal sinus hypersecretion Pyrexia Rhinorrhoea SARS-CoV-2 test positive Sinus disorder

Symptomtext

My husband had tested positive for COVID-19, I was his caregiver. I started having sinus issues, sinus drip, runny nose, a fever, I lost my sense of smell for three weeks. I suspected I was getting COVID-19; I took a home COVID-19 test that came back positive. The next day I went to Urgent Care to confirm that my home test was correct. The PCR Rapid COVID-19 test, it also came. The nurse practioner and I discussed my symptoms, that were, I really am not in the high-risk category aside from my age. We both agreed that it would not hurt for me to not take the antiviral medication. I am starting to feel more like me, my sense of smell is coming back, my energy is finally back. It did take m six or seven weeks to get my energy level back to where it was before I had COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 05MAR2023 Home COVID-19 test - positive; 06MAR2023 PCR Rapid COVID-19 test - positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Lipitor; Spironolactone; Zyrtec; Calcium; Vitamin A; Magnesium; Flax Seed Oil; Vitamin Z/ Zinc Compound
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2625688

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 53,0
Geschlecht: F
Eingang: 03.05.2023
Impfdatum: 15.10.2022
Beginn: 07.11.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Angiogram Ear pain Fatigue Magnetic resonance imaging Pyrexia Toothache Trigeminal neuralgia X-ray dental normal

Symptomtext

I experienced fever, tiredness, ear pain, teeth pain (3-4 teeth) and that prompted me to go to the ER. I initially thought it was a sinus infection but at the ER I was diagnosed with trigeminal neuralgia which causes chronic facial pain. I also went to the dentist and got X-Ray's done and the dentist did not see anything dental related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: 08Dec2022 MRI, 08Dec2022 MRA
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: ARMOUR THYROID; triamterene; progesterone; estradiol
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2620281

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CA
Alter: 76,0
Geschlecht: M
Eingang: 24.04.2023
Impfdatum: 24.10.2022
Beginn: 01.01.2023
Tage bis Beginn: 69,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Pain Paranasal sinus hypersecretion SARS-CoV-2 test positive Sinus congestion

Symptomtext

My symptoms began in January, and I had sinus congestion and drainage. I did not have fever. I had some fatigue and body aches. I tested positive for 6 days. On the 2nd day I began taking an antiviral. I was then negative for 8 days and then I had a rebound positive test for another 6 days. The symptoms were the same and lasted for about another 6 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19, positive, 012023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Arthritis
Andere Medikamente: Eliquis; Metropole; Iron; Glucosamine; Multi Vitamin; Antihistamine; Vitamin D; Fever Few; Pravastatin; Finasteride; Vitamin CArthri
Allergien: N/A
Vorherige Impfungen: -

VAERS 2620034

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: UT
Alter: 78,0
Geschlecht: M
Eingang: 24.04.2023
Impfdatum: 03.10.2022
Beginn: 01.12.2022
Tage bis Beginn: 59,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Asthenia Decreased appetite Fatigue Oropharyngeal pain Scan normal Sinusitis

Symptomtext

I had a sinus infection in December of 2022. They prescribed antibiotics, nasal spray, and an inhaler. In January or February, I was still having trouble. I was treated with another antibiotic and nasal spray. I seemed to do better. I went downhill with fatigue, joint pain, sore throat, and weakness. I saw a doctor on April 7, 2023. The doctor prescribed another round of antibiotics. I've lost about 10 pounds in the last month. I'm going back April 27, 2023, for a follow-up appointment. I've had lots of joint pain. I haven't had a fever or cough, but my throat is very sore. I haven?t had much of an appetite either.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: 01/05/2023 Sinus Scan - Negative
Aktuelle Erkrankungen: None
Vorgeschichte: Rheumatoid Arthritis; Osteoarthritis; Sinusitis
Andere Medikamente: AllerFlow; Loratadine; Low Dose Aspirin; Azelastine; Vitamin B12; B Super Complex; Vitamin C; Cimzia; Depo-Medrol Injection; Vitamin D3; Fiber; Fish Oil; Fruits and Veggie Pills; Iron; Levothyroxine; Magnesium; Diclofenac; Mupirocin; Omepra
Allergien: Seasonal; Penicillin; Milk
Vorherige Impfungen: -

VAERS 2618456

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

mild

Staat: VA
Alter: 62,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 19.10.2022
Beginn: 20.02.2023
Tage bis Beginn: 124,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Eye pain Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

I started to have a cough, and my eyes felt like they were stinging. I had a fever of 101. I took Tylenol to reduce the fever and it helped to bring it down, but my fever kept coming back. I took a COVID-19 test the next day and it came back positive. Over the next few days my symptoms had gotten worse, and I felt really tired. I had a telephone visit with a doctor on 2/27/2023 and I was prescribed Paxlovid. I was unable to get my prescription for the medication until 3/2/23. My symptoms lasted for about 6 weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Eye pain
Hospital-Tage: -
Labordaten: 20 OCT 2023- COVID-19 test- Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Chron's Disease; High Blood Pressure
Andere Medikamente: Lisinopril; Rosuvastatin; Fluoxetine; Multivitamin; Omeprazole
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2616154

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

mild

Staat: OR
Alter: 68,0
Geschlecht: F
Eingang: 17.04.2023
Impfdatum: 17.04.2021
Beginn: 01.10.2021
Tage bis Beginn: 167,0
Dosis: 2
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal X-ray Arthralgia Back pain Breast pain Cholecystectomy Cholelithiasis Laparoscopic surgery Pain in extremity X-ray abnormal

Symptomtext

It started back about October 2021. I started having pains 3 fingers underneath my breast around to my back and shoulder. A couple months later I had another attack in December. We were retired and we were out of state. In the spring when I came back north, I went to my doctor and we had an x-ray done and it was noted I had a gallbladder stone. I had a couple more attacks. In December 2022 we had another x-ray done and the stone was the size of an avocado pit. That was the sign to take the gallbladder out. I had that surgery done laparoscopically on 03/29/2023. I'm currently in the recovery stage. I'm still in recovery and I'm on restrictions. I'm not fully recovered at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: DEC2021 X-ray, indicated a gallbladder stone; DEC2022 X-ray, indicated the gallbladder stone grew to size of avocado pit; other x-rays previously that indicated gallbladder stone was present, unknown of growth
Aktuelle Erkrankungen: None
Vorgeschichte: Degenerative Disc Disease, Back, Left Hip, and Left Ankle
Andere Medikamente: Pravastatin; losartan with HCL; metformin ER; gabapentin; escitalopram; NORCO; meloxicam; vitamin D3; krill oil; vitamin B12; coQ10; milk thistle; magnesium plus zinc
Allergien: Codeine; seasonal allergies
Vorherige Impfungen: -

VAERS 2614720

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: VA
Alter: 76,0
Geschlecht: M
Eingang: 13.04.2023
Impfdatum: 10.10.2022
Beginn: 05.12.2022
Tage bis Beginn: 56,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise Oropharyngeal pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had a runny nose and a slightly sore throat. I also had a low-grade fever. It was very mild but since I was scheduled for an operation the following day, the symptoms became more severe than the previous day. I called my doctor and was prescribed. I began taking the treatment the next day. My symptoms had worsened by this point. I began to feel alright for 3 or 4 days and remained positive until December. I had mild symptoms that had been gone before the test reflected that I was negative for the virus.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 home December 6, 2022 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hyperlipidemia; Hypertension; Hypothyroidism; Osteoarthritis; Reflux Esophagitis; Colon Polyps; Cataracts
Andere Medikamente: Levothyroxine; pravastatin; telmisartan; tadalafil; vitamin D3; enteric coated aspirin
Allergien: VIOXX; spicy red peppers; egg plant
Vorherige Impfungen: -

VAERS 2614643

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 07.10.2022
Beginn: 01.04.2023
Tage bis Beginn: 176,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

On 04/01 I contacted the medical group. I had severe cough, low grade temperature, chills, congestion body aches and a fever. The doctor started treating the with two extra strength TYLENOL and PAXLOVID, tromethamine DM lots of water and rest. I was told to retest 5 more day and I tested on the 5th day and was negative. I still have a little cough which I think it's just allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; High Blood Pressure; Thyroid
Andere Medikamente: CENTRUM women's; SPIRIVA inhaler; SYMBICORT; ginkgo; magnesium; amlodipine; hydrochlorothiazide; levothyroxine; montelukast; CLARITIN; azelastine; rosuvastatin MUCINEX; calcium ; D3; fish oil; coQ10; EMERGEN C
Allergien: Opioids; shellfish
Vorherige Impfungen: -

VAERS 2614561

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OH
Alter: 63,0
Geschlecht: M
Eingang: 13.04.2023
Impfdatum: 12.10.2022
Beginn: 21.03.2023
Tage bis Beginn: 160,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Chills Cough Exposure to SARS-CoV-2 Headache Impaired work ability Influenza like illness Myalgia Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I woke up and felt achy and had a headache and muscle aches. I had been at an event over the weekend and another person at the event said her husband tested positive for COVID-19, so I thought I had it too. I took a test on 03/21/23 and it was negative and then I had a positive result on 03/22/23. My symptoms got worse. I developed a cough, sore throat, fever, weakness, chilling, and flu like symptoms. The 22nd and 23rd of March were the worst but it started to gradually ease off. I had to take some time off that week. I called the doctor and the NP said to call if it got worse or wait if it did not. I had another test on 03/29/23 and it was positive, then another test on 03/30/23 and 03/31/23 and they came back negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 21MARCH2022 COVID-19 Test ? Negative; 22MARCH2022 COVID-19 Test ? Positive; 29MARCH2022 COVID-19 Test ? Positive; 30MARCH2022 COVID-19 Test ? Negative; 31MARCH2022 COVID-19 Test ? Negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Sertraline
Allergien: None
Vorherige Impfungen: -

VAERS 2614471

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CA
Alter: 48,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 09.10.2022
Beginn: 04.04.2023
Tage bis Beginn: 177,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Feeling abnormal Headache Hyperhidrosis Impaired work ability Middle insomnia Nasal congestion Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

On Tuesday afternoon during the last hour of work I started to feel "off", just like something was being worked on in my body. When I got home I took two at-home COVID19 test and it was positive but the other one was negative. That night I was awakened by a fever with chills and sweats and a really bad headache. I took some TYLENOL which helped the fever but not the headache. I took another COVID19 test in the morning and it was immediately positive. I called into work sick, and called my PCPs office. The pharmacist called me and asked if I wanted PAXLOVID, but I declined. My symptoms were nasal congestion, headache, low fever averaging 100-101, and body aches. On the 4th day I could tell it had peaked and was not worsening, and started to improve. I still had a fever on my 6th day, of 100 but the next day I was better. I still have some nasal congestion but its resolving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 2023Apr04 COVID19 test (positive); 2023Apr04 COVID19 test (negative); 2023Apr5-COVID19 test, strong positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2612418

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OH
Alter: 61,0
Geschlecht: F
Eingang: 10.04.2023
Impfdatum: 07.10.2022
Beginn: 31.03.2023
Tage bis Beginn: 175,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I had extremely bad sore throat, coughing, I took a home COVID-19 test, it came back negative. I took a second test on the first of April, it came back positive, I called my doctor. I had a telehealth visit, I was prescribed, Paxlovid and a cough medication. I started to feel better, but the cough lingered until Saturday April 8, 2023. I went running today, I didn't have any trouble breathing at all.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 31MAR2023 Home COVID-19 test - negative; 01APR2023 Home COVID-19 test - positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Estradiol; Trazadone; Levocetirizine; Finasteride; Singulair: Atenolol; Escitalopram; Pseudoephedrine; Famotidine; Vitamin D; Calcium Mini with Vitamin D; Albuterol as needed; Mometosone Nasal; Azelastine Eye Drops
Allergien: Amoxicillin; Kiwi; Pollen
Vorherige Impfungen: -

VAERS 2611410

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 64,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 06.10.2022
Beginn: 28.01.2023
Tage bis Beginn: 114,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia Body temperature increased COVID-19 Chills Feeling hot Influenza virus test negative Musculoskeletal discomfort Myalgia Pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Streptococcus test negative

Symptomtext

I tested positive on the 30th. I started feeling sniffily on Saturday and took a test that was negative. I felt achy, had chills, and felt warm. I felt a bit better Sunday but started getting congested and had muscles aches. I did have a temperature of 101 degrees. I had some back discomfort and chills. I retested Monday morning and tested positive. I tried to get Paxlovid from my doctor, but they required me to come in. They tested me again for COVID-19, strep and the flu on February 1. I also lost my taste and smell, this symptom lasted longer than anything else.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 28JAN2023 COVID-19 Negative; 30JAN2023 COVID-19 Positive; 01FEB2023 COVID-19 test Positive; 01FEB2023 Strep screen- negative; 01FEB2023 Flu test- Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: High blood pressure
Andere Medikamente: Atenolol; Latanoprost; Citalopram; Calcium with D3; Multivitamin; Fish oil; CoQ10; Probiotic; Vitamin D3; Fiber capsule; Claritin; Flonase
Allergien: Sulfa drugs; Lovenox
Vorherige Impfungen: I got the first shingles vaccine, and I got it at the same time as a flu shot. I had an itchy rash.

VAERS 2611387

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NY
Alter: 80,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 18.10.2022
Beginn: 20.02.2023
Tage bis Beginn: 125,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Pyrexia SARS-CoV-2 test positive

Symptomtext

I had fever and cough that was mostly it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 20FEB2023 COVID-19 Test-Positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Atorvastatin; Restasis
Allergien: None
Vorherige Impfungen: -

VAERS 2611236

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OR
Alter: 58,0
Geschlecht: F
Eingang: 06.04.2023
Impfdatum: 29.09.2022
Beginn: 19.03.2023
Tage bis Beginn: 171,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Ear discomfort Ear pain Fatigue Feeling abnormal Headache Oropharyngeal pain Pain Paranasal sinus discomfort Pyrexia SARS-CoV-2 test positive Throat irritation

Symptomtext

I had a scratchy throat on Sunday night. I woke up sinus pressure. ear pressure and pain, sore throat, non-productive cough, headache, body ache, fatigue, and a low-grade temperature. I had a virtual visit on the March 20, 2023, after I tested positive for COVID-19, which prescribed Paxlovid. I finished it in five days and was feeling pretty good. I started feeling terrible on the March 27, 2023, and tested and was positive again, so I had a second virtual visit, and have been managing with over-the-counter medicine. I have not tested since March 27, 2023

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: 20MAR2023 - COVID-19 Test - Positive; 27MAR2023 - COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Iron deficiency; Copper deficiency; Zinc deficiency; Osteo Arthritis; Bilateral Hip Replacement; Knee Replacement; Ankle Replacement
Andere Medikamente: Vitamin B-12 injection; IV Iron; IV Copper; IV Zinc; Potassium Chloride; Dry Vitamin A Palmitate; Dry Vitamin D-2; Magnesium; Dry Vitamin E; Dry Vitamin K-1; Dry K-2
Allergien: Aspirin; Clindamycin; Codeine; Cortisone; Hydromorphone; Egg whites; Ertapenem; Flagyl; Erythromycin; Tetracycline; NSAID; Neomycin; Penicillin; Sulfa; Gatifloxacin; Lactose; Strawberry; Chicken; Shellfish; Latex; Soy; Prochlorperazine; Doxycycline
Vorherige Impfungen: I am allergic to egg whites and that was one of the components in Influenza vaccine twenty years ago. I had an asthma attack, an

VAERS 2609992

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: IL
Alter: 70,0
Geschlecht: F
Eingang: 05.04.2023
Impfdatum: 03.10.2022
Beginn: 15.02.2023
Tage bis Beginn: 135,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Diarrhoea Mucosal discolouration Nasal congestion Nasopharyngitis Respiratory tract congestion SARS-CoV-2 test positive Thirst

Symptomtext

I had cold symptoms the first day. I was stuffy and my head was congested. Each day I had different symptoms. One day I was extremely thirsty, and I drank so much water. However, the next day diarrhea which lasted one day also. I was totally congested; my head and nasal passengers were congested. I completed an at home COVID-19 Test that Saturday and it positive. I contacted my primary care doctor on Monday, and he prescribed Paxlovid. I was already beginning to feel better when I started taking the Paxlovid. I recovered from all the symptoms, but I needed to be prescribed an antibiotic a week later because I was coughing up a discolored yellow and green mucus that appeared to be an infection. The antibiotic worked right.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: COVID-19 Home Test-Positive-February 18, 2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Omeprazole; Metoprolol Succ ER; Dioxetane HCL; Losartan; Sertraline HCL; Allegra; Mucinex; Nasacort Nasal Spray; Probiotic; Multi Vitamin; Potassium; D-Mannose; Melatonin; Niacin; Hair, Skin and Nail Supplement; Zinc; Vitamin D; Vitamin B C
Allergien: Seasonal allergies; Medical Adhesives
Vorherige Impfungen: -

VAERS 2609899

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MA
Alter: 46,0
Geschlecht: M
Eingang: 05.04.2023
Impfdatum: 04.10.2022
Beginn: 09.03.2023
Tage bis Beginn: 156,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise Nasal congestion Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on 3/9/23. I had very mild symptoms. I had a sore throat and a small amount of congestion. I contact my doctor and was prescribed Paxlovid. After finishing Paxlovid I had a rebound case on 3/23/23. I had congestion, and nasal congestion. I was not prescribed medication this time, but I took Ibuprofen and Sudafed. I tested negative again on 3/26/23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 09MAR2023 COVID-19 Test - Positive;19MAR2023 COVID-19 Test - Negative; 23MAR2023 COVID-19 Test - Positive; 26MAR2023 COVID-19 Test - Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2608389

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NH
Alter: 36,0
Geschlecht: F
Eingang: 03.04.2023
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypersensitivity Oropharyngeal pain Pharyngeal disorder

Symptomtext

I experienced a allergic reaction that opened up my throat and caused a very sore throat.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Prenatal vitamins
Allergien: Bee venom
Vorherige Impfungen: -

VAERS 2608309

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NY
Alter: 71,0
Geschlecht: F
Eingang: 03.04.2023
Impfdatum: 01.10.2022
Beginn: 23.03.2023
Tage bis Beginn: 173,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Haemorrhage Herpes zoster Nervous system disorder Pain Pruritus

Symptomtext

I experienced Shingles on my head and the nerve system that goes around my right eye. My eyebrow area had bumps around it. It was itchy and I started scratching it. Then it started bleeding. I happened to be traveling at the time. I called my doctor and I received a prescription of Valacyclovir. I took the medication for a week. I had minor pain for the first three days. I also saw my ophthalmologist on March 27, 2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure; Overweight; Heart murmur
Andere Medikamente: Atenolol; Amlodipine; Duloxetine; Hydrochlorothiazide; Xyzal
Allergien: Codeine; Ampicillin; Carbamazepine OX
Vorherige Impfungen: -

VAERS 2597594

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 69,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 07.10.2022
Beginn: 08.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia

Symptomtext

Right shoulder began to hurt after the injection and hasn't really calmed down, unable to lay on it and I will need to send her to PT and ortho.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Trulicity, Metformin, Atorvastatin, losartan, amlodipine, fish oil, eplerenone, vit d
Allergien: sulfa
Vorherige Impfungen: -

VAERS 2596253

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WI
Alter: 86,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 14.10.2022
Beginn: 01.01.2023
Tage bis Beginn: 79,0
Dosis: 5
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia COVID-19 Chest X-ray normal Computerised tomogram head normal Fall Hemiparesis Muscular weakness Pyrexia SARS-CoV-2 test positive Speech disorder

Symptomtext

On 1/1/2023, patient presented to the emergency department with concerns for weakness and speech difficulties. She was promptly tested for COVID-19 which came back positive. Patient did have a mild fever, but her other vital signs were normal, and she was not hypoxic. There was no evidence of viral or bacterial pneumonia on chest x-ray or upon examination. Chest x-ray showed no acute cardiopulmonary findings. Treatment included IV fluids for hydration and Tylenol for a low-grade temperature of 100.4F. Patient was noted to have a fall earlier in the day at her assisted living residence. Therefore, she was evaluated for hemorrhagic versus ischemic CVA due to weakness in the left arm. Her stat head CT was unremarkable and showed no intracranial hemorrhage. Treatment for Ischemic CVA with tPA was considered but was deferred given the uncertainty of a CVA and the anticoagulation medication that the patient takes. Due to the patient's increased overall weakness, weakness in her left arm and possibility of a CVA, she was admitted to the hospital on 1/2/2023 for further treatment and evaluation. Her admission diagnoses were COVID-19 Infection, Generalized Weakness, and Questionable Left Sided Weakness (likely chronic in LUE). Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 1/1/2023 - positive COVID NAA Test 1/1/2023-1/2/2023: Stat head CT unremarkable with no intracranial hemorrhage; Chest x-ray showed no acute cardiopulmonary findings.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Dementia, Atrial fibrillation on Eliquis, congestive heart failure, hypertension, urinary incontinence, arthritis, MDD, left hand weakness.
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2593278

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CT
Alter: 42,0
Geschlecht: F
Eingang: 08.03.2023
Impfdatum: 31.01.2023
Beginn: 01.02.2023
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain

Symptomtext

Patient developed pain in the deltoid muscle after the vaccination. Pain persistent as of date of this report (3/8). No findings on exam.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Low back pain with sciatica, pancreatic cyst, chronic idiopathic urticaria, tubal infertility, major depression
Andere Medikamente: None
Allergien: Almonds (hives), cat dander (congestion), meloxicam (rash)
Vorherige Impfungen: -

VAERS 2586381

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 23.02.2023
Impfdatum: 08.10.2022
Beginn: 17.02.2023
Tage bis Beginn: 132,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anaemia COVID-19 Haemoglobin decreased Malaise Red blood cell transfusion Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Primary Care Physician at Discharge: MD Hematologist/Oncologist: Dr. Admission Date: 2/17/2023 Discharge Date: 02/20/2023 Patient's Discharge Disposition: Home in stable condition. This is a 63 yo with a history of metastatic myxoid liposarcoma who presents to hospital on 2/17/23 for planned cycle 5 of Doxorubicin/Ifosfamide. He reports after the last chemo cycle he did get more fatigued than with previous cycles but that has since resolved. For his cycles he has been discharging prior to last inpatient doses of mesna and has a PO mesna script to take after discharge. He also self-injects Nyvepria. He has both mesna and nyvepria scripts already filled. He gets labs weekly and has standing orders there that are current. He usually follows up with staff or Dr. prior to his next cycle. Patient did tolerate chemotherapy but on 2/19 he woke up feeling very congested and reported other family members were sick at home. Film array was positive for covid-19. Given this finding and patient not feeling well discharge was delayed. He did receive IV mesna after his last ifosfamide instead of taking the PO at dc. He got 2 doses of IV remdesivir. He is afebrile and was feeling better on 2/20. He was given 1 unit of PRBC given mild anemia of 8.4. Discussed with Dr. and given he is feeling okay despite covid-19 infection will discharge home today. He can still do the self-inject Nyvepria later Monday evening or Tuesday evening. He will complete PO dex Days 4-6 of this cycle (has script at home). Given he will be in covid iso through 2/23 he will get labs drawn on Friday instead of Wednesday. We reviewed that if he has any worsening symptoms related to covid-19 infection he is to call our office. The patient is discharging home tonight in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Abnormal MRI, musculoskeletal Carpal tunnel syndrome of right wrist Hyperlipemia Hypertension, unspecified type Laceration of thumb Lesion of pelvic bone Palpable mass of soft tissue of thigh Myxoid liposarcoma Liposarcoma Chemotherapy induced neutropenia
Andere Medikamente: baclofen (LIORESAL) 10 MG tablet dexamethasone (DECADRON) 4 MG tablet NYVEPRIA 6 MG/0.6ML prefilled syringe omeprazole (PRILOSEC OTC) 20 MG tablet
Allergien: CodeineUnknown
Vorherige Impfungen: -

VAERS 2566678

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: VA
Alter: 61,0
Geschlecht: M
Eingang: 24.01.2023
Impfdatum: 22.10.2022
Beginn: 23.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Bone densitometry Computerised tomogram Exercise tolerance decreased Gait disturbance Gait inability Pain Sleep disorder Walking aid user X-ray

Symptomtext

On about 12PM 10/22/2022 I received the Moderna Bivalent shot at a pharmacy, I returned home and relaxed, upon awakening on 10/23/2022 I noticed pain instability and unable to walk I took ibuprofen and used supportive aids to walk or crutches, upon sleeping I was unable due to severe pains. On 10/24/2022 I went to the emergency room and medicine and painkillers was given to me and administered. On 10/26/2022 I was still dealing with pain and was trying to work out but pain was still there so I was referred to physical therapy. On 10/27/2022 the pain was still so bad I was referred to pain management which I did not go to.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: Bone density scan, CAT scan, blood workup, X-rays.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Losartan; FLOMAX; green tea supplement; turmeric; vinegar tablet
Allergien: None
Vorherige Impfungen: -

VAERS 2565621

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CT
Alter: 47,0
Geschlecht: F
Eingang: 23.01.2023
Impfdatum: 19.10.2022
Beginn: 22.10.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bone marrow oedema Magnetic resonance imaging abnormal Musculoskeletal pain Pain Sacroiliitis

Symptomtext

A few days after the vaccine I started to experience some intermittent pain deep into the right buttock region when walking, that I had never experienced before. I had to go in for an MRI for a previous sports injury on my right hip and at the time they found bone marrow edema indicative of unilateral sacroiliitis in the area that became sore after the vaccination. My primary care retired and I am still in the process of getting follow up testing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Musculoskeletal pain
Hospital-Tage: -
Labordaten: 2022Dec06, MRI
Aktuelle Erkrankungen: N/A
Vorgeschichte: Narcolepsy; Hashimoto's
Andere Medikamente: Sodium oxalate; SYNTHROID; vitamin B complex
Allergien: N/A
Vorherige Impfungen: -

VAERS 2561382

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MA
Alter: 50,0
Geschlecht: F
Eingang: 17.01.2023
Impfdatum: 12.10.2022
Beginn: 07.11.2022
Tage bis Beginn: 26,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test normal Computerised tomogram head normal Headache Nausea

Symptomtext

On 11/07/2023, I started getting headachy. Sometimes I get headaches around my menstrual cycle which I have medication for, but this didn't seem to go away. I also took Benadryl and that seemed to help a little bit, but the headaches never fully went away. I started to feel better a few days later. However, since the beginning of November, I'll have a few good days here and there but then I'll start to get headachy again and nothing seems to help relieve the pain. On 12/09/2022, I saw a doctor who thought I may have a sinus infection. She prescribed antibiotics which I took for one week. I had begun experiencing nausea as well and the antibiotics seemed to help with that but not the headaches. on 12/12/2022, they performed blood work, but everything looked normal there. I went to a different doctor on 01/12/2023 who ordered a CT scan. He did not see any signs of a sinus infection and prescribed a daily medication, Amitriptyline, for my headaches. I began taking that on 01/14/2023. He also referred me to a neurologist for further testing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 12DEC2022 - Blood Work - Nothing Abnormal Found; 01JAN2023 - CT Scan - Nothing Abnormal Found
Aktuelle Erkrankungen: None
Vorgeschichte: Spasmatic Torticollis
Andere Medikamente: Multivitamin
Allergien: Aspirin; Ibuprofen
Vorherige Impfungen: -

VAERS 2554666

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: IL
Alter: 50,0
Geschlecht: F
Eingang: 09.01.2023
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Allergic respiratory symptom COVID-19 Cough Fatigue Headache Influenza virus test negative Malaise Nausea Pain Pyrexia Respiratory syncytial virus test negative SARS-CoV-2 test positive Somnolence

Symptomtext

The evening of vaccination and the next day I experienced fever, body aches, exhaustion, sleepiness. On 11/09/2022-11/10/2022 I was sick, nauseous, fatigued, headaches as well as coughing. I then got sick, I got COVID-19 on Tuesday 12/27/2022 I noticed it was no longer my allergy symptoms, I started with fever that day and coughing by the next day I began to feel stomach pain, extreme fatigue and sleepiness, fever. Fever stopped by 12/30/2022 but exhaustion has been continuous, Body aches and headaches are better now as of the report date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: COVID-19, Influenza, RSV test. COVID-19 the only test that resulted in positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Headaches; ADHD; Anxiety; Acid reflux
Andere Medikamente: LEXAPRO; ADDERALL; levothyroxine; vitamin D; vitamin D3 plus K2; multivitamin; magnesium citrate; cetirizine; fish oil
Allergien: Environmental allergies
Vorherige Impfungen: -

VAERS 2554591

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: AL
Alter: 72,0
Geschlecht: F
Eingang: 09.01.2023
Impfdatum: 08.10.2022
Beginn: 19.12.2022
Tage bis Beginn: 72,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Eye irritation Influenza Influenza virus test positive Malaise Pain Pyrexia SARS-CoV-2 test positive Upper respiratory tract infection

Symptomtext

12/19/2022 I had a bit of a cough and was not feeling well which is why I went to see the doctor. While at the doctor, they performed a rapid COVID-19 test which was positive. Doctor diagnosed an upper respiratory infection and I also tested positive for the Flu at that time. Doctor prescribed AUGMENTIN and a steroid shot. I had a fever off and on peaking at 102 for about 10 days. My eyes burned, and I had body aches. These lasted about 2 weeks. Sporadic cough lingers to time of reporting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 12DEC2022 rapid COVID-19 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD; Osteoarthritis; Osteoporosis; Fibromyalgia; Plantar Fasciitis; Degenerative Disc Disease
Andere Medikamente: Tramadol; losartan; estradiol; BREO ELLIPTA inhaler; clonidine; cyclobenzaprine; gabapentin; triazolam; atorvastatin; VENTOLIN inhaler; calcium; vitamin B; vitamin D3; HMB
Allergien: Latex
Vorherige Impfungen: -

VAERS 2552464

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NJ
Alter: 74,0
Geschlecht: U
Eingang: 06.01.2023
Impfdatum: 06.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dizziness Fatigue Headache Malaise Pyrexia SARS-CoV-2 test positive Visual impairment

Symptomtext

About 6 hours after receiving the vaccine, I felt dizzy like I was going to pass out. I was seeing spots before my eye. I had to sit down and put my head down. My doctor took me home and the next day all my symptoms were gone. On December 27, 2022, I woke up with a fever, headache and was extremely tired. I felt rather crappy. 100.9 was the highest fever I had. I tested for COVID-19, and it was positive. My doctor prescribed molnupiravir. My symptoms improved on the 4th day. I have completely recovered from my symptoms. I am still tired, and the fever has been gone for more than a week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: COVID-19 home December 28, 2022 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Thyroid Deficiency
Andere Medikamente: Levothyroxine; allopurinol; atorvastatin; cetirizine; calcium with vitamin D; vitamin B complex; multivitamin
Allergien: Penicillin; sulfa; cephalosporin; naproxen
Vorherige Impfungen: Moderna Dose 2, elevated heart rate, emergency room overnight observation April 3rd, 2021

VAERS 2552427

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NC
Alter: 76,0
Geschlecht: F
Eingang: 06.01.2023
Impfdatum: 06.10.2022
Beginn: 14.12.2022
Tage bis Beginn: 69,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Nasal congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I received my Covid-19 vaccine on 10/06/2022. On the morning of 12/14/202 I woke up with a runny stuffy nose and headache. I took an at home Covid-19 test and tested positive. After testing positive I reached out to my doctor and was prescribed PAXLOVID. Symptoms lasted about 9 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Degenerative Back disease
Andere Medikamente: Levothyroxine; losartan; calcium citrate; vitamin D3; magnesium; B12; fish oil; senior multivitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2551521

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OH
Alter: 52,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 01.10.2022
Beginn: 19.12.2022
Tage bis Beginn: 79,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Ageusia Anosmia Chills Cough Headache Hypogeusia Oropharyngeal pain Pyrexia Respiratory tract congestion

Symptomtext

I contracted COVID. My symptoms started with headache and sore throat. The next day I tested positive and had chills and fever that was not being reduced by ADVIL or TYLENOL. I also had head congestion. The head congestion lasted for 10 to 14 days. And head coughing. I retested positive on the 30th of December. I took all over the counter medication to help calm symptoms. I also lost my taste and smell. I am recovered now but my taste is diminished but all other symptoms did clear with time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin; vitamin D; vitamin C
Allergien: Penicillin; seasonal allergies
Vorherige Impfungen: -

VAERS 2550221

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: TX
Alter: 73,0
Geschlecht: M
Eingang: 04.01.2023
Impfdatum: 03.10.2022
Beginn: 25.11.2022
Tage bis Beginn: 53,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Pyrexia SARS-CoV-2 test positive

Symptomtext

11/25/2022 Felt allergy symptoms in the morning. Tested 11/26 Positive with an At Home COVID-19 Test. Developed a fever peaking at 100.6 with allergy symptoms continued. 11/27 Visited Doctor who prescribed Lagevrio, Zinc, Vitamin C, Vitamin D3. Tested positive again on a rapid COVID-19 test. Advised to treat symptomatically. Fever fell to 99 on 11/28 and gone completely by 11/29. Allergy symptoms persisted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: tested 11/26 Positive with an At Home COVID-19 Test Tested positive again on a rapid COVID-19 test 11/27.
Aktuelle Erkrankungen: No
Vorgeschichte: High Blood Pressure
Andere Medikamente: Tamsulosin; Amlodipine; Metoprolol; Enalapril; Zyrtec; Ostiobiflex; Multivitamin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2550195

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CT
Alter: 67,0
Geschlecht: F
Eingang: 04.01.2023
Impfdatum: 04.10.2022
Beginn: 21.12.2022
Tage bis Beginn: 78,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Pyrexia SARS-CoV-2 test positive

Symptomtext

On 12/21/2022, I woke up with a cough. I had just spent the day before doing a serious cleaning in my basement, so I thought I was reacting to dust. I had family coming for the holiday though, so on 12/22/2022, when I still had a cough and a slight fever, I took an at home COVID-19 test and it was positive. I took some TYLENOL to treat the fever and called my doctor who prescribe PAXLOVID. I started taking that the same night. By the next morning, I was already feeling better. The PAXLOIVD made me feel sicker that the COVID-19. By 12/25/2022, I tested again, and it was negative. Overall, it was a very mild case.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 22DEC2022 at home COVID-19 test positive; 25DEC2022 at home COVID-19 test negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Pantoprazole; LIPITOR; multivitamin; calcium
Allergien: Penicillin; azithromycin; tetracycline
Vorherige Impfungen: Shingles vaccine 2021 Age: 66, fatigue, extreme arm pain

VAERS 2550069

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 79,0
Geschlecht: M
Eingang: 04.01.2023
Impfdatum: 04.10.2022
Beginn: 26.12.2022
Tage bis Beginn: 83,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dizziness Exercise tolerance decreased Exposure to SARS-CoV-2 Fatigue Headache Malaise Productive cough Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I received the Moderna Bivalent booster on 10/4/2022. On 12/26/2022, I had congestion and fatigue. I had had a common cold about three weeks before. Also, I was in a higher altitude than what I'm accustomed to, so I thought that maybe that also played a role in my symptoms. On 12/27/2022, I developed a dry cough that later became a productive cough. My wife tested positive for COVID-19 that day; I tested myself the same day, but my result was negative. I then tested myself again on 12/28/2022 and also got a positive result. I progressively became more fatigued and felt lightheaded for the next few days. At the time of this writing, this is the first day since my illness that I have not been lightheaded. I spoke with my doctor to see if he recommended PAXLOVID, but he advised me that it was almost too late for me to begin taking it for it to be effective. Not only that, but I also take a statin, and if I had begun taking the PAXLOVID, I would have had to stop taking the statin, which is inadvisable. The only medicine I took during my illness was one ALEVE on 12/28/2022, which helped with the headache. I now feel that I'm getting better. The lightheadedness is gone. I also have more energy. I still have some congestion, though it is less pronounced, plus I am coughing less.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: 12/27/2022 home antigen test negative result; 12/28/2022 home antigen test positive result.
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Atorvastatin; magnesium calcium citrate zinc supplement with vitamin D3.
Allergien: Grass; pollen.
Vorherige Impfungen: -

VAERS 2549021

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 69,0
Geschlecht: F
Eingang: 03.01.2023
Impfdatum: 30.09.2022
Beginn: 19.12.2022
Tage bis Beginn: 80,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dysphonia Headache Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

December 20th I had a raspy throat, coughing, headache, my temperature was normal, the COVID-19 test was positive. I initially spoke with a nurse at the office and they initially told me it was probably COVID but there was no medication to take. I heard there was an antiviral medication available and I had a tele-health with a doctor and she prescribed Paxlovid, and I started taking that night. I stayed in the house, and kept my mask on after the initial 5 days. I didn't leave the house until December 29th. On December 30th I stared developing nasal drainage and sneezing and I retested and was positive again. On January 2nd, I was still testing positive. My temperature is normal and no more runny nose, just a little bit of congestion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 at-home rapid tests (positive) (12/20/22), COVID-19 at-home rapid tests (positive)- (12/31/22), COVID-19 at-home rapid tests (positive)- (01/02/23)
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; High Cholesterol; Glaucoma; Osteoporosis; Pre-diabetes
Andere Medikamente: Diltiazem; Atorvastatin; Timolol; Loratadine; Iron; Calcium
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2548870

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: TN
Alter: 68,0
Geschlecht: F
Eingang: 03.01.2023
Impfdatum: 05.10.2022
Beginn: 01.01.2023
Tage bis Beginn: 88,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Pain Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

I tested positive for COVID-19 on 1/1/23. I had a runny nose, cough, body aches, fatigue, and sneezing. I have not received any prescriptions because I have not been able to make it to my doctor's office due to the holiday. I did take some over-the-counter medication, Mucinex and Sudafed. I am still dealing with the symptoms at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 01JAN2023 COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Glaucoma; Meniere's Disease
Andere Medikamente: Triamterene Hydrochlorothiazide; Fluticasone; Migravent; Vitamin K2; Vitamin D3; AREDS; Timolol
Allergien: N/A
Vorherige Impfungen: -

VAERS 2548408

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

mild

Staat: -
Alter: 81,0
Geschlecht: F
Eingang: 02.01.2023
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site bruising Injection site pruritus

Symptomtext

patient reported bruising, itching at the injection site. By 10/14 she had made a full recovery

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2547138

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MA
Alter: 67,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 29.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site erythema Injection site urticaria

Symptomtext

It was a progression of redness that was like a welt at the injection site. I've never gotten anything like that before. It looked like a hive then it started to spread and became wider. It started to circle my arm. I started marking it over the next few days. I was told to take some BENADRYL and I started icing the area. I hadn't had it with any of the other vaccines. I had 3 Moderna vaccines with a fourth dose being Pfizer, then I had another Moderna vaccination. I'm curious to see if having another Moderna vaccine after that Pfizer vaccine caused me to have a reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Atrial Fibrillation; GERD; Overweight; Kidney Stones; Barrett's Esophagus; Thyroid Disease; Hyperlipidemia
Andere Medikamente: Atorvastatin; ELIQUIS; levothyroxine; famotidine; omeprazole; metoprolol; vitamin C; multivitamin; probiotic blend
Allergien: None
Vorherige Impfungen: -

VAERS 2545837

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: IA
Alter: 8,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 27.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity Pruritus Urticaria

Symptomtext

Hives/large welts on both forearms, pain and itching on arms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Open heart surgery Oct 31, 2022
Vorgeschichte: Complex congenital heart disease, protein losing enteropathy, Fontan associated liver disease
Andere Medikamente: Spironolactone Aspirin Budesonide Sildenafil Furosemide Enalapril
Allergien: Latex Gadavist (spelling? MRI contrast)
Vorherige Impfungen: -

VAERS 2530376

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

mild

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 12.11.2022
Beginn: 07.12.2022
Tage bis Beginn: 25,0
Dosis: 6
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Headache Muscle spasms Nasopharyngitis Pyrexia SARS-CoV-2 test positive Sneezing Throat irritation Upper-airway cough syndrome

Symptomtext

I had my vaccination on 11/12/2022. I started to have cold like symptoms on 12/07/2022 such as a scratchy throat post nasal drip coughing sneezing slight headache chills and low grade fever. I had the PCR test on 12/08/2022 and diagnosed COVID-19 Positive on 12/09/2022. Cough is non productive with spasms as of 12/12/2022. I am COVID-19 Negative on 12/13/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 12/09/2022 COVID-19 Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Chronic Inflammation; Rosacea; Lingering difficulty walking after undiagnosed COVID-19 2019; Asthmatic
Andere Medikamente: Flaxseed oil; Vitamin D3; Calcium; Magnesium; Zinc; Multivitamin; Turmeric; Zyrtec; Cortisone; Rescue Inhaler
Allergien: Sulfa; Penicillin; Sodium
Vorherige Impfungen: COVID-19 vaccinations chilled. Flu shots looks like bee sting.

VAERS 2528377

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 79,0
Geschlecht: F
Eingang: 10.12.2022
Impfdatum: 12.10.2022
Beginn: 10.12.2022
Tage bis Beginn: 59,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Pyrexia

Symptomtext

FEVER, CHILLS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2512574

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

mild

Staat: KS
Alter: 60,0
Geschlecht: M
Eingang: 21.11.2022
Impfdatum: 28.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Herpes zoster Pyrexia Vaccination site discolouration Vaccination site erythema Vaccination site induration Vaccination site warmth Vein discolouration

Symptomtext

Shingles; Approximately 15-Oct-2022: left arm had a blue spot around the area that I got injection in; The veins in my arm up to my shoulder are blue; had Covid arm, It was hot; had Covid arm, It was hard; had Covid arm. It was red; slight fever; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (had Covid arm, It was hot), VACCINATION SITE DISCOLOURATION (Approximately 15-Oct-2022: left arm had a blue spot around the area that I got injection in), VEIN DISCOLOURATION (The veins in my arm up to my shoulder are blue), HERPES ZOSTER (Shingles) and VACCINATION SITE INDURATION (had Covid arm, It was hard) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Chemotherapy in December 2016. Concurrent medical conditions included Immune disorder (NOS) (patient did not have any Immunoglobulin A), Brain tumor (Patient had last chemo in Dec-2016) and Artificial cardiac pacemaker user. On 28-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Sep-2022, the patient experienced VACCINATION SITE WARMTH (had Covid arm, It was hot), VACCINATION SITE INDURATION (had Covid arm, It was hard), VACCINATION SITE ERYTHEMA (had Covid arm. It was red) and PYREXIA (slight fever). In October 2022, the patient experienced VACCINATION SITE DISCOLOURATION (Approximately 15-Oct-2022: left arm had a blue spot around the area that I got injection in) and VEIN DISCOLOURATION (The veins in my arm up to my shoulder are blue). On 15-Nov-2022, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, VACCINATION SITE WARMTH (had Covid arm, It was hot), VACCINATION SITE DISCOLOURATION (Approximately 15-Oct-2022: left arm had a blue spot around the area that I got injection in), VEIN DISCOLOURATION (The veins in my arm up to my shoulder are blue), HERPES ZOSTER (Shingles), VACCINATION SITE INDURATION (had Covid arm, It was hard), VACCINATION SITE ERYTHEMA (had Covid arm. It was red) and PYREXIA (slight fever) outcome was unknown. No concomitant drug was reported. Patient received first dose on 18Mar2021, Lot: 03N20A. Patient received second dose on 13Apr2021, Lot: 003B21A. Patient received third dose on 01Nov2021, Lot: 014F21A. Patient received fourth dose on 22Apr2022, Lot: 00ZM21A. Patient read somewhere that Covid arm should go away in about 21 days. Approximately 15Oct2022, patient left arm had a blue spot around the area that patient got injection in. The veins in patient arm up to shoulder are blue. Patient went to physician on 15-Nov-2022 and they were going to do a sonogram on patient's arm. No treatment drug was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Artificial cardiac pacemaker user; Brain tumor (Patient had last chemo in Dec-2016); Immune disorder (NOS) (patient did not have any Immunoglobulin A)
Vorgeschichte: Medical History/Concurrent Conditions: Chemotherapy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2511682

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: PA
Alter: 65,0
Geschlecht: F
Eingang: 18.11.2022
Impfdatum: 13.10.2022
Beginn: 14.11.2022
Tage bis Beginn: 32,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Headache Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I was having a headache on Monday long with fatigue. On Tuesday I was starting to get congestion and runny nose the next day the congestion was worse so that Wednesday I did a COVID-19 home test and it was positive. I called my doctor and they had me get zinc and vitamin D3 and C along with putting me on PAXLOVID. I am very fatigued right now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 home test
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Multivitamin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2510726

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: IA
Alter: 49,0
Geschlecht: F
Eingang: 17.11.2022
Impfdatum: 11.11.2022
Beginn: 12.11.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Canalith repositioning procedure Dizziness Headache Swelling face Vertigo

Symptomtext

Vaccine on Friday afternoon. Mild lower facial swelling next morning (noticed 21 hrs post vaccine). Dizziness/vertigo (22 hours post vaccine went to ER, given allergy cocktail, tested for heart attack etc, blood panels were normal). Felt a bit better several hours later and went home. Mild to moderate dizziness and headache for the next two days (Sun/Mon). Went to Urgent Care Mon night. Tried Epley maneuver Monday night and Tues monday. Severe vertigo on Tues after epley maneuver. Went back to the doctor Tues afternoon, still dizzy with headache. Will follow up with vestibular therapy. Weds and Thurs still dizzy, but not severe vertigo.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: ER visit 11/12/22 Urgent Care visit 11/14/22 Doctor visit 11/15/22
Aktuelle Erkrankungen: internal nose sore that had resolved several weeks
Vorgeschichte: reflux
Andere Medikamente: Famotidine Allegra
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2508613

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NJ
Alter: 68,0
Geschlecht: F
Eingang: 15.11.2022
Impfdatum: 18.10.2022
Beginn: 02.11.2022
Tage bis Beginn: 15,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Aphonia COVID-19 Cough Dysphonia Headache Hypersomnia Nasal congestion Oropharyngeal pain Paranasal sinus discomfort Pyrexia Rhinorrhoea SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

On 11/02/2022, I had a stuffy nose, a headache, sinus pressure, and a low-grade fever. I tested positive with an at home COVID-19 test and I was able to have a telehealth appointment that day where a nurse practitioner prescribed PAXLOVID, and I began taking the medication that evening. 11/03/2022, I slept a lot with fever, sore throat, and headache. 11/04/2022, I had low fever, sore throat, and cough with another positive COVID-19 test. 11/05/2022, the fever was gone, but I still had a headache, some digestive upset, cough, and was losing my voice. 11/06/2022, I had cough, sore throat and hoarseness. On 11/07/2022, I had some sore throat still but tested negative. However, on 11/12/2022, I began to get a runny nose and fever again. I tested for COVID-19 again on 11/13/2022, and it was positive. On 11/14/2022, I had stuffy nose, cough, and low fever. Today, the fever is gone, but I am still positive, and I have a deep bronchial cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 02NOV2022 at home COVID-19 test positive; 04NOV2022 at home COVID-19 test positive; 07NOV2022 at home COVID-19 test negative; 13NOV2022 at home COVID-19 test positive; 15NOV2022 at home COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin
Allergien: Tetracycline
Vorherige Impfungen: -

VAERS 2505845

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OR
Alter: 69,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 06.10.2022
Beginn: 25.10.2022
Tage bis Beginn: 19,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest discomfort Cough Headache Lower respiratory tract congestion Pyrexia SARS-CoV-2 test positive

Symptomtext

I had heavy cough, tight chest congestion, low-grade fever, and a headache after going to the beach with a friend a couple of days later. So I went to a local pharmacy on 10/31/2022 to take PCR COVID-19 test which came back positive. I used my breathing candy and sucked on ginger to help rebuild my immunity and get better. Later, my doctor just prescribed me albuterol to use my nebulizer for breathing treatments.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 test: 10/31/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma
Andere Medikamente: Albuterol; TRELEGY; lovastatin; aspirin; calcium; vitamin D3; immunity supplement
Allergien: Morphine
Vorherige Impfungen: -

VAERS 2505712

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 14.10.2022
Beginn: 15.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Erythema Feeling cold Feeling hot Hyperhidrosis Immunisation reaction Injection site erythema Injection site pruritus Injection site warmth Pruritus Skin warm

Symptomtext

She got her vaccine, she got very hot and sweaty, very cold, felt faint and when she went to get dressed her arm to her shoulder past her elbow was red and itchy, hot to the touch. She thought for a while it was going to be OK. She went on 10/16/22 to the UC and said that she was having a reaction to the booster shot and gave her an injection of Benadryl. She was told to put Benadryl cream on it and it took about 5 days before it all went down. She then saw her doctor and told him about the whole incident, and made aware of it. She was OK by the point that she saw her doctor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None.
Vorgeschichte: High blood pressure, arthritis, CAD.
Andere Medikamente: Lisinopril, Metoprolol, Methotrexate, Atorvastatin.
Allergien: Penicillin, Clindamycin.
Vorherige Impfungen: -

VAERS 2499858

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OR
Alter: 22,0
Geschlecht: M
Eingang: 05.11.2022
Impfdatum: 15.10.2022
Beginn: 15.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Immediate post-injection reaction Injection site erythema Injection site induration Product administered at inappropriate site

Symptomtext

Vaccinating RN administered vaccine superior to deltoid muscle target area, observed by FNP on duty to be near joint. An immediate red, indurated area appeared, approx. 30mm in diameter. Recipient denied pain, discomfort and had no impact on range of motion. Patient was observed for 30 minutes, reassessed and provided precautionary guidance by FNP on duty prior to leaving the clinic. No other clinical manifestations presented during observation period.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2493832

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: IN
Alter: 65,0
Geschlecht: M
Eingang: 31.10.2022
Impfdatum: 03.10.2022
Beginn: 14.10.2022
Tage bis Beginn: 11,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Rash erythematous Rash pruritic

Symptomtext

Intermittent, itchy, pink skin rash patches, daily, starting 11 days after the vaccine, and still continuing to this day (28 days), although fewer than initially.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Centrum multivitamin, vitamin C
Allergien: -
Vorherige Impfungen: -

VAERS 2493346

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

mild

Staat: WA
Alter: 64,0
Geschlecht: F
Eingang: 29.10.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Urticaria

Symptomtext

I broke out in hives starting the afternoon of the vaccine. There are about 20 on my left shoulder, neck, arm, wrist, and hand and another 10 on my trunk, both legs, and front/back of trunk. They are continuing to form.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Mild asthma
Andere Medikamente: 5% Minoxidil
Allergien: Dog dander, dust mites, weeds
Vorherige Impfungen: -

VAERS 2492678

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OR
Alter: 32,0
Geschlecht: F
Eingang: 28.10.2022
Impfdatum: 29.09.2022
Beginn: 22.10.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Nausea

Symptomtext

I woke up Saturday morning feeling really nauseous. there wasn't really a reason for it. I got solid sleep. I am prone to dizziness so I'm good about staying hydrated. I thought it would go away have through the day. Throughout the day it continued, I tried eating it didn't make me vomit but worsened the nausea. I tried to drink peppermint tea but that didn't work. I had left over Ondansetron and that cleared it right up. I also had a headache that day

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypothyroidism: Depression
Andere Medikamente: Levothyroxine; Prenatal Vitamin; Biotin
Allergien: Nitrous oxide; Horses
Vorherige Impfungen: -

VAERS 2491532

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WI
Alter: 56,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: 06.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Dysphonia Nasal pruritus Oral pruritus Rhinorrhoea Sneezing Speech disorder Swelling

Symptomtext

About 4:15pm, I had an abrupt onset of sneezing with a runny, itchy nose and cough. I also developed a very raspy voice, could not speak loudly at all. (I have never experienced anything like that with my voice.) This remained until, at 5:15pm, I developed itching around my mouth and sensation of swelling, which did not appear visually. I took 25mg diphenhydramine at that point. Within 20 minutes, the symptoms began to fade and resolved completely within 2 hours. No further symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nasal pruritus
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Diltiazem, Vit D, Calcium, multivitamin
Allergien: Penicillin, Hydrocodone
Vorherige Impfungen: -

VAERS 2490088

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

mild

Staat: VA
Alter: 40,0
Geschlecht: F
Eingang: 26.10.2022
Impfdatum: 06.10.2022
Beginn: 16.10.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Biopsy skin abnormal Chest discomfort Pruritus Rash Urticaria

Symptomtext

rash, hives, itching, tightness in chest

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: Skin biopsy of hives on October 15, 2022. Findings suggested that it may have been a reaction to a medication.
Aktuelle Erkrankungen: none
Vorgeschichte: fibromyalgia, sjogrens
Andere Medikamente: Vitamin D, zoloft, ambien, xanex
Allergien: sulfa, hydrocodone
Vorherige Impfungen: -

VAERS 2490002

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 27,0
Geschlecht: F
Eingang: 26.10.2022
Impfdatum: 08.10.2022
Beginn: 09.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pyrexia Tinnitus

Symptomtext

I developed a 100.2 degree fever about 12-14 hours after vaccine administration. Took Ibu profen at about 14 hours and fever was gone when I woke up about 6-7 hours after that. I noticed a ringing tinnitus sound in my left ear at around 12 hours after vaccine administration. When I woke up the ringing sound was still there, and it did not completely fade until around 3 days later.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: Type 1 Diabetic
Andere Medikamente: Novalog insulin Sronyx birth control Vitamin D Atorvastatin Ibu Profen taken about 14 hours after vaccine administration due to fever
Allergien: shellfish
Vorherige Impfungen: -

VAERS 2487233

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge 027E22A

mild

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 24.10.2022
Impfdatum: 24.10.2022
Beginn: 24.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Muscle spasms Myalgia Neck pain Oesophageal spasm Pain Throat clearing

Symptomtext

Vaccine injection 13:25, Two minutes later her client described sudden shooting sharp pain in the left neck and shoulder muscles. Pain rated 9/10, constant. Client was given medical cold pack to apply, brought to a quiet area & sat at a table, drank cold water, encouraged to relax. At 13:40, Additionally had intermittent cough and throat clearing but no respiratory symptoms. Speech was normal throughout episode, which presented more like esophageal spasm. Talked with a nurse about 1 hr, Throat clearing and cough only lasted 20 minutes. By 2:30 pm Pain diminished to achy muscle cramp in trapezius muscle and neck, VS WNL. Client released, departed at 2:40 pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: VS 1:35 pm BP 139/85 rt upper arm, HR 94 bpm, p02 98% VS before departing BP 118/82, HR 82 bpm, pO2 99%
Aktuelle Erkrankungen: None endorsed
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Multiplefood allergies
Vorherige Impfungen: First dose Pfizer monovalent three 2221, developed anaphylaxis, treated with Epi IM at clinic, no hospitalization Second dose no

VAERS 2486231

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 57,0
Geschlecht: M
Eingang: 22.10.2022
Impfdatum: 18.10.2022
Beginn: 18.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Asthenia Body temperature increased Bone pain Fatigue Feeling abnormal Influenza like illness Myalgia Peripheral coldness Sleep disorder

Symptomtext

Serious fatigue, muscle ache, bone pain all over body. Random 'arthritis pain,' toes, fingers, arms, legs, everywhere. One area would hurt for a minute, then something else would hurt. No one place lasted more than a few seconds. But it just kept coming. Over heated core temperature with cold hands and feet, woke me up from a deep sleep, but I was too weak and miserable to do anything about it, like peel the covers back to cool off. Miserable Very similar reaction to each of the other vaccine doses in the series. But this was the worst. Seems a very 'flu like,' response, only lasting about twelve hours. The worst of it was only three or four hours. Once I was strong enough to get out of bed for more than a couple minutes, about six hours later, some Aleve really helped with the symptoms. Much better the evening following the injection. Still a little foggy and taking it slow, four days later. Again, very similar reaction to the first three doses. I just did not report the symptoms then.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Similar symptoms from all Moderna COVID-19 injections Age 56 4/8/2021 5/1/2021 12/17/2021 I don't remember the bone pain before

VAERS 2485277

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 34,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 07.10.2022
Beginn: 09.10.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: - / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Laboratory test Pain Rash

Symptomtext

painful, throbbing rash w/patchs on knees, and all over Thigh and torso, Pain has gotten worse over The week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: Swab at ER (not submitted)
Aktuelle Erkrankungen: NO
Vorgeschichte: self diagnosed allergic to grass
Andere Medikamente: No.
Allergien: -
Vorherige Impfungen: -

VAERS 2483184

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 60,0
Geschlecht: M
Eingang: 19.10.2022
Impfdatum: 15.10.2022
Beginn: 16.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Chills Cough Injection site pain Oropharyngeal pain Pain Productive cough Pulmonary congestion Pyrexia Rhinitis SARS-CoV-2 test negative Sneezing Sputum discoloured Throat irritation Throat tightness

Symptomtext

I received the Moderna bivalent vaccine at about 1:15 pm on Saturday, October 15, 2022. There was a strong stinging sensation with the vaccine was administered which continued for just a few minutes. Other than soreness around the injection site, there was no issue until about 3 am on Sunday, October 16, 2022 when I was experiencing fever and chills. Later on the 16th, I had a mild sore throat. By the evening of the 16th, I had also developed a cough. On Monday, October 17, there was lung congestion and a productive cough (yellowish sputum). That continued, along with fever and aches, on Monday October 17 and Tuesday, October 18. I also had very limited energy. By now, Wednesday, October 19 at 1:30 pm, the coughing is improved, but my throat is a bit raw and occasionally feels constricted. However, I have considerable sneezing and rhinitis. It seems like I have a cold or flu which happened to start right after my vaccination. However, my wife who lives with me and my brother with whom I have spent several hours each day have not contracted this cold or flu. This makes me suspect that my symptoms are the result of the vaccine and not a coincidental separate event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: I took home Covid tests on Monday, October 17 and Tuesday, October 18, 2022 to determine whether I happened to have started a Covid infection at the same time as getting the latest vaccination. However, both tests were negative.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin D, Fish Oil, Turmeric
Allergien: Betadiene topical disinfectant
Vorherige Impfungen: After earlier Moderna Covid vaccine injections, I had a day or two of fever and lethargy in 2020 and 2021.

VAERS 2483142

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 61,0
Geschlecht: M
Eingang: 19.10.2022
Impfdatum: 08.10.2022
Beginn: 08.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pyrexia

Symptomtext

Fever

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Injection site pain

VAERS 2482832

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: VA
Alter: 67,0
Geschlecht: M
Eingang: 19.10.2022
Impfdatum: 11.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Extra dose administered Malaise Nasal congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I experienced COVID-19 in 08/02/2022 after my fifth dose Moderna vaccine. I was experiencing the symptoms for one day and half before the date of 08/02/2022. I was positive on 08/02/2022. I had a telehealth meeting with my PCP and was given PAXLOVID therapy pack. The symptoms I experienced were coughing, head congestion, nasal drip and just a bad cough. I have recovered from my COVID-19 symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 08/02/2022 COVID-19 test; positive
Aktuelle Erkrankungen: None
Vorgeschichte: Obese
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2482824

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: MA
Alter: 72,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 11.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Rash papular Rash pruritic

Symptomtext

The day after the vaccine I got a rash on my rib cage. Over the next two days it spread to my whole back from my wait to neck to my head. It also spread to my belly and down my arms and then down my legs. It was very itchy and slightly raised. I treated it with over-the-counter anti-itch cream. I went to the doctor yesterday; I saw the PA. The only change in my life has been the vaccine. She concluded it could be from the vaccine. She prescribed prednisone 6-day treatment. She also mentioned to do an AVENO anti-itch cream. I am still itching but it seems to be getting better. I have not stopped doing my daily activities. I have been taking cool showers to help.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Atorvastatin; fish oil; calcium.
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2479732

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WI
Alter: 28,0
Geschlecht: M
Eingang: 16.10.2022
Impfdatum: 16.10.2022
Beginn: 16.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cataplexy Cold sweat Dizziness Pallor Unresponsive to stimuli

Symptomtext

Injection completed at approximetly 1146. Patient sat up in chair whie documentation completed. Approximetly 1146 AM, patient stated, "Whoa! I feel a little dizzy." Patient instructed to rest head and take deep breaths while I went to grab an ice pack approximetly 20 feet away . Upon return, patient noted to be slumped in chair, head extended and back. Eyes open. No audible sound of air exchange noted. Patient did not respond to verbal commands or physical stimulation. Head assisted and held in flexed position to move tongue, which was obstructing airway. Skin tone pale, cool, clammy. Pharmacist entered room. Audible breathing spontaneously resumed. Patient responded to verbal command. Pharmacist instructed him to consume water. Ice pack applied to back of neck with cool, damp papertowel offered to wipe brow and apply to neck/face. Patient oriented to self, situation at 1148. Patient instructed to place head down and take slow, deep breaths. Patient able to hold regular conversation, answer questions and ambulate around office without difficulty or any sign of orthostatic hypotension noted. Patient able to sit and stand without vasovagal syncope occurring at 11:55pm. Patient sat in office with me for 20 more minutes to ensure return to homeostasis occurred as much as possible. Patient d/c at 12:25 pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None reported
Vorgeschichte: None reported
Andere Medikamente: Unknown
Allergien: No allergies listed
Vorherige Impfungen: Unknown as to what vaccine it was, patient reported he has vasovagaled w synocpal episode when he was a child.

VAERS 2479728

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CA
Alter: 63,0
Geschlecht: F
Eingang: 16.10.2022
Impfdatum: 13.10.2022
Beginn: 14.10.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chills Flatulence Flushing Injection site erythema Injection site pain Nausea Pyrexia

Symptomtext

Increasing redness and pain in arm at injection site and spreading from site started 1 cm x 1 cm enlarged to 1.5 cm x 2.5 cm with my measurements.before tx recieved. Nausea,gassy. Later in day flushed face,temp increasing,chills. My normal temp 96-97 ,went up to 99.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Er Dr looked at it and said good think I had marked it. He also said could be skin infection from vaccine but gave Rx for mupirion not oral.. I? still have sore arm and redness today. But chills,nausea and fever have resolved
Aktuelle Erkrankungen: Asthma,thyroid nodules,high triglycerides,LVH,radiculopathy Lt shin,endometriosis,ha of frequent sinus infections . Had toenail root burned Oct 6 with 5 days of Keflex ,hiatal hernia
Vorgeschichte: Asthma,LVH,endometriosis,thyroid nodules,ha of frequent sinus infections,hiatal hernia
Andere Medikamente: Routine daily meds. Saline nasal Flonase,Azelastine,Folic acid,fenofibrate,MVI,Fish oil,Biotin. Take Vit D weekly,Albuterol prn, take tylenol prn but did not take any tylenol prior to moderna bivalent
Allergien: Sensitivities to Motrin,Naproxen,emycin,kenalog injection =N/V. He of cellulitis within 12 hrs from original Moderna vaccines,but no reaction to Johnson booster
Vorherige Impfungen: Moderna

VAERS 2477319

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: WA
Alter: 80,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 11.10.2022
Beginn: 11.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Nausea Pain in extremity

Symptomtext

8 PM No issues at bedtime until shortly thereafter. Up most of the night with heavy nausea and dizziness. gave her Pepto at 5:45 AM?she?s more comfortable sitting up-right in bed. 8 AM - Had light breakfast, and an aspirin for her sore arm. Nausea and dizziness gone. Area soreness the next few days ? used Salonpas on injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: Levothyroxine, Liothyronine, Anastrozole, Fosamax, Multi-Vitamin, Vitamin D 3, Vitamin B12, Calcium, Probiotics 10, Probiotics 10
Allergien: None known
Vorherige Impfungen: -

VAERS 2475744

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NM
Alter: 63,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Inflammation Pruritus Rash

Symptomtext

Itching, rash, redness, and inflammation 4 days post injection on Left shoulder and arm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none reported
Vorgeschichte: chronic heartburn, osteoporosis
Andere Medikamente: None
Allergien: sulfa antibiotics
Vorherige Impfungen: -

VAERS 2473093

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

mild

Staat: CO
Alter: 66,0
Geschlecht: M
Eingang: 09.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Blood glucose increased Headache Hyperhidrosis Influenza Nasopharyngitis Pain

Symptomtext

Patient has cold and flu symptoms for 2-3 days after the vaccination, but 5 days after he still experiencing body ache, joint pain, headache, excessive sweating. His blood glucose is >360 on day 5.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Self test of blood glucose >360
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2473091

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

mild

Staat: AK
Alter: 61,0
Geschlecht: F
Eingang: 09.10.2022
Impfdatum: 03.10.2022
Beginn: 03.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immunisation reaction Pain Pruritus Swelling

Symptomtext

PT SATES SHE EXPERIENCED COVID ARM AFTER BIVALENT BOOSTER. STATES SORENESS, SWELLING, ITCHING, AND PAIN. USED APAP AND BENADRYL TO TREAT. STILL EXPERIENCING MINOR SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2472737

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 08.10.2022
Impfdatum: 01.10.2022
Beginn: 02.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chills Discomfort Disturbance in attention Dizziness Fatigue Headache Hyperhidrosis Impaired work ability Muscle fatigue Nausea Pain in extremity Pyrexia Vomiting

Symptomtext

Intense abdominal pressure began approx 18 hours after shots. Followed by nausea and several strong bouts of vomiting. Then intense chills (teeth chattering) with no fever. Vomiting over 8hr period. Chills lasted several hours. Following day (48 hrs post injection) had fever of 101.7 for most of day. Some ongoing nausea. Strong fatigue. Day 3 post injection, continued fever but lower - 100.7 along with fatigue. Sweats and headache. Covid shot arm became more sore. Day 4 had minor fever 99.6 but very low energy and still unable to work. Feeling of weakness / fatigued muscles along with difficulty concentrating and some light headedness continued for 2 more days. All symptoms finally gone today - one week subsequent to injections.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes type 2; High cholesterol; High blood pressure
Andere Medikamente: Metformin ER; Glyburide; Benazepril; Atorvastatin; Pioglitazone; Venlafaxine; Amlodipine; Zyrtec; multivitamin.
Allergien: Vicodin
Vorherige Impfungen: Severe chills followed by fever after receiving tetanus, MMR booster and pneumonia vaccines at same time in July 2020. Age 52

VAERS 2471440

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: NM
Alter: 88,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Diarrhoea Nausea Vomiting

Symptomtext

patient called day after receiving vaccines stating she has diarrhea, nausea and vomiting that only occurred that day of vaccine administration. patient stated today she is feeling much better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: patient did not go see a doctor for treatment
Aktuelle Erkrankungen: -
Vorgeschichte: osteoarthritis, insomnia, high cholesterole
Andere Medikamente: Ropinirole - last filled with our pharmacy in february
Allergien: no known drug allergies
Vorherige Impfungen: -

VAERS 2470289

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

mild

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Pain in extremity

Symptomtext

severe pain in the right arm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2468655

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

mild

Staat: OH
Alter: 80,0
Geschlecht: M
Eingang: 04.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Grimacing Moaning Muscle spasms Pain

Symptomtext

Patient received covid vaccine and instructed to sit in waiting area near the pharmacy for 15 minutes. Patient ambulated to waiting area and sat down. Approximately 2 minutes later a customer walked in and stated " That man is having a reaction". As this nurse walked over, this patient could be seen grimacing and moaning in pain. Patients Right hand noted to be over his chest area. Per patient statement " I am having severe muscle spasms. They hurt so bad" BP 184/98 HR 73. Muscle Spasms and grimacing continued. 911 Called and Squad arrived to pharmacy area. Patient taken to Truck. No further info regarding ED visit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: NKA
Vorherige Impfungen: -

VAERS 2466930

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

mild

Staat: NC
Alter: 70,0
Geschlecht: F
Eingang: 02.10.2022
Impfdatum: 29.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Axillary pain Breast pain Breast swelling Lymphadenopathy Oedema peripheral

Symptomtext

pt called reporting pain and swelling under in her underarm and near her breast. She stated she thought her lymph nodes were swollen and one was golf ball size.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2689363

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MN
Alter: 80,0
Geschlecht: F
Eingang: 02.10.2023
Impfdatum: 22.11.2022
Beginn: 29.09.2023
Tage bis Beginn: 311,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest X-ray Respiratory symptom SARS-CoV-2 test positive

Symptomtext

Tested positive at Nursing home on 9/29/23, presented to ED on 9/30/23 with respiratory symptoms. PCR positive 9/30/23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 2,0
Labordaten: COVID PCR, Chest Xray
Aktuelle Erkrankungen: -
Vorgeschichte: Pulm fibrosis
Andere Medikamente: -
Allergien: Chicken, Corn, Tetanus vaccine, Tomato
Vorherige Impfungen: Tetanus per history, pt does not recall the reaction.

VAERS 2679834

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 027E22A

gering

Staat: NY
Alter: 65,0
Geschlecht: M
Eingang: 07.09.2023
Impfdatum: 28.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Oct2022 as dose 4 (booster), single (Lot number: 027E22A) at the age of 65 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: patient received COVID 19 Treatment (Brand: Pfizer) from 23Aug2023 to 28Aug2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Penicillin allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2658841

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 20.07.2023
Impfdatum: 03.10.2022
Beginn: 13.03.2023
Tage bis Beginn: 161,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypersensitivity

Symptomtext

ALLERGIC REACTION, SUBSEQ

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypersensitivity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2657769

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 18.07.2023
Impfdatum: 07.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 20,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Neuropathy peripheral

Symptomtext

PERIPHERAL NEUROPATHY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Neuropathy peripheral
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2655917

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: -
Alter: 80,0
Geschlecht: F
Eingang: 13.07.2023
Impfdatum: 08.11.2022
Beginn: 12.04.2023
Tage bis Beginn: 155,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Hypoxia Metabolic encephalopathy

Symptomtext

R09.02 HYPOXIA 4/19/2023 METABOLIC ENCEPHALOPATHY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoxia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649860

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 27.06.2023
Impfdatum: 10.11.2022
Beginn: 23.03.2023
Tage bis Beginn: 133,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Coronary artery disease Hypoxia Peripheral artery occlusion

Symptomtext

R09.02 HYPOXIA 3/23/2023 RIGHT FEMORAL ARTERY OCCLUSION R09.02 HYPOXIA 3/23/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coronary artery disease
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2648458

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 22.06.2023
Impfdatum: 02.11.2022
Beginn: 21.11.2022
Tage bis Beginn: 19,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chronic respiratory failure Respiratory failure

Symptomtext

CHRONIC HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chronic respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2643996

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 12.06.2023
Impfdatum: 26.10.2022
Beginn: 28.04.2023
Tage bis Beginn: 184,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Pericardial calcification

Symptomtext

I31.1 PERICARDIAL CALCIFICATION 4/28/2023 PERICARDIAL CALCIFICATION

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericardial calcification
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642348

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: -
Alter: 65,0
Geschlecht: M
Eingang: 07.06.2023
Impfdatum: 11.11.2021
Beginn: 01.04.2023
Tage bis Beginn: 506,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chronic respiratory failure Lung neoplasm malignant Respiratory failure

Symptomtext

CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/1/2023 LUNG CANCER, RIGHT UPPER LOBE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chronic respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2637443

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 027E22A

gering

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 26.05.2023
Impfdatum: 05.10.2022
Beginn: 05.11.2022
Tage bis Beginn: 31,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Aortic arteriosclerosis Atrial fibrillation Cardiac failure congestive Chronic left ventricular failure Hypoxia Jaundice

Symptomtext

HYPOXEMIA 1/15/2023 ATRIAL FIBRILLATION, UNSPECIFIED HYPOXEMIA 1/15/2023 SYSTOLIC HEART FAILURE, CHRONIC HYPOXEMIA 1/15/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED HYPOXEMIA 1/15/2023 JAUNDICE HYPOXEMIA 1/15/2023 ATHEROSCLEROSIS OF AORTA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Aortic arteriosclerosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630703

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.05.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

10 doses of bivalent vaccine were given from vials beyond their recommended use date: 01may23; The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered from 01-May-2023 to 07-May-2023; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date: 01may23), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered from 01-May-2023 to 07-May-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date: 01may23), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered from 01-May-2023 to 07-May-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date: 01may23), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered from 01-May-2023 to 07-May-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date: 01may23) and PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered from 01-May-2023 to 07-May-2023). Concomitant product use was not provided by the reporter. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Approximately 10 doses of bivalent vaccine were given from vials beyond their recommended use date. The vials had been moved from freezer to the refrigerator on 31-Mar-2023. 10 Doses were given between 1-May-2023 and 7-May-2023 from these vials. The vaccine expiration date was reported as 18-May-2023. 10 patients who received Moderna Bivalent Covid-19 vaccine was past its use by date of 29-Apr-2023. The remaining vials were quarantined and salvaged out of our inventory. Treatment drug was not reported. This case contains information for the 10th of 9 patients reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-723501 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 09-May-2023: Live Significant follow-up information received: Drug administration date and narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-723501:Patient no. 1 (Master case)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630702

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.05.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023; 10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023). No relevant concomitant medications were reported. The vials had been moved from our freezer to the refrigerator on 31 Mar 2023. 10 Doses were given between 01 May 2023 and 07 May 2023 from these vials. No treatment medication reported. This case was linked to US-MODERNATX, INC.-MOD-2023-723501 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 09-May-2023: Vaccine information reported.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-723501:Patient no. 1 (Master case)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630701

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.05.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered on 01-May-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered on 01-May-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered on 01-May-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23 and administered on 01-May-2023.). Concomitant product use was not provided by the reporter. Approximately 10 doses of bivalent vaccine were given from vials beyond their recommended use date. The vials had been moved from freezer to the refrigerator on 31-Mar-2023. 10 Doses were given between 1-May-2023 and 7-May-2023 from these vials. The vaccine expiration date was reported as 18-May-2023. 10 patients who received Moderna Bivalent Covid-19 vaccine was past its use by date of 29-Apr-2023. The remaining vials were quarantined and salvaged out of our inventory. Treatment information was not provided. This case was reported for 4th patient out of 10. This case was linked to US-MODERNATX, INC.-MOD-2023-723501 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 09-May-2023: Live follow-up information received included Date of start of reaction/event and Narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-723501:Patient no. 1 (Master case)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630700

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.05.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023; 10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023). This case contains information for the 8th of 10 adult patients described by the reporter. Concomitant medication was not reported. The vials had been moved from our freezer to the refrigerator on 31-Mar-2023. Use by date for vials was 29-Apr-2023. Patient received dose between 01-May-2023 and 07-May-2023 from these vials. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-723501 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 09-May-2023: Vaccine information was reported.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-723501:Patient no. 1 (Master case)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630699

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.05.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023; The vials had been moved from our freezer to the refrigerator on 3/31/23.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and PRODUCT STORAGE ERROR (The vials had been moved from our freezer to the refrigerator on 3/31/23.). The case contains 6th of patient out of 10 patients reported by reporter. Concomitant Medication use information was not provided by reporter. Approximately 10 doses of bivalent vaccine were given from vials beyond their recommended use date. The vials had been moved from freezer to the refrigerator on 31 March 2023. 10 Doses were given between 1 May 2023 and 7 May 2023 from these vials. 10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023 Treatment Medication use information was not provided by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-723501 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 09-May-2023: Live Follow up received that contains significant information includes vaccine details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-723501:Patient no. 1 (Master case)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630212

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.05.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of 29-Apr-2023; The vials had been moved from freezer to the refrigerator on 31-Mar-2023. 10 Doses were given between 1-May-2023 and 7-May-2023 from these vials; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of 29-Apr-2023) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of 29-Apr-2023) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of 29-Apr-2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (10 doses of bivalent vaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of 29-Apr-2023). The case was for the patient number 2 out of 10 patients. No concomitant medications were reported. It was reported that 10 doses of bivalent vaccine were given from vials beyond their recommended use date. The vials had been moved from our freezer to the refrigerator on 31-Mar-2023. 10 Doses were given between 01-May-2023 and 07-May-2023 from the vials that was past it's use by date of 29-Apr-2023. The lot number was 027E22A and the vaccine expiration date was 18-May-2023. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-723501 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 09-May-2023: Live-Significant follow-up appended: Narrative update.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-723501:Patient no. 1 (Master case)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630210

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 11.05.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023; 10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023), PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023) and PRODUCT STORAGE ERROR (10 doses of bivalentvaccine were given from vials beyond their recommended use date/10 patients who received Moderna Bivalent Covid-19 vaccine between May 1 and May 7 that was past it's use by date of April 29, 2023). This case is for 10th patient out of 10 patients. No relevant concomitant medications were reported. The vials had been moved from our freezer to the refrigerator on 31 Mar 2023. 10 Doses were given between 01 May 2023 and 07 May 2023 from these vials. No treatment medication reported. This case was linked to US-MODERNATX, INC.-MOD-2023-723501 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 09-May-2023: Live follow-up include vaccine details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-723501:Patient no. 1 (Master case)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2629716

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 89,0
Geschlecht: F
Eingang: 10.05.2023
Impfdatum: 05.10.2022
Beginn: 08.05.2023
Tage bis Beginn: 215,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 1/28/21 Lot# 028L20A; Moderna 2/25/21 Lot# 004M20A; Moderna 10/5/22 Lot# 027E22

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624119

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 70,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 12.10.2022
Beginn: 26.04.2023
Tage bis Beginn: 196,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 2/11/21 Lot# 016M20A; Moderna 3/1/21 Lot# 030A21A; Moderna 11/3/21 Lot# 077C21B; Moderna 10/12/22 Lot# 027E22A;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2621340

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 26.04.2023
Impfdatum: 25.10.2022
Beginn: 24.04.2023
Tage bis Beginn: 181,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Post-acute COVID-19 syndrome SARS-CoV-2 test positive

Symptomtext

I had my DOSE five COVID-19 on 25OCT2022 and previous to that I have had long Covid symptoms starting around April 2022. I have been going to the Doctors since then including a Cardiologist yesterday 25APR2023 was a day of long Covid symptoms and therefore my reporting in VSAFE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 18JAN2022 COVID-19 Test-Positive.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Levothyroxine; Estradiol;
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2620035

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: NJ
Alter: 62,0
Geschlecht: F
Eingang: 24.04.2023
Impfdatum: 23.10.2022
Beginn: 26.01.2023
Tage bis Beginn: 95,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Atrial fibrillation Echocardiogram normal Electrocardiogram abnormal Extrasystoles Feeling hot Therapy change

Symptomtext

I had gone to the doctor for a checkup, he was listening to my heart for a very long time. I asked why, he said he heard extra heartbeats and was waiting to see if it was going to come back around. I told him I wanted to have a echocardiogram right then. I thought I was just a little warm from rushing to get into the building because it was a little cold that morning. I went to the hospital straight from the doctor's office, checked in gave them the paperwork from the doctor's office. I was given medications to get my heart rate down. I had the echocardiogram the next day. I have been put on medications, Eliquis, higher dose of Metoprolol Tartrate, I am not longer taking Indapamide, Enalapril, Meloxicam. I am getting back into my exercise routine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anticoagulant therapy
Hospital-Tage: 1,0
Labordaten: 26JAN2023 EKG - positive for Atrial Fibrillation; 27JAN2023 Echocardiogram - did not show anything specific, no signific changes from 2019
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes; Hypertension; Arthritis; PSVT
Andere Medikamente: Verapamil; Metformin; Pantoprazole; Metoprolol Succinate; Enalapril; Indapamide; Levothyroxine; Lipitor; Anastrozole; Restasis Eye Drops; Meloxicam
Allergien: Latex; Clindamycin; Augmentin sensitivity
Vorherige Impfungen: -

VAERS 2618956

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: PA
Alter: 50,0
Geschlecht: F
Eingang: 21.04.2023
Impfdatum: 17.10.2022
Beginn: 28.03.2023
Tage bis Beginn: 162,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Mammogram abnormal

Symptomtext

A general mammogram was performed 28MAR2023 and unusual findings were detected that requires further testing to be performed 23MAY2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mammogram abnormal
Hospital-Tage: -
Labordaten: Mammogram unusual finding requiring further testing.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Atorvastatin; Paxil; Lisinopril
Allergien: None
Vorherige Impfungen: -

VAERS 2617824

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MN
Alter: 66,0
Geschlecht: F
Eingang: 19.04.2023
Impfdatum: 18.10.2022
Beginn: 31.01.2023
Tage bis Beginn: 105,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram abdomen abnormal Hernia Ovarian cancer Ovarian disorder Ovarian neoplasm Ovarian neoplasm surgery Radiotherapy

Symptomtext

I went in to have a hernia evaluated, my doctor ordered a CT scan to see just how bad it was. The CT scan revealed that I had something abnormal going on with ovaries, the size of the tumor on my ovaries presented cancer. I underwent surgery to remove the cancerous tumor and tissue. I am now receiving radiation treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Computerised tomogram abdomen abnormal
Hospital-Tage: 15,0
Labordaten: 25JAN2023 CT scan - positive for abnormal growth on ovaries
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Citracal; Tylenol as needed
Allergien: Penicillin; Augmentin
Vorherige Impfungen: -

VAERS 2614688

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 73,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 09.10.2022
Beginn: 23.01.2023
Tage bis Beginn: 106,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

Tested positive for COVID on January 23, 2023

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID test January 23, 2023
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2613059

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MN
Alter: 69,0
Geschlecht: F
Eingang: 11.04.2023
Impfdatum: 02.10.2022
Beginn: 24.02.2023
Tage bis Beginn: 145,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Aphonia COVID-19 Cough SARS-CoV-2 test positive

Symptomtext

I had started the bronchia cough nonstop. I took a home COVID-19 test just as a precaution. The home COVID-19 test did come back positive; I called my doctor to have a telehealth visit. We discussed my symptoms; I was prescribed the PAXLOVID. I started the medication immediately. The initial symptoms started to leave in a week. It did take over a month for me to get over COVID-19, I lost my sense of taste, my voice, I am just now starting to get my voice back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ageusia
Hospital-Tage: -
Labordaten: 26FEB2023 home COVID-19 positive
Aktuelle Erkrankungen: No
Vorgeschichte: Chronic Bronchitis; Rheumatoid Arthritis; Osteoarthritis; PTSD; Shingles
Andere Medikamente: LOTEMAX SM; hydroxychloroquine; hydrochlorothiazide; celecoxib; sertraline; metoprolol; trazadone; vitamin D; aspirin; loratadine; fish oil; L-lysine; hydrocortisone ointment; triamcinolone ointment
Allergien: No
Vorherige Impfungen: -

VAERS 2609249

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 69,0
Geschlecht: M
Eingang: 04.04.2023
Impfdatum: 01.10.2022
Beginn: 03.04.2023
Tage bis Beginn: 184,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 1/22/21 Lot# 027L20A; MOderna 2/19/21 Lot# 010M20A; Moderna 10/1/22 Lot# 027E22A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2608469

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 03.04.2023
Impfdatum: 12.10.2022
Beginn: 17.11.2022
Tage bis Beginn: 36,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 SARS-CoV-2 test positive

Symptomtext

I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 on an airplane going out of town. I tested positive on 11/17/2022. I contacted my doctor over the phone and got the prescription for PAXLOVID. I tolerated the medication without any complications. I did not have any lingering symptoms of COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 17NOV2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Heart Arrhythmia; High Cholesterol; Hypothyroidism; Chronic Kidney Disease
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2596885

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MN
Alter: 92,0
Geschlecht: M
Eingang: 15.03.2023
Impfdatum: 22.11.2022
Beginn: 14.03.2023
Tage bis Beginn: 112,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

hospitalized after found down in assisted living apt. Requiring 2L O2.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Acute kidney injury ? Aortic valve sclerosis ? Arthritis ? Basal cell carcinoma (BCC) of face ? Benign essential hypertension ? Benign paroxysmal positional vertigo, bilateral ? Chronic kidney disease (CKD), stage III (moderate) ? Gait instability ? GERD without esophagitis ? History of kidney stones ? Hyperlipidemia ? Hypertension ? IBS (irritable bowel syndrome) ? Idiopathic peripheral neuropathy ? Insomnia ? Parkinson disease ? Ulcerative colitis
Andere Medikamente: -
Allergien: Fish
Vorherige Impfungen: -

VAERS 2596252

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 96,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 05.10.2022
Beginn: 28.01.2023
Tage bis Beginn: 115,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 1/28/21 Lot# 028L20A; Moderna 2/25/21 Lot# 004M20A; Moderna 10/5/22 Lot# 027E22A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2589492

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: DC
Alter: 45,0
Geschlecht: M
Eingang: 01.03.2023
Impfdatum: 28.11.2022
Beginn: 28.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration Interchange of vaccine products

Symptomtext

PATIENT RECEIVED 1 SHOT OF PRIMARY MODERNA ON 12/27/21 AND THEN GOT A 2ND SHOT OF JANSSEN ON 1/4/22 WITHOUT COMPLETING THE PRIMARY MODERNA SERIES AND THEN CAME TO OUR CLINIC AND RECEIVED THE MODERNA BIVALENT. I SPOKE WITH THE PATIENT AND PATIENT SAID THE PLACE WHERE HE GOT HIS FIRST MODERNA VACCINE DID NOT HAVE THE VACCINE AVAILABLE SO HE WENT TO A PHARMACY AND GOT JANSSEN.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: NOT INDICATED ON THE CONSENT FORM THAT PATIENT FILLED OUT.
Aktuelle Erkrankungen: not indicated on the consent form that patient filled out
Vorgeschichte: not indicated on the consent form that the patient filled out
Andere Medikamente: not indicated on the consent form that patient filled out
Allergien: patient said no to the question we asked on the consent form asking if they've ever had a severe allergic reaction to something or a reaction that you were treated with epipen.
Vorherige Impfungen: -

VAERS 2588456

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 54,0
Geschlecht: F
Eingang: 28.02.2023
Impfdatum: 07.10.2022
Beginn: 25.02.2023
Tage bis Beginn: 141,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough case All Moderna dose 1 3/17/21 007B21A dose 2 4/14/21 043B21A dose 3 11/26/21 067F (lot number incorrect, but do not have access to correct number)

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ 2/25/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2582348

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: DC
Alter: 56,0
Geschlecht: F
Eingang: 15.02.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered

Symptomtext

PATIENT RECEIVED INFLUENZA VACCINE ON 10/04/2022. PATIENT HAD PREVIOUSLY RECEIVED AN INFLUENZA VACCINE ON 09/20/2022 AT ANOTHER FACILITY.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2573429

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: VA
Alter: 80,0
Geschlecht: F
Eingang: 01.02.2023
Impfdatum: 01.02.2023
Beginn: 01.02.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

Moderna Bivalent given unnecessarily. Patient had already been given this dose on 11/8/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Major neurocognitive disorder, Parkinson, hypertension, hyperlipidemia, bladder incontinence, overactive bladder, insomnia, acute UTI, adjustment disorder, scoliosis, restlessness
Vorgeschichte: listed above
Andere Medikamente: ASA, Atorvastatin, Aricept, Cozaar, Mirtazapine, Multivitamin, Miralax, Quetiapine, Tylenol, Milk of Mag, Muscle rub
Allergien: Sulfa drugs
Vorherige Impfungen: -

VAERS 2570642

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 64,0
Geschlecht: F
Eingang: 30.01.2023
Impfdatum: 18.10.2022
Beginn: 18.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

COVID +

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567662

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: VA
Alter: 79,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

Patient had not received the Moderna primary series doses prior to receiving the Moderna bivalent booster.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Schizophrenia; GERD
Andere Medikamente: Levothyroxine; Paliperidone injection; Mylanta PRN
Allergien: None
Vorherige Impfungen: -

VAERS 2562591

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 101,0
Geschlecht: F
Eingang: 18.01.2023
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given Moderna Bivalent Booster 0.25mcg not 0.5mcg. Wrong dose given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2562586

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 66,0
Geschlecht: F
Eingang: 18.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Moderna Bivalent Booster 0.25mcg was given to patient, was to be given 0.5mcg. Wrong dose given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2562416

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 73,0
Geschlecht: F
Eingang: 18.01.2023
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given Moderna Bivalent Booster 0.25mcg, was to be given 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2561309

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 90,0
Geschlecht: F
Eingang: 17.01.2023
Impfdatum: 11.10.2022
Beginn: 17.01.2023
Tage bis Beginn: 98,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID positive test 1/16/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560635

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 67,0
Geschlecht: M
Eingang: 16.01.2023
Impfdatum: 17.10.2022
Beginn: 12.01.2023
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID positive test 1/13/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560201

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: NY
Alter: 49,0
Geschlecht: M
Eingang: 15.01.2023
Impfdatum: 20.10.2022
Beginn: 12.01.2023
Tage bis Beginn: 84,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Computerised tomogram abdomen abnormal Renal disorder

Symptomtext

A 1 cm low-attenuation structure in the right kidney, indeterminate with CT density of approximately 57 Hounsfield units. This was an incidental discovery during a follow-up test for scarring that was discovered on the liver 10/2022. There is much concern now with what has been occurring to myself since 03/06/2021 after the 1st Pfizer dose now that we can connect dots and speak with true medical experts.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Computerised tomogram abdomen abnormal
Hospital-Tage: -
Labordaten: CT Scan
Aktuelle Erkrankungen: Cirrhosis/scarring on liver discovered 10/2022 E-Report Number: Date of Report: 01/03/2023 Date of Vaccination: 11/06/2021 Patient Age at Vaccination (years): 48.00 Vaccine Information: 1. COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER\BIONTECH / EW0164
Vorgeschichte: Cardiomyopathy - Managed condition, familial cardiomyopathy
Andere Medikamente: Entresto, Lasix, Spironolactone, Metoprolol, Naltrexone, Wellbutrin, Lexapro, Zonisamide, Multivitamin
Allergien: N/A
Vorherige Impfungen: Pfizer 03/05/21 47 yrs old - LOT# EN6203 Pfizer 03/26/21 47 yrs old - LOT# EN6208 VAERS ID: E-Report Number: VAERS ID: E-Repo

VAERS 2559607

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 55,0
Geschlecht: F
Eingang: 13.01.2023
Impfdatum: 10.10.2022
Beginn: 10.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given half dose of Moderna Bivalent Booster 0.25mcg not 0.5mcg. Wrong dosage given

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559603

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 76,0
Geschlecht: F
Eingang: 13.01.2023
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given half dose of Covid Booster Moderna Bivalent, Patient was given wrong dosage 0.25mcg not 0.5mcg.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559598

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 68,0
Geschlecht: F
Eingang: 13.01.2023
Impfdatum: 17.10.2022
Beginn: 17.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Moderna Bivalent Booster 0.25mcg was given to patient, was to be given 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559595

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 77,0
Geschlecht: F
Eingang: 13.01.2023
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Moderna Bivalent Booster 0.25mcg was given to patient, was to be given 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559589

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 68,0
Geschlecht: M
Eingang: 13.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Moderna Bivalent Booster 0.25mcg was given to patient, was to be given 0.5mcg, wrong dosage given to patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559580

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 74,0
Geschlecht: F
Eingang: 13.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was give half dose of Moderna Bivalent Booster but was to be given full dose 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559577

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 68,0
Geschlecht: F
Eingang: 13.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given 0.25mcg of Moderna Bivalent Booster but was to be given 0.5mcg, wrong dosage given

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558965

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 81,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Moderna Bivalent Booster 0.25mcg was given to patient but was to be given 0.5mcg, wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558961

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 82,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given 0.25mcg of Moderna Bivalent Booster and was to be given 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558960

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 77,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given 0.25mcg Moderna Bivalent Booster which is half dose, was to be given 0.5mcg. Patient was given wrong dosage.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558955

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 41,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Moderna Bivalent Booster 0.25mcg was given to patient which is only half dose, was to be given 0.5mc g. Wrong dose given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558951

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 67,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was given 0.25mcg Moderna Bivalent Booster but was to be given 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558944

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 41,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 03.10.2022
Beginn: 03.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Patient was given half dose of the Moderna Bivalent Booster, patient was to be given a full dose. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558783

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 46,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was given 0.25mcg of Moderna Bivalent Booster, Patient was to receive 0.5mcg . Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558779

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 75,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was given half dose of Moderna Bivalent Booster 0.25mcg, patient was to be given 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558778

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 72,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was only given half dose of Moderna Bivalent Booster 0.25mcg and was to be given 0.5mcg. Wrong dosage given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2557441

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 68,0
Geschlecht: M
Eingang: 11.01.2023
Impfdatum: 24.10.2022
Beginn: 08.01.2023
Tage bis Beginn: 76,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case. Moderna 1/29/21 007M20A, 2/26/21 010A21A, 11/4/21 034F21A and 10/24/22 027E22A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Positive COVID test on 1/8/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2556618

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: PA
Alter: 82,0
Geschlecht: F
Eingang: 11.01.2023
Impfdatum: 03.10.2022
Beginn: 06.01.2023
Tage bis Beginn: 95,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered No adverse event

Symptomtext

No adverse event; Shot 5: Bivalent Booster on 03OCT2022, Shot 6: Bivalent Booster on 06JAN2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (Shot 5: Bivalent Booster on 03OCT2022, Shot 6: Bivalent Booster on 06JAN2023) and NO ADVERSE EVENT (No adverse event) in an 82-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. AS7168B and 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 06-Jan-2023, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 06-Jan-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXTRA DOSE ADMINISTERED (Shot 5: Bivalent Booster on 03OCT2022, Shot 6: Bivalent Booster on 06JAN2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (Shot 5: Bivalent Booster on 03OCT2022, Shot 6: Bivalent Booster on 06JAN2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (Shot 5: Bivalent Booster on 03OCT2022, Shot 6: Bivalent Booster on 06JAN2023). No concomitant drug information was provided. Patient had received 4 monovalent doses. Dose 21 JAN2021 with Lot no 013L20A, Dose 2 on 15FEB2021 with Lot no. 016M20A, Dose 3 (First monovalent booster) 16NOV2021 with Lot no. 067F21A and dose 4 (second monovalent booster) on 09MAY2022 Lot no. 001M21A It was reported that the patient had received 6 Moderna doses. The patient told the reporter that her doctor told her to go ahead and get another booster. Reporter stated that the doctor must have not checked her vaccination card. No treatment drug information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2552846

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 20,0
Geschlecht: M
Eingang: 06.01.2023
Impfdatum: 06.01.2023
Beginn: 06.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Underdose

Symptomtext

Patient received Moderna BIV 6m-5yrs instead of Moderna BIV 6+. Patient will be revaccinated with appropriate dosage.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551566

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: NV
Alter: 51,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 03.10.2022
Beginn: 18.11.2022
Tage bis Beginn: 46,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acoustic stimulation tests Computerised tomogram Tinnitus Visual acuity tests normal

Symptomtext

A month and a half after COVID-19 vaccine I got a Flu shot; The following week I woke up and could only hear a fuzzy white noise out of my right ear; Believe it could be Tinnitus; Went to an urgent care to find out if there was any wax build up or fluid in my ear, there wasn't; Went to an ENT the next day and was given a visual and hearing test; There was no hearing loss out of my left ear; Was told to come back for a follow up appointment for further testing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acoustic stimulation tests
Hospital-Tage: -
Labordaten: CT scan inconclusive; Visual test clear; Hearing test, left ear was clear; Not sure about right ear yet.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Ulcerative Colitis; Hypothyroidism with Hashimoto's; Rosacea.
Andere Medikamente: ENTYVIO infusion for ulcerative colitis; EUTHYROX; vitamin B12; iron; vitamin D3; multivitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2550101

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: AR
Alter: 65,0
Geschlecht: F
Eingang: 04.01.2023
Impfdatum: 30.09.2022
Beginn: 23.12.2022
Tage bis Beginn: 84,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Discomfort SARS-CoV-2 test positive Sneezing Throat irritation

Symptomtext

My symptoms included scratchy throat, sneezing, and coughing. I didn't have achy muscles or fever. I controlled my discomfort with ibuprofen, DAYQUIL, and NYQUIL. My doctor prescribed valacyclovir on December 22, 2022. I took one tablet twice daily. I tested positive for COVID-19 on December 25, 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 12/25/2022 Abbott COVID-19 test positive; 12/29/2022 Abbott COVID-19 test positive; 01/04/2023 Abbott COVID-19 test negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Dust; cat dander; pollen
Vorherige Impfungen: -

VAERS 2546937

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MO
Alter: 68,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 29.09.2022
Beginn: 21.11.2022
Tage bis Beginn: 53,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Breast cancer Breast conserving surgery Breast mass

Symptomtext

I did not have an adverse reaction to the vaccine. I went in for a mammogram 11/21/2022 and they found a mass in my left breast. I had a biopsy, and it was determined to be a malignant tumor. I had lumpectomy on 12/27/2022. I have no family history of breast cancer.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Breast cancer
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD; Mitral Valve Prolapse
Andere Medikamente: N/A
Allergien: Erythromycin
Vorherige Impfungen: -

VAERS 2543697

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CO
Alter: 17,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 02.11.2022
Beginn: 02.11.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration Incorrect product formulation administered Interchange of vaccine products No adverse event

Symptomtext

The patient received first dose of monovalent Pfizer on 7/1/22, then received a Moderna Bivalent booster on 11/2/22. Thus, the primary series was not completed before the bivalent booster was administered and different manufacturers were administered. There were no known adverse reactions as a result of this administration. The person submitting this form was not the person who administered the bivalent vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2542049

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: OR
Alter: -
Geschlecht: U
Eingang: 23.12.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

No adverse effects. Staff at our clinic continued to give 0.25 mL for booster dose to Adults when we switched to giving booster doses from Moderna to Moderna Bivalent. This affected 52 patients. All have been informed and many have come back to receive their full doses. All staff are now educated on the correct dose of Moderna Bivalent to give to an Adult being 0.5 mL not 0.25 mL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2540523

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 93,0
Geschlecht: M
Eingang: 22.12.2022
Impfdatum: 11.10.2022
Beginn: 19.12.2022
Tage bis Beginn: 69,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID positive test 12/21/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536558

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: TX
Alter: 61,0
Geschlecht: F
Eingang: 19.12.2022
Impfdatum: 09.12.2022
Beginn: 11.12.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Pollakiuria Urinary tract infection Urine analysis abnormal

Symptomtext

Two days after receiving the Moderna bivalent vaccine, I experienced a UTI. I do not get UTI's, so I was a bit shocked. The UTI started out with frequent urination, but it was not severe. On 12/14/2022, the UTI became severe. I never experienced any pain, but I did have to use the restroom every 5 minutes. I had a urinalysis completed on 12/14/2022 and was given antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pollakiuria
Hospital-Tage: -
Labordaten: Urinalysis
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure; Hypothyroidism; High Cholesterol
Andere Medikamente: Xyzal; Claritin; Dimysta; Sudafed; Procardia; Armor thyroid; Multivitamin; B12 Complex; Vitamin D3; Magnesium
Allergien: Codeine; Onions
Vorherige Impfungen: -

VAERS 2533212

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: KY
Alter: 38,0
Geschlecht: M
Eingang: 15.12.2022
Impfdatum: 14.10.2022
Beginn: 16.10.2022
Tage bis Beginn: 2,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema Eye swelling Swelling face

Symptomtext

Dr reported Right eye swelling with facial swelling and redness requiring steriods.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Erythema
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: -
Allergien: NSAIDS ASPIRN
Vorherige Impfungen: -

VAERS 2528295

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

gering

Staat: VA
Alter: 41,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 31.10.2022
Beginn: 31.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

drew up 0.3ml and injected instead on 0.5ml I called her back in after I realized it and administer 0.2ml more in same arm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2517145

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 26.11.2022
Impfdatum: 22.11.2022
Beginn: 22.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Dose administered after more than 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. At the time of vaccination, patient has no medical history related to both Acute and Chronic illnesses. Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE (1st dose, Intramuscular route) on 22-Mar-2021, JANSSEN COVID-19 VACCINE (2nd dose) on 11-May-2021, Pfizer Vaccine (1st booster and Lot number:SM7553) on 27-May-2022. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE, JANSSEN COVID-19 VACCINE and Pfizer Vaccine. Concurrent medical conditions included Blood pressure abnormal. Concomitant products included INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) from 22-Nov-2022 to an unknown date for an unknown indication. On 22-Nov-2022 at 7:45 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Nov-2022 at 7:45 AM, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture). Patient was under treatment for blood pressure but did not know name of medications. The vial size was 2.5 ml and individual vial. the vial was initially stored in the refrigerator on 21Nov2022 The vial was first punctured on 21Nov2022 8:00 am and stored post puncture at Room temperature. the vial did not undergo any temperature excursions. The total amount of time the vial was exposed to room temperature range (8 degrees centigrade to 25 degrees centigrade to 46 to 77 degrees F) was approximately less than 24 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Blood pressure abnormal
Vorgeschichte: Comments: At the time of vaccination, patient has no medical history related to both Acute and Chronic illnesses.
Andere Medikamente: FLU [INFLUENZA VACCINE]
Allergien: -
Vorherige Impfungen: -

VAERS 2513553

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: KY
Alter: -
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: -
Beginn: 14.11.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Poor quality product administered Product temperature excursion issue

Symptomtext

Patient received Moderna Covid-19 bivalent booster dose that underwent a temperature excursion; No adverse event; The bivalent Moderna Covid-19 vaccine that was in the refrigerator when a power outage occurred vaccine reached 50 degrees Farenheight for 30 minutes; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (The bivalent Moderna Covid-19 vaccine that was in the refrigerator when a power outage occurred vaccine reached 50 degrees Farenheight for 30 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 bivalent booster dose that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Nov-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The bivalent Moderna Covid-19 vaccine that was in the refrigerator when a power outage occurred vaccine reached 50 degrees Farenheight for 30 minutes). On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 bivalent booster dose that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (The bivalent Moderna Covid-19 vaccine that was in the refrigerator when a power outage occurred vaccine reached 50 degrees Farenheight for 30 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 bivalent booster dose that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (The bivalent Moderna Covid-19 vaccine that was in the refrigerator when a power outage occurred vaccine reached 50 degrees Farenheight for 30 minutes) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 bivalent booster dose that underwent a temperature excursion). Concomitant product use was not provided by the reporter. The vial size was 2.5 ml. Vaccine was visualized and looks normal. It was reported that only one vial was involved and that vial was discarded and the vaccine was transferred to pharmacy from another pharmacy. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2512468

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CA
Alter: 27,0
Geschlecht: F
Eingang: 20.11.2022
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Error: Wrong Dose of Vaccine - Too Low-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2511353

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22A

gering

Staat: WI
Alter: 27,0
Geschlecht: M
Eingang: 17.11.2022
Impfdatum: 06.10.2022
Beginn: 17.11.2022
Tage bis Beginn: 42,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered No adverse event

Symptomtext

Patient has not reported any adverse events, but they received the Moderna Bivalent booster as their 2nd shot when they only received 1 monovalent Pfizer shot

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2505722

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 20.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 7,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

Onset of both tinnitus and pulsatile tinnitus. Started about 1 week after the vaccination and has not abated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Pulsatile migraines, histamine intolerance and mast cell activation
Andere Medikamente: Methimazole, Trazodone, magnesium, probiotic, spirulina, saccharomyces boulardii
Allergien: Sulfa allergy
Vorherige Impfungen: -

VAERS 2505152

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022; No adverse event; Bivalent vaccine were administered to patients after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in an 80-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Hepatitis A on 11-Nov-1942, MMR on 17-Nov-2006, Pneumococcal adult on 12-Jul-2011, Tdap on 29-Jun-2012, Pneumococcal adult on 16-Sep-2015, Seasonal influenza on 19-Oct-2016, Seasonal influenza on 20-Oct-2017, Seasonal influenza on 10-Aug-2018, Seasonal influenza on 09-Sep-2019, Zoster on 09-Sep-2019, Zoster on 17-Jan-2020, INFLUENZA VACCINE on 15-Oct-2020, Sars-Cov-2 on 27-Feb-2021, Sars-Cov-2 on 27-Mar-2021, Seasonal influenza on 20-Oct-2021, Sars-Cov-2 on 17-Nov-2021, Hepatitis B on 01-Apr-2022 and Seasonal influenza on 30-Aug-2022. Past adverse reactions to the above products included No adverse event with Hepatitis A, Hepatitis B, INFLUENZA VACCINE, MMR, Pneumococcal adult, Pneumococcal adult, Sars-Cov-2, Sars-Cov-2, Sars-Cov-2, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Tdap, Zoster and Zoster. On 30-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022). No concomitant medications were reported. Vial size was 2.5 ml. Date the vial was initially stored in the refrigerator was 29-Sep-2022. The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022.The vial didn't undergo any temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505151

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

administered dose of the bivalent vaccine to patient after the 30 day beyond use date and initially moved from the freezer to the refrigerator on 29-Sep-2022; No adverse event; administered dose of the bivalent vaccine to patient after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered dose of the bivalent vaccine to patient after the 30 day beyond use date), PRODUCT STORAGE ERROR (administered dose of the bivalent vaccine to patient after the 30 day beyond use date and initially moved from the freezer to the refrigerator on 29-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: DTAP on 25-Mar-2013, Seasonal influenza (Seasonal influenza) on 23-Jan-2017, Seasonal influenza (Seasonal influenza) on 11-Dec-2017, Seasonal influenza on 12-Dec-2018, Zoster (Zoster) on 06-Dec-2019, Seasonal influenza (Seasonal influenza) on 06-Dec-2019, Zoster (Zoster) on 26-Jul-2020, Seasonal influenza (Seasonal influenza) on 24-Oct-2020, Seasonal influenza (Seasonal influenza) on 06-Dec-2021 and Seasonal influenza (Seasonal influenza) on 30-Oct-2022. Past adverse reactions to the above products included No adverse event with DTAP, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Seasonal influenza, Zoster and Zoster. Concomitant products included INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication. On 30-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered dose of the bivalent vaccine to patient after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (administered dose of the bivalent vaccine to patient after the 30 day beyond use date and initially moved from the freezer to the refrigerator on 29-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered dose of the bivalent vaccine to patient after the 30 day beyond use date), PRODUCT STORAGE ERROR (administered dose of the bivalent vaccine to patient after the 30 day beyond use date and initially moved from the freezer to the refrigerator on 29-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (administered dose of the bivalent vaccine to patient after the 30 day beyond use date) and PRODUCT STORAGE ERROR (administered dose of the bivalent vaccine to patient after the 30 day beyond use date and initially moved from the freezer to the refrigerator on 29-Sep-2022). It was reported that patient had received Moderna vaccine on 20-Mar-2021 (dose 1), 17-Apr-2021 (dose 2) and 22-Nov-2021 (dose 3). The vaccine was contained in individual vials within broken carton. The vial was initially stored in the refrigerator on 29-Sep-2022. The size of the vial was 2.5 ml. The vial was initially stored in refrigerator on 29-Sep-2022. The vial did not undergo any temperature excursions. The medication error was discovered on 31-Oct-2022. It was reported that the patient had no reported adverse events or symptoms, and no additional doses, medications or treatments were administered to the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: FLU [INFLUENZA VACCINE]
Allergien: -
Vorherige Impfungen: -

VAERS 2505150

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022; No adverse event; bivalent vaccine were administered to patients after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 75-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. It was unknown whether patient had diagnosed with or tested positive for COVID-19. Previously administered products included for Product used for unknown indication: DTap on 07-Apr-1998, HEPATITIS A on 07-Apr-1998, Influenza (IIV3, High dose, 72 years 7 months) on 24-Oct-2019, prevnar 13 (72 years 9 months) on 27-Dec-2019, Fluad quad (IIV4, Pre filled injection, 73 years 8 months) on 17-Nov-2020, Fluad quad (IIV4, Pre filled injection and 74 years 8 months) on 14-Dec-2021. Past adverse reactions to the above products included No adverse event with DTap, Fluad quad, Fluad quad, HEPATITIS A, Influenza and prevnar 13. Concomitant products included INFLUENZA VACCINE INACT SAG 4V (FLUAD QUAD) for an unknown indication. On 30-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022). The size of the vial was 2.5ml. The vial was initially stored in refrigerator on 29-Sep-2022. The vial did not undergo any temperature excursions. Patient got administered with Moderna as Dose 1 on 10-Feb-2021 (73 years 10 months), Dose 2 on 10-Mar-2021 (73 years 11 months) and Dose 3 on 28-Oct-2021 (74 years 7 months). On 30-Oct-2022, 10 (ten) Moderna Bivalent vaccines were administered to 10 patients. The by-use-date on the product was 29Oct2022. LOT 027E22A. The error was discovered on 31Oct2022. It was reported that patients had no reported symptoms, no additional doses, medications, or treatments.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown whether patient had diagnosed with or tested positive for COVID-19.
Andere Medikamente: FLUAD QUAD
Allergien: -
Vorherige Impfungen: -

VAERS 2505149

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022; No adverse event; bivalent vaccine were administered to patient after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date), PRODUCT STORAGE ERROR (vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: tdap on 13-Nov-2017, COVID-19 (PFR 30 mcg) (PFR 30 mcg, 64 years 10 months) on 05-Mar-2021, COVID-19 (PFR 30 mcg) (PFR 30 mcg, 64 years 11 months) on 31-Mar-2021, influenza iiv4 (IIV 4 high dose, (Inject), 65 years 6 months) on 29-Oct-2021, COVID-19 (PFR 30 mcg) (PFR 30 mcg, 65 years 6 months) on 29-Oct-2021, COVID-19 (PFR 30 mcg) (PFR-BNT 30 mcg/0.3 ml) on 20-Apr-2022, Fluad Quad (IIV 4, (P- Free Inject) and 66 years 6 months) on 29-Oct-2022. Past adverse reactions to the above products included No adverse event with COVID-19 (PFR 30 mcg), COVID-19 (PFR 30 mcg), COVID-19 (PFR 30 mcg), COVID-19 (PFR 30 mcg), Fluad Quad, influenza iiv4 and tdap. Concomitant products included INFLUENZA VACCINE INACT SAG 4V (FLUAD QUAD) for an unknown indication. On 30-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date), PRODUCT STORAGE ERROR (vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date) and PRODUCT STORAGE ERROR (vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022). Patient age was 66 year 7 months. Individual vials within broken carton and vial size were 2.5mL. Date the vial was initially stored in the refrigerator was 29-Sep-2022. Vial did not undergo any temperature excursions. 10 patients had administered 10 doses of the bivalent vaccine after the 30 days beyond use. The by use date of the product was 29-Oct-2022. The error was discovered on 31-Oct-2022. No reported symptoms. Since the vaccine was evaluated as valid, no adverse event occurred. Treatment drug was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: FLUAD QUAD
Allergien: -
Vorherige Impfungen: -

VAERS 2505148

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 82,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 29.09.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

No adverse event; Bivalent vaccine were administered to patients after the 30 day beyond use date; The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in an 82-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Pneumococcal infection: Prevnar 13 (PCV 13, 75 years 2 months, Series Complete) on 02-Mar-2015, Prevnar 13 (PCV 13, 76 years 2 months, Series Complete) on 08-Mar-2016, ZOSTAVAX (Zoster ZVL, 76 years 3 months, Due now) on 25-Mar-2016, PNEUMOVAX 23 (PPSV23 and 78 years 3 months; Series Complete) on 15-Mar-2018; for Product used for unknown indication: DTP (Dose 1 and Tdap (adol/adult) 76 years 2 months) on 08-Mar-2016; for Influenza: INFLUENZA (Seasonal influenza; Influenza IIV4 (P-Free Inj), 76 years 9 months, Season Complete) on 28-Sep-2016, INFLUENZA (Seasonal influenza; Influenza IIV3, High dose, 77 years 9 months, Season Complete) on 03-Oct-2017, INFLUENZA (Seasonal influenza; Influenza IIV3, High dose, 78 years 9 months, Season Complete) on 01-Oct-2018, INFLUENZA (Seasonal influenza; Influenza IIV3, High dose, 79 years 9 months, Season Complete) on 07-Oct-2019, FLUZONE HIGH DOSE QUADRIVALENT (Seasonal influenza; Influenza IIV4, High dose (FluZone HD Quad), 80 years 8 months, Season Complete) on 10-Sep-2020, FLUZONE HIGH DOSE QUADRIVALENT (Seasonal influenza; Influenza IIV4, High dose (FluZone HD Quad), 82 years 9 months and Season Complete) on 14-Sep-2022; for SARS-CoV-2 infection: MODERNA COVID-19 VACCINE (Dose 1, COVID-19 (MOD 100 mcg), Age - 81 years 1 month, Due now) on 16-Jan-2021, MODERNA COVID-19 VACCINE (Dose 2, COVID-19 (MOD 100 mcg), Age - 81 years 2 months) on 13-Feb-2021, MODERNA COVID-19 VACCINE (Dose 3, COVID-19 (MOD 100 mcg) and Age - 81 years 10 months) on 10-Nov-2021. Past adverse reactions to the above products included No adverse event with DTP, FLUZONE HIGH DOSE QUADRIVALENT, FLUZONE HIGH DOSE QUADRIVALENT, INFLUENZA, INFLUENZA, INFLUENZA, INFLUENZA, MODERNA COVID-19 VACCINE, MODERNA COVID-19 VACCINE, MODERNA COVID-19 VACCINE, PNEUMOVAX 23, Prevnar 13, Prevnar 13 and ZOSTAVAX. On 30-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 29-Sep-2022, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022). On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine were administered to patients after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022). Concomitant product use was not provided by the reporter. Unknown if the patient was pregnant. Patient's race was reported as UNKNOWN. Unknown if the patient has ever been diagnosed with or tested positive for COVID-19. Unknown if the patient had acute illnesses at the time of vaccination and up to one month before. Unknown if the patient had chronic or long-standing health conditions. On 30-Oct-2022, Moderna Bivalent vaccines were administered to 10 patients. The By-use-date on the product was 29-Oct-2022. The error was discovered on 31-Oct-2022. They had administered 10 doses of the bivalent vaccine to patients after the 30 days beyond use date. The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-666556 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666556:Master Case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505147

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 70,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022; No adverse event; bivalent vaccine were administered to patients after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Influenza vaccine (IIV 3, (Inject), 65 years 9 months, High dose) on 25-Jan-2018, Prevenar 13 (65 years and 9 months) on 25-Jan-2018, Influenza vaccine (IIV 3, (Inject), 65 years 9 months, High dose) on 05-Oct-2018, Pneumovax (67 years and 4 months) on 22-Aug-2019, Flucelvax (IIV 3, (Inject), 67 years 8 months, High dose) on 08-Jan-2020, Pfizer biontech (68 years 10 months, PFR 30 mcg) on 02-Mar-2021, Pfizer biontech (68 years 11 months, PFR 30 mcg) on 24-Mar-2021, Pfizer biontech (68 years 11 months, PFR 30 mcg) on 04-Oct-2021, FLUAD QUAD (IIV 4, (Inject), 69 years 5 months, High dose) on 04-Oct-2021, FLUAD QUAD (V 4, (Inject), 70 years 6 months and High dose) on 30-Oct-2022. Past adverse reactions to the above products included No adverse event with FLUAD QUAD, FLUAD QUAD, Flucelvax, Influenza vaccine, Influenza vaccine, Pfizer biontech, Pfizer biontech, Pfizer biontech, Pneumovax and Prevenar 13. Concomitant products included INFLUENZA VACCINE INACT SAG 3V (FLUAD) for an unknown indication. On 30-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patients after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022). The size of the vial was 2.5ml. The vial was initially stored in refrigerator on 29-Sep-2022. The vial did not undergo any temperature excursions. On 30-Oct-2022, 10 (ten) Moderna Bivalent vaccines were administered to 10 patients. The by-use-date on the product was 29Oct2022. LOT 027E22A. The error was discovered on 31Oct2022. It was reported that patients had no reported symptoms, no additional doses, medications, or treatments.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505146

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vaccine was initially moved from the freezer to the refrigerator on 29-SEP- 2022 and administered on 30-Oct-2022; No adverse event; bivalent vaccine were administered to patient after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-SEP- 2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: DTaP (Patient age group: Adult 55 years 1 month, Dose number: 1) on 01-Jun-2015, Influenza 11V3 (Influenza 11V3(Inject) 57 years 9 months,Dose number: 1) on 17-Jan-2018, influenza cciiv4 (influenza cciiv4 (Flucelvax Quad P-Free Inj) 58 years 8 months, Dose number: 2) on 06-Jan-2019, Shingrix (Zoster RZV) on 12-Jul-2019, influenza (INFLUENZAIIV4 (P- Free Inject), 59 years 5 months, Dose number: 3) on 20-Sep-2019, Shingrix (Zoster RZV) on 20-Sep-2019, INFLUENZA (INFLUENZAIIV4 (P- Free Inject), 60 years 4 months,Dose number: 4) on 29-Aug-2020, Pfizer (COVID-19 (PFR 30 mcg), 60years 10 months,Dose number: 1) on 01-Mar-2021, Pfizer (COVID-19 (PFR 30 mcg), 60years 11months,Dose number: 2) on 22-Mar-2021, Pfizer (COVID-19 (PFR 30 mcg), 61years 6 months,Dose number: 3) on 10-Oct-2021, Pfizer (COVID-19 (PFR-BNT 30 mcg/0.3 ml ), 62 years 4 months andDose number: 4) on 09-Aug-2022. Past adverse reactions to the above products included No adverse event with DTaP, INFLUENZA, Influenza 11V3, Pfizer, Pfizer, Pfizer, Pfizer, Shingrix, Shingrix, influenza and influenza cciiv4. Concomitant products included INFLUENZA VACCINE (INFLUENZA) for an unknown indication. On 30-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-SEP- 2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-SEP- 2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent vaccine were administered to patient after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-SEP- 2022 and administered on 30-Oct-2022). Patient age reported as 62 years 6 months at the time of Moderna bivalent vaccination. It was reported patient age reported as 62 years 6 months at INFLUENZAIIV4 (P- Free Inject) Dose 5 vaccination. No concomitant medications were reported. The vial was initially stored in refrigerator on 29-Sep-2022. The vial did not undergo any temperature excursions. It was reported that patients had no reported symptoms, no additional doses, medications, or treatments. On 30-Oct-2022, the patient received Moderna bivalent vaccine. The by-use-date on the product was 29Oct2022. LOT 027E22A The error was discovered on 31Oct2022. Hepatitis B vaccine due date was 01-Apr-2022. The patient had ever been diagnosed with/ tested positive for COVID-19 was unknown. The patient had any acute illness at the time of vaccination and up to 1 month before was unknown. The chronic or long-standing health conditions was unknown. It was reported prescription, over the counter medication, dietary supplements or herbal remedies being taken at the time of vaccination and or at the time of adverse event was unknown. It was reported 10(ten) Moderna Bivalent vaccines were administered to 10 patients the by use date. Reporter contacted Moderna to report the error. Moderna the did an analysis of the LOT. The vaccine maintained the activity necessary to protect against the virus at the time of administration. Since the vaccine was evaluated as valid, no adverse event occurred. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: INFLUENZA
Allergien: -
Vorherige Impfungen: -

VAERS 2505145

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022; No adverse event; 10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 73-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: TDAP (adol/adult 58 yrs 5 months, Dose 1) on 26-Oct-2007, Prevnar 13 (PCV 13, 65 yrs 9 months, Dose 1) on 02-Mar-2015, PREVNAR 13 (PCV 13, 66 yrs 9 months, Dose 2) on 07-Mar-2016, TDAP (adol/adult 67 yrs, Dose 2) on 11-Jun-2016, INFLUENZA (IIV3, High dose, 68 yrs 4 months, Dose 1) on 03-Oct-2017, INFLUENZA (IIV3, High dose, 69 years 4 months, Dose 2) on 01-Oct-2018, PPSV23 (PPSV23, 66 yrs 11 months) on 02-May-2019, INFLUENZA (IIV3, High dose, 70 yrs 4 months, Dose 3) on 07-Oct-2019, FluZone HD Quad (IIV4, High dose, 71 yrs 3 months, Dose 4) on 10-Sep-2020, FLUZONE HIGH DOSE QUADRIVALENT (IIV4, High dose, 72 yrs 4 months, Dose 5) on 05-Oct-2021, FLUZONE HIGH DOSE QUADRIVALENT (IIV4, High dose, 73 yrs 3 months and Dose 6) on 14-Sep-2022. Past adverse reactions to the above products included No adverse event with FLUZONE HIGH DOSE QUADRIVALENT, FLUZONE HIGH DOSE QUADRIVALENT, FluZone HD Quad, INFLUENZA, INFLUENZA, INFLUENZA, PPSV23, PREVNAR 13, Prevnar 13, TDAP and TDAP. On 30-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022). The patient had received three doses of the Moderna vaccine: the first on 16-Jan-2021, second on 13-Feb-2021, third on 10-Nov-2021, all of which were 100 mcg. The patient had received a Moderna Bivalent booster when she was 73 years and 5 months old. The size of the vial was 2.5ml. The vial was initially stored in refrigerator on 29-Sep-2022. The vial did not undergo any temperature excursions. It was reported that patients had no reported symptoms, no additional doses, medications, or treatments. On 30-Oct-2022, 10 (ten) Moderna Bivalent vaccines were administered to 10 patients. The by-use-date on the product was 29-Oct-2022. Lot 027E22A The error was discovered on 31-Oct-2022. It was unknown if patient had been diagnosed with or tested positive for COVID-19. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505144

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

No adverse event; Bivalent vaccine administered after the 30 day beyond use date; The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine administered after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 62-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Tdap (Dose 1, when patient was 52 yrs 1 month) on 24-Apr-2012, HEPATITIS A (Dose 1, when patient was 58 yrs 10 months) on 25-Jan-2019, Influenza IIV4 (Dose 1, P-Free-Inj, when patient was 60 yrs 5 months) on 02-Sep-2020, Sars-Cov-2 (Mod 100 mcg) on 21-Feb-2021, Sars-Cov-2 (Mod 100 mcg) on 21-Mar-2021, Sars-Cov-2 (Mod 100 mcg) on 27-Nov-2021, Sars-Cov-2 (Mod 100 mcg) on 16-Jul-2022, INFLUENZA VACCINE (Dose 2, P-Free-Inj and when patient was 62 yrs 5 months) on 04-Sep-2022. Past adverse reactions to the above products included No adverse event with HEPATITIS A, INFLUENZA VACCINE, Influenza IIV4, Sars-Cov-2, Sars-Cov-2, Sars-Cov-2, Sars-Cov-2 and Tdap. On 30-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. In 2022, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022). On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine administered after the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine administered after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine administered after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022 and administered on 30-Oct-2022). No concomitant product was reported. Patient had due vaccinations namely Td, MMR, Hepatitis A, Zoster RZV (Shingrix) and Hepatitis B was next due on 01-Apr-2022. Patient received Moderna vaccine first dose on 21-Feb-2021, 100 mcg; second dose on 21-Mar-2021, 100 mcg; third dose on 27-Nov-2021, 100 mcg and fourth dose on 16-Jul-2022, 100 mcg. It was reported that patient was administered with bivalent vaccine dose after the 30 day beyond use date. Dose was administered on 30-Oct-2022 from lot number 027E22A, expiration date on vial was 18-May-2023. It was an individual vial within broken carton with vial size of 2.5 ml. The vaccine was initially moved from the freezer to the refrigerator on 29-Sep-2022. Patient was administered with expired vaccine and the error was discovered on 31-Oct-2022. Moderna was contacted for further analysis where it was analyzed that the vaccine maintained the activity necessary to protect against the virus at the time of administration. No reported symptoms. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-666556 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666556:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505086

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 66,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022; No Adverse Event; 10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No Adverse Event) in a 66-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Influenza (IIV 4, (Inject), 62 years 10 months) on 15-Oct-2018, Prevnar 13 (63 years 10 months) on 03-Oct-2019, Influenza (IIV 4, (P- Free Inject), 63 years 10 months) on 03-Oct-2019, DTaP on 15-Oct-2020, Influenza (IIV 4, (P- Free Inject), 64 years 10 months) on 15-Oct-2020, PFIZER BIONTECH COVID-19 VACCINE (65 years 3 months) on 02-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE (65 years 3 months) on 24-Mar-2021, Fluad Quad (all V 4, (P- Free Inject), 65 years 10 months) on 29-Sep-2021 and PFIZER BIONTECH COVID-19 VACCINE (65 years 10 months) on 29-Sep-2021. Past adverse reactions to the above products included No adverse effect with DTaP, Fluad Quad, Influenza, Influenza, Influenza, PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and Prevnar 13. Concomitant products included INFLUENZA VACCINE INACT SAG 4V (FLUAD QUAD) for an unknown indication. On 30-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 30-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date), PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (10 doses of the bivalent vaccine were administered to patients after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vaccine was initially moved from the freezer to the refrigerator on 29SEP2022 and administered on 30-Oct-2022). The size of the vial was 2.5ml. The vial was initially stored in refrigerator on 29-Sep-2022. The vial did not undergo any temperature excursions. It was reported that patients had no reported symptoms, no additional doses, medications, or treatments. On 30-Oct-2022, the patient received Moderna bivalent vaccine. The by-use-date on the product was 29Oct2022. LOT 027E22A The error was discovered on 31Oct2022. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2022: Follow up received included report type, dose details, patient information, other relevant history, concomitant medications and narrative was updated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: FLUAD QUAD
Allergien: -
Vorherige Impfungen: -

VAERS 2497240

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: CA
Alter: 58,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 08.10.2022
Beginn: 10.10.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthritis reactive Blood test Inflammatory marker test Red blood cell sedimentation rate SARS-CoV-2 test

Symptomtext

patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts; This spontaneous case was reported by a patient and describes the occurrence of ARTHRITIS REACTIVE (patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts) in a 58-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Allergies with medications, food and other products. No Medical history related to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. On 08-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Oct-2022, the patient experienced ARTHRITIS REACTIVE (patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts) (seriousness criterion medically significant). At the time of the report, ARTHRITIS REACTIVE (patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: blood work done, sedimentation rate, everything was normal.. On an unknown date, Inflammatory marker test: normal. On an unknown date, Red blood cell sedimentation rate: normal. On an unknown date, SARS-CoV-2 test: Negative. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Patient received first dose of Moderna vaccine on 30Dec2020, Lot number: 011G20A Patient received Second dose of Moderna vaccine on 27Jan2021, Lot number: 025L20A Patient received Third dose of Moderna vaccine on 01Nov2021, Lot number: 032F2IA Events immunisation reaction, burning sensation, mobility decreased, neck pain were subsumed under the event Arthritis reactive. On 09 Oct 2022, patient felt a bit stiffed however per patient this was normal. Patient's shoulders, neck, back hip and hands hurt. The low back burns, both of his hips burn. It had been a month and it did not go away. There was nothing patient can do. Patient gets up from a chair and it was like he was 90 years old. Doctors did not know what to do. It can get worse/better/worse on the same day. The patient did not experience a similar event in the past. They improved but sometimes they can get worse again, patient could not understand. No treatment drug were reported. Company Comment: This spontaneous case concerns a male patient aged 58 years with no medical history reported, who experienced the unexpected serious (Medically significant) AESI event of Arthritis reactive about two days after 4th dose of mRNA-1273 Bivalent BA.4/BA.5 vaccination in covid-19 vaccination series. Patient had a scary reaction on day two and reactive arthritis. About 10 days later he had burning sensation in low back, both hips. He could not cough, sneeze or swim as it would hurt. He also had neck pain. He sought medical care, symptoms would improve and worsen again. Inflammatory markers, Red blood cell sedimentation rate, other blood tests done on unknown dates were normal. SARS-CoV-2 test done was negative. No further information on risk factors, detailed clinical course, other investigations, treatment of the event was available in the report. Outcome of the event was not resolved at the time of report. Patient had received initial three doses of mRNA-1273, the last dose about 11 months prior to current vaccination. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a male patient aged 58 years with no medical history reported, who experienced the unexpected serious (Medically significant) AESI event of Arthritis reactive about two days after 4th dose of mRNA-1273 Bivalent BA.4/BA.5 vaccination in covid-19 vaccination series. Patient had a scary reaction on day two and reactive arthritis. About 10 days later he had burning sensation in low back, both hips. He could not cough, sneeze or swim as it would hurt. He also had neck pain. He sought medical care, symptoms would improve and worsen again. Inflammatory markers, Red blood cell sedimentation rate, other blood tests done on unknown dates were normal. SARS-CoV-2 test done was negative. No further information on risk factors, detailed clinical course, other investigations, treatment of the event was available in the report. Outcome of the event was not resolved at the time of report. Patient had received initial three doses of mRNA-1273, the last dose about 11 months prior to current vaccination. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 Vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthritis reactive
Hospital-Tage: -
Labordaten: Test Name: blood test; Result Unstructured Data: blood work done, sedimentation rate, everything was normal.; Test Name: Inflammatory marks; Result Unstructured Data: normal; Test Name: Sedimentation rate; Result Unstructured Data: normal; Test Name: COVID-19 test; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: No Allergies with medications, food and other products. No Medical history related to mentioned AE and both Acute and Chronic illnesses at the time of vaccination.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2497240

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CA
Alter: 58,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 08.10.2022
Beginn: 10.10.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthritis reactive Blood test Inflammatory marker test Red blood cell sedimentation rate SARS-CoV-2 test

Symptomtext

patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts; This spontaneous case was reported by a patient and describes the occurrence of ARTHRITIS REACTIVE (patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts) in a 58-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Allergies with medications, food and other products. No Medical history related to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. On 08-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Oct-2022, the patient experienced ARTHRITIS REACTIVE (patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts) (seriousness criterion medically significant). At the time of the report, ARTHRITIS REACTIVE (patient experiencing reactive arthritis since day 2/ The second day he had a "scary reaction", it got so bad/ low back burns,both hips burn/ cannot swim/ neck hurts) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: blood work done, sedimentation rate, everything was normal.. On an unknown date, Inflammatory marker test: normal. On an unknown date, Red blood cell sedimentation rate: normal. On an unknown date, SARS-CoV-2 test: Negative. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Patient received first dose of Moderna vaccine on 30Dec2020, Lot number: 011G20A Patient received Second dose of Moderna vaccine on 27Jan2021, Lot number: 025L20A Patient received Third dose of Moderna vaccine on 01Nov2021, Lot number: 032F2IA Events immunisation reaction, burning sensation, mobility decreased, neck pain were subsumed under the event Arthritis reactive. On 09 Oct 2022, patient felt a bit stiffed however per patient this was normal. Patient's shoulders, neck, back hip and hands hurt. The low back burns, both of his hips burn. It had been a month and it did not go away. There was nothing patient can do. Patient gets up from a chair and it was like he was 90 years old. Doctors did not know what to do. It can get worse/better/worse on the same day. The patient did not experience a similar event in the past. They improved but sometimes they can get worse again, patient could not understand. No treatment drug were reported. Company Comment: This spontaneous case concerns a male patient aged 58 years with no medical history reported, who experienced the unexpected serious (Medically significant) AESI event of Arthritis reactive about two days after 4th dose of mRNA-1273 Bivalent BA.4/BA.5 vaccination in covid-19 vaccination series. Patient had a scary reaction on day two and reactive arthritis. About 10 days later he had burning sensation in low back, both hips. He could not cough, sneeze or swim as it would hurt. He also had neck pain. He sought medical care, symptoms would improve and worsen again. Inflammatory markers, Red blood cell sedimentation rate, other blood tests done on unknown dates were normal. SARS-CoV-2 test done was negative. No further information on risk factors, detailed clinical course, other investigations, treatment of the event was available in the report. Outcome of the event was not resolved at the time of report. Patient had received initial three doses of mRNA-1273, the last dose about 11 months prior to current vaccination. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a male patient aged 58 years with no medical history reported, who experienced the unexpected serious (Medically significant) AESI event of Arthritis reactive about two days after 4th dose of mRNA-1273 Bivalent BA.4/BA.5 vaccination in covid-19 vaccination series. Patient had a scary reaction on day two and reactive arthritis. About 10 days later he had burning sensation in low back, both hips. He could not cough, sneeze or swim as it would hurt. He also had neck pain. He sought medical care, symptoms would improve and worsen again. Inflammatory markers, Red blood cell sedimentation rate, other blood tests done on unknown dates were normal. SARS-CoV-2 test done was negative. No further information on risk factors, detailed clinical course, other investigations, treatment of the event was available in the report. Outcome of the event was not resolved at the time of report. Patient had received initial three doses of mRNA-1273, the last dose about 11 months prior to current vaccination. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 Vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthritis reactive
Hospital-Tage: -
Labordaten: Test Name: blood test; Result Unstructured Data: blood work done, sedimentation rate, everything was normal.; Test Name: Inflammatory marks; Result Unstructured Data: normal; Test Name: Sedimentation rate; Result Unstructured Data: normal; Test Name: COVID-19 test; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: No Allergies with medications, food and other products. No Medical history related to mentioned AE and both Acute and Chronic illnesses at the time of vaccination.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2500592

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MN
Alter: 59,0
Geschlecht: F
Eingang: 07.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Wrong product administered

Symptomtext

Pt received primary Moderna doses on 2/3/21 & 3/3/21. Pt received monovalent booster on 2/4/22. Pt received bivalent booster on 10/27/22. Pt is immunocompromised due to chronic steroid use and should have received a 3rd primary dose instead of booster doses. Spoke with the patient after 10/27/22 booster dose and advised she should have received a 3rd primary dose due to her immunosuppression. Patient stated she only wanted the booster dose and refused to return to clinic for a 3rd primary series dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Rheumatoid arthritis. Immunosuppression due to chronic steroid use.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2499357

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: OH
Alter: 74,0
Geschlecht: M
Eingang: 04.11.2022
Impfdatum: 06.10.2022
Beginn: 17.10.2022
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Dry throat Nasopharyngitis SARS-CoV-2 test negative

Symptomtext

Around Oct 17, 2 weeks later after the vaccine, started with dry throat, cold, cough, symptoms were gone by the 26, but I still have the cough, the nurse said it was not unusually to have the cold for several weeks. I am taking cough pills and it's helping. I had a home COVID-19 test and it was negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: 20OCT2022 COVID-19 test negative; 22OCT2022 COVID-19 test negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: ZYRTEC; vitamin D; COLACE; probiotic; SAM-E
Allergien: N/A
Vorherige Impfungen: -

VAERS 2498681

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027e22a

gering

Staat: NE
Alter: 78,0
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 27.10.2022
Beginn: 31.10.2022
Tage bis Beginn: 4,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Influenza virus test Oxygen saturation SARS-CoV-2 test

Symptomtext

tested positive for COVID; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (tested positive for COVID) in a 78-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027e22a) for COVID-19 vaccination. The patient never had COVID positive test or diagnosis in the past before. The patient had no history relating to mentioned adverse event and both Acute and Chronic illnesses at the time of vaccination. Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE on 24-Aug-2022; for Hormone replacement therapy: femhrt. Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE; and TIA with femhrt. Concurrent medical conditions included Arthritis (patient experienced achy joints in the past.), Spinal disorder NOS and Drug allergy (to some medications not true allergies but side effects). On 27-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 31-Oct-2022, the patient experienced COVID-19 (tested positive for COVID). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for COVID) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2022, Oxygen saturation: 93 % and 91 %. On 31-Oct-2022, Influenza virus test: Negative. On 31-Oct-2022, SARS-CoV-2 test: Positive. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant information provided Patient received 1st dose on 14Jan2021 with lot 041l20a Patient received 2nd dose 11Feb2021 with lot 024m20a Patient received1st booster 25Oct2021 with lot 0760217 Patient received 2nd booster 20April2022 with lot 005m214 It was reported that following vaccination within 18 hours of vaccination patient started to experience: was very sick, clearing her throat briefly, headache, cough, joints aching, fatigue and weakness. The patient sought medical care to get testing done. Patient tested for COVID on 31-Oct-2022 and on 01-Nov-2022 she was told she was positive. This case was linked to MOD-2022-667354, MOD-2022-667365 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221031; Test Name: tested for influenza; Test Result: Negative ; Test Date: 202210; Test Name: oxygen level; Test Result: 93 %; Test Date: 202210; Test Name: oxygen level; Test Result: 91 %; Test Date: 20221031; Test Name: tested for COVID; Test Result: Positive
Aktuelle Erkrankungen: Arthritis (patient experienced achy joints in the past.); Drug allergy (to some medications not true allergies but side effects); Spinal disorder NOS
Vorgeschichte: Comments: The patient never had COVID positive test or diagnosis in the past before. The patient had no history relating to mentioned adverse event and both Acute and Chronic illnesses at the time of vaccination.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2497622

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 57,0
Geschlecht: M
Eingang: 03.11.2022
Impfdatum: 07.10.2022
Beginn: 03.11.2022
Tage bis Beginn: 27,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough case dose 1 Moderna 5/12/21 023C21A dose 2 Moderna 6/9/21 050C21A dose 3 Moderna 11/26/21 039F21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ 11/2/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2497305

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: KY
Alter: 27,0
Geschlecht: F
Eingang: 03.11.2022
Impfdatum: 31.10.2022
Beginn: 31.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was initially stored in refrigerator on 29-Sep-2022 and was administered on 31-Oct-2022; No adverse event; Dose administered after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 29-Sep-2022 and was administered on 31-Oct-2022) and NO ADVERSE EVENT (No adverse event) in a 27-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. Patient had no medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. It was unknown if patient ever tested positive or diagnosed with COVID-19. Previously administered products included for Product used for unknown indication: FLU [INFLUENZA VACCINE] on 11-Oct-2022. Past adverse reactions to the above products included No adverse event with FLU [INFLUENZA VACCINE]. Concurrent medical conditions included Penicillin allergy. On 31-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 31-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 29-Sep-2022 and was administered on 31-Oct-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 29-Sep-2022 and was administered on 31-Oct-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 29-Sep-2022 and was administered on 31-Oct-2022). Concomitant drugs were not reported. Patient received Dose 1 of Moderna on 06-Jan-2021 lot number 012L20A. Patient received Dose 2 of Moderna on 03-Feb-2021 lot number 010M20A. Patient received Dose 3 of Moderna on 16-Nov-2021 lot number 077C21B. The 2.5 ml individual vial was initially stored in refrigerator on 29-Sep-2022 and did not undergo any temperature excursion. Treatment medications were not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Penicillin allergy
Vorgeschichte: Comments: Patient had no medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. It was unknown if patient ever tested positive or diagnosed with COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2497121

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: PA
Alter: -
Geschlecht: M
Eingang: 03.11.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Needle issue No adverse event Underdose

Symptomtext

vaccine squirted out; Caller believes it was faulty needle; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (vaccine squirted out), NEEDLE ISSUE (Caller believes it was faulty needle) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (vaccine squirted out), NEEDLE ISSUE (Caller believes it was faulty needle) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (vaccine squirted out), NEEDLE ISSUE (Caller believes it was faulty needle) and NO ADVERSE EVENT (No adverse event) outcome was unknown. No Concomitant medications were provided. It was reported that patient received Moderna Covid Bivalent booster the new one and when they entered the needle into the patients arm the vaccine squirted out. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Needle issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2495750

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: HI
Alter: 9,0
Geschlecht: M
Eingang: 02.11.2022
Impfdatum: 30.10.2022
Beginn: 30.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered Needle issue Syringe issue

Symptomtext

While administering vaccination, the needle popped off of the syringe barrel (wasn't screwed on tight) and the vaccine shot out of the barrel. It is unknown the dose the patient actually received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2495386

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

gering

Staat: CO
Alter: 23,0
Geschlecht: M
Eingang: 01.11.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

The wrong vaccine was given in the series. He was given the Moderna bivalent dose as a primary 1st dose. Per CDC that dose is void and to re-dose with the original Moderna. He has not experienced any side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2494047

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CA
Alter: 72,0
Geschlecht: F
Eingang: 31.10.2022
Impfdatum: 31.10.2022
Beginn: 31.10.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration Incorrect product formulation administered Product administration error

Symptomtext

Administration Error. Patient had her first Monovalent Moderna dose on 7/14/22, and never had 2nd dose completed. Today (10/31/22) bivalent Moderna dose was given in error as her 2nd dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2492095

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: KY
Alter: 48,0
Geschlecht: M
Eingang: 28.10.2022
Impfdatum: 25.10.2022
Beginn: 25.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

No adverse event; Given bivalent booster dose as 1st dose of primary series; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Given bivalent booster dose as 1st dose of primary series) and NO ADVERSE EVENT (No adverse event) in a 48-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 vaccination. No Medical History information was reported. On 25-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 25-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Given bivalent booster dose as 1st dose of primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Given bivalent booster dose as 1st dose of primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Given bivalent booster dose as 1st dose of primary series). The concomitant medication was not reported by reporter. Nurse reported that in one of their clinics, another nurse inadvertently gave the bivalent booster dose as a 1st does in the primary series today, 25-Oct-2022. This was given at 0.5 ml intramuscularly. The treatment medication was not reported by reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2488607

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: KY
Alter: 48,0
Geschlecht: M
Eingang: 25.10.2022
Impfdatum: 25.10.2022
Beginn: 25.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered Wrong product administered

Symptomtext

Patient came in for a Covid vaccine and stated to the CMA administering the vaccine "I have never had any covid vaccines before.' The vaccine administered was Moderna Bi-valent as his first dose as primary vaccine. The CMA reported that patient had told her this and I explained that the wrong vaccine had been given and she stated "I thought this was the only Moderna vaccine we were giving now." I immediately contacted out vaccine coordinator to find out what action we needed to take. She explained to me that he needed a Moderna monovalent dose immediately. I called the patient and explained to him what had happened and advised him to come in ASAP for this monovalent dose because the wrong vaccine was given, I explained to him that he received a booster dose instead of a primary dose and that it should not hurt him it just would not be effective for him. none

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: No medications
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 2486844

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: NJ
Alter: 55,0
Geschlecht: F
Eingang: 24.10.2022
Impfdatum: 13.10.2022
Beginn: 17.10.2022
Tage bis Beginn: 4,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

COVID-19/ tested positive for covid/Coughing/ can't breathe/has the usual symptoms of COVID; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (COVID-19/ tested positive for covid/Coughing/ can't breathe/has the usual symptoms of COVID) in a 55-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. The patient's past medical history included Adenocarcinoma (Lobectomy for Adenocarcinoma and patient tries to be very careful) in 2017 and Hearing loss. Previously administered products included for COVID-19 vaccination: Moderna COVID-19 vaccine (Within few weeks after the first shot of moderna vaccine patient had some hearing loss.). Past adverse reactions to the above products included Hearing loss with Moderna COVID-19 vaccine. On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Oct-2022, the patient experienced COVID-19 (COVID-19/ tested positive for covid/Coughing/ can't breathe/has the usual symptoms of COVID) (seriousness criterion medically significant). At the time of the report, COVID-19 (COVID-19/ tested positive for covid/Coughing/ can't breathe/has the usual symptoms of COVID) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Oct-2022, SARS-CoV-2 test: (Positive) Positive. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown Route), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient clarified that it was tested positive for COVID on 17-Oct-2022 after the bivalent vaccine and previously tested for 2 days but it was shown as negative, and patient thought that those tests were performed wrongly. Patient reported that all the previous COVID vaccines were with Moderna only. It was reported that there is no idea about how the patient got COVID infection, the patient doesn't go out and wears a mask everywhere even on the sub way. The patient is in the street wearing a mask. The patient went out with another couple but they're fine. Patient has the usual symptoms of COVID that is just can't breathe, and coughing. Patient has not yet started the Paxlovid and about to take it. Patient had querying about the vaccine and interfering with efficacy. No treatment medications were reported. Company comment: This spontaneous case concerns a 55-year-old, female patient with medical history of adenocarcinoma, (reported as lobectomy for adenocarcinoma), who experienced the unexpected, serious (medically significant) event of COVID-19. The event occurred approximately four days after receiving the mRNA-1273.222 vaccine. The patient was tested positive for COVID -19 four days after the vaccination and was previously tested for 2 days, but the test was negative. Symptoms included coughing, loss of breath ("can't breathe") and it was also reported that the patient had the "usual symptoms of COVID". The patient's past COVID-19 vaccination included mRNA-1273 ("within few weeks after the first shot of mRNA-1273, the patient "had some hearing loss"). No further details were provided. The outcome of the event was unknown at the time of the report. Medical history of adenocarcinoma (lobectomy for adenocarcinoma) remains as confounder for the event. The benefit-risk relationship of the mRNA-1273 original vaccine is not affected by this report. This case was linked to MOD-2022-660865 (Patient Link).; Sender's Comments: This spontaneous case concerns a 55-year-old, female patient with medical history of adenocarcinoma, (reported as lobectomy for adenocarcinoma), who experienced the unexpected, serious (medically significant) event of COVID-19. The event occurred approximately four days after receiving the mRNA-1273.222 vaccine. The patient was tested positive for COVID -19 four days after the vaccination and was previously tested for 2 days, but the test was negative. Symptoms included coughing, loss of breath ("can't breathe") and it was also reported that the patient had the "usual symptoms of COVID". The patient's past COVID-19 vaccination included mRNA-1273 ("within few weeks after the first shot of mRNA-1273, the patient "had some hearing loss"). No further details were provided. The outcome of the event was unknown at the time of the report. Medical history of adenocarcinoma (lobectomy for adenocarcinoma) remains as confounder for the event. The benefit-risk relationship of the mRNA-1273 original vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221017; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Adenocarcinoma (Lobectomy for Adenocarcinoma and patient tries to be very careful); Hearing loss
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2486334

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MA
Alter: 75,0
Geschlecht: M
Eingang: 22.10.2022
Impfdatum: 06.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Blood test normal Chest X-ray normal Computerised tomogram head normal Magnetic resonance imaging head normal SARS-CoV-2 test negative Scan with contrast normal Vertigo Vestibular neuronitis

Symptomtext

10 days following my vaccine injection I experienced severe vertigo requiring ambulance to hospital and 2 days in hospital treatment. Diagnosis was Vestibular neuritis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test normal
Hospital-Tage: 2,0
Labordaten: Full blood work, CT scan of head both with and without dye and a MRI of head all with no apparent defects. Chest exray and covid test both neg.
Aktuelle Erkrankungen: None
Vorgeschichte: Elevated blood pressure
Andere Medikamente: Lisinopril 20 mg Amlodipine 2.5 mg Atorvastatin 10 mg
Allergien: None
Vorherige Impfungen: -

VAERS 2486319

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: OH
Alter: 14,0
Geschlecht: U
Eingang: 22.10.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

We held a vaccine clinic for the school dsitrict that was specfic for bivalent boosters, no primary series were advertised. We were told some of the teachers may bring their children so we set up two tables of vaccinators, one would handle 18 and over the other would take any below 18 years of age. We had two people checking forms and directing to the correct table. Somehow this 14 year old was directed to the adult table and the MOderna bivalent vaccine for 18 and over was administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: None yet
Aktuelle Erkrankungen: None apparent or described
Vorgeschichte: None
Andere Medikamente: Unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2486314

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: OH
Alter: 14,0
Geschlecht: F
Eingang: 22.10.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

We held a bivalent booster clinic for teachers of the local district. We wer told a few might bring their children. We set up two tables one for 18 and over and teh other would handle those under 18. We had two people checking forms to help direct to the correct table. Somehow two (2) 14 year olds made it to the adult table and recieved Moderna Bivalent booster which is desginated for 18 and over.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: None so far
Aktuelle Erkrankungen: None apparent or described
Vorgeschichte: None
Andere Medikamente: Unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2485210

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 21,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 21.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered No adverse event

Symptomtext

Patient received the Moderna Bivalent booster vaccine. She did not have the primary series yet. Patient was monitored and tolerated the injection well with no complaints or complications.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism, tachycardia, palpitations, anxiety, depression
Andere Medikamente: Lexapro, Synthroid, Singulair, Seroquel, Zyrtec
Allergien: Penicillin, Seafood, Prozac, Wellbutrin
Vorherige Impfungen: -

VAERS 2484282

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22A

gering

Staat: CA
Alter: 45,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 19.10.2022
Beginn: 19.10.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

none , pt. was scheduled to received her 2nd dose (primary series) of covid Moderna Vaccine instead pt received a bivalent Covid Moderna

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: Gastritis
Andere Medikamente: none
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2483486

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: PA
Alter: 76,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 19.10.2022
Beginn: 19.10.2022
Tage bis Beginn: 0,0
Dosis: 6
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Inappropriate schedule of product administration

Symptomtext

PATIENT PREVIOUSLY RECEIVED PFIZER COVID-19 BIVALENT VACCINE ON 9/14/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: NONE KNOWN
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: NKA
Vorherige Impfungen: -

VAERS 2483088

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: WA
Alter: 34,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 14.10.2022
Beginn: 18.10.2022
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Menstruation irregular

Symptomtext

Period became irregular. Got period again 2 weeks after previous menstrual cycle.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Menstruation irregular
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2479523

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: DC
Alter: 5,0
Geschlecht: F
Eingang: 15.10.2022
Impfdatum: 15.10.2022
Beginn: 15.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

There was no adverse reaction. Reporting medication error. Moderna bivalent booster was given to a 5 yr 10 month old.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: None
Vorherige Impfungen: -

VAERS 2478439

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

gering

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 14.10.2022
Impfdatum: 11.10.2022
Beginn: 13.10.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site erythema

Symptomtext

The area surrounding the vaccine site (3 inch diameter circle) was red. It was not warm or anything else. She stated she woke up with this on 10/13/22 and it was still there when she came into the pharmacy today (10/14/22)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2478414

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MN
Alter: 73,0
Geschlecht: M
Eingang: 14.10.2022
Impfdatum: 13.10.2022
Beginn: 13.10.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

None at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2478011

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MI
Alter: 52,0
Geschlecht: F
Eingang: 14.10.2022
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; patient received 0.25 ml of Moderna bivalent vaccine instead of 0.5 ml; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (patient received 0.25 ml of Moderna bivalent vaccine instead of 0.5 ml) and NO ADVERSE EVENT (No adverse event) in a 52-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 01-Oct-2022, the patient experienced UNDERDOSE (patient received 0.25 ml of Moderna bivalent vaccine instead of 0.5 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patient received 0.25 ml of Moderna bivalent vaccine instead of 0.5 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient received 0.25 ml of Moderna bivalent vaccine instead of 0.5 ml). No concomitant drug was reported. No treatment drug was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2477349

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MN
Alter: 43,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 13.10.2022
Beginn: 13.10.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Syringe issue

Symptomtext

Vaccine syringe leaked over half dose lost. Discussed with charge nurse and patient. Vaccine repeated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2477279

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027e22a

gering

Staat: MI
Alter: 86,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 13.10.2022
Beginn: 13.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Incorrect vaccine was administered - patient received monovalent vaccine rather than bivalent

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2477271

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

gering

Staat: MI
Alter: 64,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 13.10.2022
Beginn: 13.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Incorrect vaccine was administered - patient received monovalent vaccine rather than bivalent

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2477147

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 52,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

received 2.5 ml instead of .5 ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2477138

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 54,0
Geschlecht: M
Eingang: 13.10.2022
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

received 2.5 ml instead of .5 ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475020

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: MA
Alter: 32,0
Geschlecht: M
Eingang: 12.10.2022
Impfdatum: 09.10.2022
Beginn: 09.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; administered a dose of the Moderna COVID-19 bivalent vaccine from a vial that had been punctured for more than 12 hours; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna COVID-19 bivalent vaccine from a vial that had been punctured for more than 12 hours) and NO ADVERSE EVENT (no adverse event) in a 32-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Oct-2022 at 9:30 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna COVID-19 bivalent vaccine from a vial that had been punctured for more than 12 hours). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna COVID-19 bivalent vaccine from a vial that had been punctured for more than 12 hours) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna COVID-19 bivalent vaccine from a vial that had been punctured for more than 12 hours). No concomitant medication information was provided. The reporter reported that a patient was administered a dose of the Moderna COVID-19 bivalent vaccine from a vial that had been punctured for more than 12 hours. She would like to know the validity of this dose that was administered to this patient. The vial size was 2.5 mL. The vial was initially stored in the refrigerator on 08-Oct-2022. The vial was first punctured on 08-Oct-2022 at 2:30 P.M. The vial was stored in the fridge post its puncture. The vial did not undergo any temperature excursions. The vial was exposed to room temperature range for a period less than or equal to 24 hours. The patient had not reported any adverse reactions at that time. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475544

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 48,0
Geschlecht: U
Eingang: 11.10.2022
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered Underdose

Symptomtext

wrong dosage of 2.5ml instead of .5ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475405

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

dosage was incorrect, received 2.5 ml.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475240

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: OR
Alter: 33,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Syringe issue

Symptomtext

Error: Leaking from Syringe-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syringe issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475221

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CA
Alter: 87,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

Error: Wrong Vaccine/Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2473500

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: OR
Alter: 14,0
Geschlecht: M
Eingang: 10.10.2022
Impfdatum: 08.10.2022
Beginn: 08.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product administered to patient of inappropriate age

Symptomtext

The patient is 14 and received the Moderna Bivalent vaccine only authorized for those 18 and older.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2473124

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

gering

Staat: MA
Alter: 29,0
Geschlecht: F
Eingang: 10.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

Error: Wrong Vaccine/Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2472329

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027e22a

gering

Staat: DC
Alter: 14,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product administered to patient of inappropriate age

Symptomtext

Upon registration patient was approved as candidate for vaccination. Consent was identified with white sticker on paper as appropriate candidate for vaccination with consent of mother as guardian per protocol. Patient identified via 6 routes of medication. Pt noted to stay for 15 minutes post vaccination with no adverse or side effects noted upon exiting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: No adverse effects or side effects noted
Aktuelle Erkrankungen: n/a
Vorgeschichte: -
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2472035

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: NY
Alter: 65,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered Inappropriate schedule of product administration Nervousness

Symptomtext

patient came to the pharmacy and completed the intake form for the Moderna Bivalent COVID19 vaccine. The pharmacist administered the Moderna Bivalent COVID19 vaccine. The patient then informed the pharmacist that she had received the Moderna Bivalent COVID19 vaccine the week prior and she had come in today for the flu shot. The patient felt nervous but was assured that she may have amplified side effects which can be managed with Tylenol, hydration and rest. The patient called the pharmacy about 20-30 minutes later and informed the pharmacist that she checked with an infectious disease doctor and was assured the same thing. She felt fine at this point.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: N/A
Allergien: NONE KNOWN
Vorherige Impfungen: -

VAERS 2471780

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: -
Alter: 81,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 03.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Peripheral swelling

Symptomtext

Patient came in 4 days after the vaccine and said that her arm swelled up quite a bit. She is doing better now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Peripheral swelling
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2471337

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 027E22A

gering

Staat: CO
Alter: 48,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

No adverse event; bivalent booster inadvertently administered instead of 1st dose of primary; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (bivalent booster inadvertently administered instead of 1st dose of primary) and NO ADVERSE EVENT (No adverse event) in a 48-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 027E22A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Oct-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 05-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (bivalent booster inadvertently administered instead of 1st dose of primary). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (bivalent booster inadvertently administered instead of 1st dose of primary) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (bivalent booster inadvertently administered instead of 1st dose of primary). No concomitant medication was reported. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2471495

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CA
Alter: 37,0
Geschlecht: M
Eingang: 06.10.2022
Impfdatum: 05.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoacusis Tinnitus

Symptomtext

Muffled hearing , increased sensitivity, louder tinnitus in left ear.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoacusis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: High Blood Pressure FSGS
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2471460

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: CA
Alter: 40,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Device dislocation Incorrect dose administered Syringe issue

Symptomtext

Patient was receiving Moderna Bivalent Booster vax. While getting the vaccine, the needle dislodged from syringe. Shot giver inserted the needle into pt's arm. At the time of pushing the plunger, shot giver and pt felt being splashed by the vaccine. The needle was on pt's arm and syringe was empty on shot giver's hand. Shot giver removed needle from pt's arm. Shot giver and pt are not sure on how much vaccine was injected. Patient described as she heard a pop when it happened and then felt the splash on her face and dripping on her arm. Pt. stayed at observation for 15 minutes, she was feeling fine before leaving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Device dislocation
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2470845

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: NC
Alter: 44,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 06.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered No adverse event

Symptomtext

No adverse event, but patient received Moderna Bivalent as second dose instead of Pfizer second dose. Patient requested a booster, but should have been second dose

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2470653

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: MI
Alter: 31,0
Geschlecht: M
Eingang: 06.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered No adverse event Wrong product administered

Symptomtext

Vaccine administration error: Patient was in to receive a Flu vaccine and the Moderna Bivalent booster. During the administration process the technician who was administering the vaccines gave the patient two doses of the Moderna bivalent. No adverse events occurred. After the error was identified the patient was contacted and returned to the pharmacy. I counselled the patient on what to look out for and I then administered the correct flu vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: N/a
Vorgeschichte: N/a
Andere Medikamente: N/a
Allergien: N/a
Vorherige Impfungen: -

VAERS 2469711

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: NY
Alter: 28,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Underdose

Symptomtext

On 09/30/22 at approximately 3:30pm the provider ordered 0.25 ml Moderna Bivalent Vaccine to be administered instead of 0.5 ml. The nurse carried out the order as ordered and administered 0.25 ml to the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Type 1 Diabetes
Vorgeschichte: Type 1 Diabetes
Andere Medikamente: Insulin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2468635

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 027E22A

gering

Staat: OH
Alter: 23,0
Geschlecht: F
Eingang: 04.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Erythema Hyperhidrosis Posture abnormal

Symptomtext

Patient received covid booster and instructed to stay near the pharmacy for approximately 15 minutes. Patient acknowledged and then stood up and ambulated out of vaccination area with parent. This nurse was approached by parent stating "My daughter is having a reactions and she is on the floor". This nurse found patient crouched down on the floor on her bilateral knees. Patient noted to be Red, Diaphoretic, & Clammy. This nurse assisted patient to her feet and ambulated back to vaccination area with this nurse to be watched for 30 minutes. Upon entering vaccination area, patients BLE were elevated, fluids offered, and BP taken. BP 149/87 HR 94. Color improved drastically within 60 seconds. Patient was calm and alert throughout event. After 30 minutes BP 113/78 HR 87. Patient stated she felt 100% better. Patient and parent instructed to follow up with PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cold sweat
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: N/A
Allergien: NKA
Vorherige Impfungen: -